Duke University et al v. Sandoz Inc. > Documents

Date Field	Doc. No.	Description (Pages)
Oct 13, 2023	346	Notice of Appeal* (1)
Sep 21, 2023	345	ORDER denying 330 Motion for Judgment as a Matter of Law Under Rule 50 and 331 Motion for a New Trial Under Rule 59. SO ORDERED by Judge Raymond P. Moore on 9/21/2023.(jtorr, ) (Entered: 09/21/2023) (14)
Aug 17, 2023	344	ORDER granting 343 Sandoz's Unopposed Motion to Withdraw Duplicate Docket Entry 341. ECF No. 341 is deemed WITHDRAWN. SO ORDERED by Judge Raymond P. Moore on 8/17/2023. (Text Only Entry)(rmsec) (Entered: 08/17/2023) (0)
Aug 16, 2023	343	Unopposed MOTION to Withdraw Duplicate Docket Entry 341 by Defendant Sandoz Inc.. (Kappers, Robert) (Entered: 08/16/2023) (4)
Aug 15, 2023	340	REPLY to Response to 331 MOTION for New Trial Under Rule 59 filed by Defendant Sandoz Inc.. (Kappers, Robert) (Entered: 08/15/2023) (18)
Aug 15, 2023	341	WITHRAWN (DUPLICATIVE OF ECF NO. 342) REPLY to Response to 330 MOTION for Judgment as a Matter of Law Under Rule 50 filed by Defendant Sandoz Inc.. (Kappers, Robert) Modified on 8/17/2023 (rmsec). (Entered: 08/15/2023) (18)
Aug 15, 2023	342	REPLY to Response to 330 MOTION for Judgment as a Matter of Law Under Rule 50 filed by Defendant Sandoz Inc.. (Kappers, Robert) (Entered: 08/15/2023) (27)
Jul 25, 2023	338	RESPONSE to 331 MOTION for New Trial Under Rule 59 Plaintiffs Opposition To Sandozs Motion For A New Trial Under Rule 59 (D.I. 331) filed by Plaintiffs Allergan Sales, LLC, Duke University. (Rey, Jacob) (Entered: 07/25/2023) (25)
Jul 25, 2023	339	RESPONSE to 330 MOTION for Judgment as a Matter of Law Under Rule 50 Plaintiffs Opposition To Sandozs Renewed Motion For A Judgment As A Matter Of Law filed by Plaintiffs Allergan Sales, LLC, Duke University. (Rey, Jacob) (Entered: 07/25/2023) (30)
Jul 21, 2023	337	Costs Taxed by Clerk in the amount of $90,000.00 against Defendant Sandoz, Inc. and in favor of Plaintiffs. Costs awarded pursuant to the parties' Stipulation, Docket no. 336. Accordingly, the hearing set for July 27, 2023 is VACATED. (ashee) (Entered: 07/21/2023) (1)
Jul 19, 2023	336	STIPULATION re 325 Proposed Bill of Costs Stipulation Specifying Awardable Costs by Plaintiffs Allergan Sales, LLC, Duke University. (Rey, Jacob) (Entered: 07/19/2023) (3)
Jul 5, 2023	335	ORDER granting 334 Motion to Withdraw as Attorney. Attorney Chuan Cheng terminated. SO ORDERED by Judge Raymond P. Moore on 7/5/2023. (Text Only Entry)(rmsec) (Entered: 07/05/2023) (0)
Jun 30, 2023	334	MOTION to Withdraw as Attorney (Chuan "CiCi" Cheng) by Plaintiffs Allergan Sales, LLC, Duke University. (Cheng, Chuan) (Entered: 06/30/2023) (4)
Jun 27, 2023	332	Joint MOTION for Extension of Time to File Response/Reply as to 331 MOTION for New Trial Under Rule 59, 330 MOTION for Judgment as a Matter of Law Under Rule 50 , Joint MOTION for Leave to File Excess Pages by Defendant Sandoz Inc.. (Kappers, Robert) (Entered: 06/27/2023) (5)
Jun 27, 2023	333	ORDER granting 332 Joint Motion to Extend Certain Briefing Deadlines and for Additional Pages. SO ORDERED by Judge Raymond P. Moore on 6/27/2023. (Text Only Entry)(rmsec) (Entered: 06/27/2023) (0)
Jun 20, 2023	330	MOTION for Judgment as a Matter of Law Under Rule 50 by Defendant Sandoz Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5)(Kappers, Robert) (Entered: 06/20/2023) (0)
Jun 20, 2023	331	MOTION for New Trial Under Rule 59 by Defendant Sandoz Inc.. (Kappers, Robert) (Entered: 06/20/2023) (19)
Jun 16, 2023	329	ORDER granting 328 Defendant Sandoz Inc.s Unopposed Motion for Approval of Bond and Stay of Execution on the Judgment. The bond tendered by Sandoz and attached as Exhibit A to its Motion is APPROVED. Execution on the Final Judgment (including execution on damages, pre-judgment interest, post-judgment interest, and costs) is STAYED pending the final resolution of any post trial motions and/or appeal in this case. SO ORDERED by Judge Raymond P. Moore on 6/16/2023.(jtorr, ) (Entered: 06/16/2023) (2)
Jun 15, 2023	328	Unopposed MOTION for Bond Approval and Stay of Execution on the Judgment by Defendant Sandoz Inc.. (Attachments: # 1 Exhibit A-Executed Appeal Bond, # 2 Exhibit B-Proposed Order)(Kappers, Robert) (Entered: 06/15/2023) (0)
Jun 14, 2023	327	NOTICE by Clerk re 325 Proposed Bill of Costs. As set in the Proposed Bill, the hearing for this matter will be held on July 27, 2023 at 9:30 a.m. MST. The hearing will be held IN PERSON - the parties are directed to have counsel asserting the Proposed Bill of Costs and opposing counsel presenting objections be physically present for the hearing. The hearing will be held in Courtroom C401 (4th floor) of the Byron Rogers U.S. Courthouse, 1929 Stout Street, Denver [NOT the Arraj Courthouse]. Due to the page length of the Proposed Bill of Costs, the Clerk reminds Plaintiffs to deliver a binder containing a copy of the Bill of Costs to the Clerk's office no later than July 21, 2023. See p. 16 of the Guide. The Clerk reminds the parties that a Statement of Conferral must be filed no later than the close of business of the clerk's office at 5:00 p.m. (Mountain Time) the day before the hearing in order to confirm the attempts to reach a settlement on either some or all of the requested costs, per local rules LCivR 54.1 and 77.1, and to confirm the parties have utilized the Clerk's Guide to Bills of Cost Hearings (see attached) in their discussions. Failure to file a Statement of Conferral by the close of business the day before the hearing will result in the Bill of Costs being summarily denied and the hearing will be vacated. Finally, the Clerk strongly encourages the parties to reach an agreement as to individual costs items - or preferably - a global settlement, in light of the Rule One directive that the court and PARTIES work to secure the just, speedy, and inexpensive determination of every action and proceeding. (ashee) (Entered: 06/14/2023) (30)
Jun 9, 2023	326	ORDER granting 324 Joint Motion to Request Additional Pages and to Extend Certain Briefing Deadlines for Upcoming Rule 50(b) Briefing. SO ORDERED by Judge Raymond P. Moore on 6/9/2023. (Text Only Entry)(rmsec) (Entered: 06/09/2023) (0)
Jun 5, 2023	325	Proposed Bill of Costs by Plaintiffs Allergan Sales, LLC, Duke University. (Rey, Jacob) (Entered: 06/05/2023) (30)
May 31, 2023	324	Joint MOTION for Leave to File Excess Pages and to Extend Certain Briefing Deadlines for Upcoming Rule 50(b) Briefing by Defendant Sandoz Inc.. (Kappers, Robert) (Entered: 05/31/2023) (4)
May 22, 2023	322	ORDER DIRECTING THE CLERK OF THE COURT TO ENTER JUDGMENT by Judge Raymond P. Moore on 5/22/2023. (cpear) (Entered: 05/22/2023) (3)
May 22, 2023	323	FINAL JUDGMENT pursuant to 322 Order. Entered by the Clerk of the Court on 5/22/2023. (cpear) (Entered: 05/22/2023) (3)
May 19, 2023	321	NOTICE re 320 Minute Order,,, (JOINT SUBMISSION OF PROPOSED FINAL JUDGMENT) by Plaintiffs Allergan Sales, LLC, Duke University (Attachments: # 1 Exhibit A - Proposed Order, # 2 Exhibit B - Proposed Judgment After Verdict)(Rey, Jacob) (Entered: 05/19/2023) (0)
May 11, 2023	320	MINUTE ORDER: This matter is before the Court sua sponte and in light of Plaintiffs' Notice Regarding Division of the Damages Award Among Plaintiffs 316 . In that Notice, Plaintiffs informed the Court that they were preparing a proposed final judgment reflecting the proper division of the damages award, as well as the proportional shares of pre-judgment interest. Plaintiffs intended to file that document by May 1, 2023, along with a status report on Defendant's counterclaims. On May 1, 2023, however, Defendant filed a joint stipulation to dismiss the counterclaims 318 . No proposed final judgment has been filed to date. Therefore, the Court ORDERS Plaintiffs to file a proposed final judgment on or before May 31, 2023. SO ORDERED by Judge Raymond P. Moore on 5/11/2023. (Text Only Entry) (rmsec) (Entered: 05/11/2023) (0)
May 1, 2023	318	STIPULATION and Proposed Order of Dismissal of Sandoz's Counterclaims by Defendant Sandoz Inc.. (Kappers, Robert) (Entered: 05/01/2023) (4)
May 1, 2023	319	ORDER OF DISMISSAL OF COUNTERCLAIMS. The Court, having reviewed the 318 Stipulation and being fully advised, hereby GRANTS the parties' joint request for dismissal and ORDERS that Sandoz's Counterclaims I-VI are dismissed without prejudice pursuant to Fed. R. Civ. P. 41(a)(1)(A)(ii). By Judge Raymond P. Moore on 5/1/2023. (sdunb, ) (Entered: 05/01/2023) (2)
Apr 19, 2023	317	STIPULATION (Joint) on Deposition Clips Played During Trial by Defendant Sandoz Inc.. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2, # 3 Exhibit 3, # 4 Exhibit 4, # 5 Exhibit 5, # 6 Exhibit 6)(Wallace, Lillian) (Entered: 04/19/2023) (0)
Apr 10, 2023	316	NOTICE Regarding Division of the Damages Award Among Plaintiffs by Plaintiffs Allergan Sales, LLC, Duke University (Rey, Jacob) (Entered: 04/10/2023) (3)
Apr 3, 2023	315	AMENDED COURTROOM MINUTES for proceedings held before Judge Raymond P. Moore: Docket entry 305 Courtroom Minutes re: Jury Trial - Day 5 is amended only to include the Clerk's Note regarding exhibits and depositions as highlighted. Court Reporter: Tammy Hoffschildt. (cpear) (Entered: 04/03/2023) (3)
Mar 31, 2023	302	Proposed Verdict Form (Revised) by Plaintiffs Allergan Sales, LLC, Duke University. (Rey, Jacob) (Entered: 03/31/2023) (9)
Mar 31, 2023	304	Proposed Jury Instructions Regarding Teaching-Away by Defendant Sandoz Inc.. (Filarski, Thomas) (Entered: 03/31/2023) (2)
Mar 31, 2023	305	COURTROOM MINUTES for proceedings held before Judge Raymond P. Moore: Jury Trial - Day 5. Trial completed on 3/31/2023. Court Reporter: Tammy Hoffschildt. (cpear) (Entered: 03/31/2023) (3)
Mar 31, 2023	306	Plaintiffs' Exhibit List - Courtroom Deputy trial copy. (cpear) (Entered: 03/31/2023) (30)
Mar 31, 2023	307	Defendant's Exhibit List - Courtroom Deputy trial copy. (cpear) (Entered: 03/31/2023) (30)
Mar 31, 2023	308	Final Jury Instructions. (cpear) (Entered: 03/31/2023) (30)
Mar 31, 2023	309	Jury Note #1 - Unredacted - Level 3 - Viewable by Court Only. (cpear) (Entered: 03/31/2023) (0)
Mar 31, 2023	310	Jury Note #1. (cpear) (Entered: 03/31/2023) (1)
Mar 31, 2023	311	Jury Note #2- Unredacted - Level 3 - Viewable by Court Only. (cpear) (Entered: 03/31/2023) (0)
Mar 31, 2023	312	Jury Note #2. (cpear) (Entered: 03/31/2023) (1)
Mar 31, 2023	313	Jury Verdict - Unredacted - Level 3 - Viewable by Court Only. (cpear) (Entered: 03/31/2023) (0)
Mar 31, 2023	314	JURY VERDICT. (cpear) (Entered: 03/31/2023) (3)
Mar 30, 2023	303	COURTROOM MINUTES for proceedings held before Judge Raymond P. Moore: Jury Trial - Day 4 held on 3/30/2023. Court Reporter: Tammy Hoffschildt. (cpear) (Entered: 03/31/2023) (4)
Mar 29, 2023	301	COURTROOM MINUTES for proceedings held before Judge Raymond P. Moore: Jury Trial - Day 3 held on 3/29/2023. Trial continues. Court Reporter: Tammy Hoffschildt. (cpear) Modified on 3/30/2023 to correct text (cpear). (Entered: 03/30/2023) (3)
Mar 28, 2023	299	Exhibit List (Plaintiffs' Revised Exhibit List) by Plaintiffs Allergan Sales, LLC, Duke University. (Rey, Jacob) (Entered: 03/28/2023) (30)
Mar 28, 2023	300	COURTROOM MINUTES for proceedings held before Judge Raymond P. Moore: Jury Trial - Day 2 held on 3/28/2023. Trial continues. Court Reporter: Tammy Hoffschildt. (cpear) (Entered: 03/29/2023) (4)
Mar 27, 2023	295	OBJECTIONS to Evidence and Argument Subject to Issue Preclusion by Defendant Sandoz Inc.. (Kappers, Robert) (Entered: 03/27/2023) (3)
Mar 27, 2023	296	COURTROOM MINUTES for proceedings held before Judge Raymond P. Moore: Jury Trial - Day 1 held on 3/27/2023. Trial continues. Court Reporter: Tammy Hoffschildt. (cpear) (Entered: 03/28/2023) (4)
Mar 27, 2023	297	Jury List - Unredacted - Level 3 - Viewable by Court Only. (cpear) (Entered: 03/28/2023) (0)
Mar 27, 2023	298	Jury List. (cpear) (Entered: 03/28/2023) (1)
Mar 26, 2023	294	Exhibit List (Plaintiffs' Revised Exhibit List) by Plaintiffs Allergan Sales, LLC, Duke University. (Rey, Jacob) (Entered: 03/26/2023) (30)
Mar 24, 2023	292	NOTICE of Entry of Appearance by Lindsay H. Autz on behalf of Allergan Sales, LLC, Allergan, Inc., Duke University Attorney Lindsay H. Autz added to party Allergan Sales, LLC(pty:pla), Attorney Lindsay H. Autz added to party Allergan, Inc.(pty:cd), Attorney Lindsay H. Autz added to party Duke University (pty:pla) (Autz, Lindsay) (Entered: 03/24/2023) (3)
Mar 24, 2023	293	Witness List (Revised) by Defendant Sandoz Inc.. (Wallace, Lillian) (Entered: 03/24/2023) (3)
Mar 23, 2023	291	MINUTE ORDER: This matter comes before the Court on the deposition designation of Gregory Hartwig. The following objections are sustained: pp. 76-77, pp. 79-80, pp. 229-233. A ruling on the following objections is deferred and will be addressed with counsel before Mr. Hartwig's testimony is presented to the jury: pp. 67-71, pp. 118-119, pp. 226-227. All other objections are overruled. SO ORDERED by Judge Raymond P. Moore on 3/23/2023. (Text Only Entry) (rmsec) (Entered: 03/23/2023) (0)
Mar 22, 2023	288	MINUTE ORDER: This matter comes before the Court on the various deposition designations submitted by the parties. Other than with respect to Mr. Hartwig who will be addressed separately and later, the Court overrules the objections to the designations, except as set forth below. The following objections are sustained: Azzalina at 216; DeLong at 127-133, 135, 144; Fuqua at 33-34, 55; Herrick at 75; McIver at 64-65; Storm at 123-124, 169; and Hill at 35 (as to lines 23 and 24 only). SO ORDERED by Judge Raymond P. Moore on 3/22/2023. (Text Only Entry) (rmsec) (Entered: 03/22/2023) (0)
Mar 22, 2023	289	Exhibit List Plaintiffs' Revised Exhibit List by Plaintiffs Allergan Sales, LLC, Duke University. (Rey, Jacob) (Entered: 03/22/2023) (30)
Mar 22, 2023	290	Exhibit List (Revised) by Defendant Sandoz Inc.. (Wallace, Lillian) (Entered: 03/22/2023) (30)
Mar 20, 2023	282	NOTICE of Entry of Appearance by Gerard Justin Cedrone on behalf of Sandoz Inc.Attorney Gerard Justin Cedrone added to party Sandoz Inc.(pty:dft) (Cedrone, Gerard) (Entered: 03/20/2023) (2)
Mar 20, 2023	283	TRIAL BRIEF by Defendant Sandoz Inc.. (Kappers, Robert) (Entered: 03/20/2023) (13)
Mar 20, 2023	284	TRIAL BRIEF by Plaintiffs Allergan Sales, LLC, Duke University. (Rey, Jacob) (Entered: 03/20/2023) (9)
Mar 20, 2023	285	APPENDIX Joint Trial Glossary by Plaintiffs Allergan Sales, LLC, Duke University. (Rey, Jacob) (Entered: 03/20/2023) (7)
Mar 20, 2023	286	STIPULATION Regarding Scope of Claim by Defendant Sandoz Inc.. (Wallace, Lillian) (Entered: 03/20/2023) (3)
Mar 20, 2023	287	STIPULATION Regarding Facts by Defendant Sandoz Inc.. (Wallace, Lillian) (Entered: 03/20/2023) (7)
Mar 17, 2023	281	RESTRICTED DOCUMENT - Level 1: ORDER granting 221 Motion in Limine No. 4 to Limit the Damages Period as a Matter of Law and denying 224 Allergan's Motion in Limine #5 to Preclude Sandoz from Offering Evidence or Argument Regarding Non-Asserted Patents and Patent Claims. By Judge Raymond P. Moore on 3/17/2023. (sdunb, ) (Entered: 03/17/2023) (0)
Mar 16, 2023	278	Proposed Verdict Form (Revised, Joint Submission) by Plaintiffs Allergan Sales, LLC, Duke University. (Rey, Jacob) (Entered: 03/16/2023) (15)
Mar 16, 2023	279	Proposed Jury Instructions (Revised, Joint Submission) by Plaintiffs Allergan Sales, LLC, Duke University. (Rey, Jacob) (Entered: 03/16/2023) (30)
Mar 16, 2023	280	NOTICE of Entry of Appearance by William McGinley Jay on behalf of Sandoz Inc.Attorney William McGinley Jay added to party Sandoz Inc.(pty:dft) (Jay, William) (Entered: 03/16/2023) (2)
Mar 15, 2023	277	ORDER: This matter is before the Court on Defendants Motion Regarding Order of Proof at Trial 271 . The Court approves Plaintiffs' proposed order of presentation, except that Plaintiffs shall close first, followed by Defendant. The Court will consider a brief rebuttal closing by Plaintiffs. That matter will be resolved at a later time. Otherwise, the Motion is DENIED. Entered by Judge Raymond P. Moore on 3/15/2023. Text Only Entry (cpear) (Entered: 03/15/2023) (0)
Mar 14, 2023	276	NOTICE of Entry of Appearance by Carolyn S. Wall on behalf of Allergan Sales, LLC, Allergan, Inc., Duke University Attorney Carolyn S. Wall added to party Allergan Sales, LLC(pty:pla), Attorney Carolyn S. Wall added to party Allergan, Inc.(pty:cd), Attorney Carolyn S. Wall added to party Duke University (pty:pla) (Wall, Carolyn) (Entered: 03/14/2023) (3)
Mar 13, 2023	272	Joint MOTION for Extension of Time to Submit Deposition Designations and Objections by Plaintiffs Allergan Sales, LLC, Duke University. (Attachments: # 1 Proposed Order (PDF Only) (Granting Joint Motion for Extension of Time to Submit Deposition Designations and Objections))(Rey, Jacob) (Entered: 03/13/2023) (0)
Mar 13, 2023	273	ORDER: This matter is before the Court on the Parties' Joint Motion for Extension of Time to Submit Deposition Designations and Objections 272 in which the request until March 17, 2023 in which to file their deposition designations and objections. Being fully advised, the Motion is GRANTED. SO ORDERED by Judge Raymond P. Moore on 3/13/2023. (Text Only Entry)(rmsec) (Entered: 03/13/2023) (0)
Mar 13, 2023	274	Exhibit List Plaintiffs' Revised Exhibit List by Plaintiffs Allergan Sales, LLC, Duke University. (Rey, Jacob) (Entered: 03/13/2023) (30)
Mar 13, 2023	275	Exhibit List Defendant's Revised Trial Exhibit List by Defendant Sandoz Inc.. (Wallace, Lillian) (Entered: 03/13/2023) (30)
Mar 10, 2023	271	MOTION for Order to Request Order of Witness Presentation at Trial by Defendant Sandoz Inc.. (Attachments: # 1 Exhibit A)(Wallace, Lillian) (Entered: 03/10/2023) (0)
Mar 3, 2023	268	NOTICE of Entry of Appearance by James Y. Li on behalf of Allergan Sales, LLC, Allergan, Inc., Duke University Attorney James Y. Li added to party Allergan Sales, LLC(pty:pla), Attorney James Y. Li added to party Allergan, Inc.(pty:cd), Attorney James Y. Li added to party Duke University (pty:pla) (Li, James) (Entered: 03/03/2023) (3)
Mar 3, 2023	269	NOTICE of Entry of Appearance by Jing Ying Zhao on behalf of Allergan Sales, LLC, Allergan, Inc., Duke University Attorney Jing Ying Zhao added to party Allergan Sales, LLC(pty:pla), Attorney Jing Ying Zhao added to party Allergan, Inc.(pty:cd), Attorney Jing Ying Zhao added to party Duke University (pty:pla) (Zhao, Jing Ying) (Entered: 03/03/2023) (3)
Mar 3, 2023	270	NOTICE of Entry of Appearance by Jing Ying Zhao on behalf of Allergan Sales, LLC, Allergan, Inc., Duke University (Zhao, Jing Ying) (Entered: 03/03/2023) (3)
Mar 2, 2023	265	Unopposed MOTION for Leave to Restrict by Plaintiffs Allergan Sales, LLC, Duke University. (Attachments: # 1 Exhibit A (2008 Distributorship Agreement, Redacted) to Plaintiffs' Opposition to Sandoz's Motion in Limine #4 (ECF No. 243))(Rey, Jacob) (Entered: 03/02/2023) (0)
Mar 2, 2023	266	ORDER: This matter is before the Court on Plaintiffs' Unopposed Motion to Restrict Exhibit A to Plaintiffs' Opposition to Sandoz's Motion in Limine #4 (ECF No. 243) 265 . Plaintiffs request that that unredacted exhibit be maintained at Restriction Level 1. Being fully advised, the Motion is GRANTED. The Clerk of the Court is directed to maintain Exhibit A to Plaintiffs' Opposition to Sandoz's Motion in Limine #4 [243-1] UNDER RESTRICTION AT LEVEL 1. The Clerk is directed to enter ECF 265-1, Exhibit A to Plaintiffs' Opposition to Sandoz's Motion in Limine #4, as a separate, unrestricted docket entry. Plaintiffs indicate that they do not seek to restrict public access to the remainder of their Opposition to Sandoz's Motion in Limine #4 243 . Therefore, the Clerk is directed to lift the restriction on that document except as to Exhibit A [243-1]. SO ORDERED by Judge Raymond P. Moore on 3/2/2023. (Text Only Entry)(rmsec) (Entered: 03/02/2023) (0)
Mar 2, 2023	267	Exhibits in Support of 243 Restricted Document - Level 1, by Plaintiff Duke University. Filed per Ecf No. 266. (sphil, ) (Entered: 03/02/2023) (13)
Mar 1, 2023	260	NOTICE of Entry of Appearance by Tyler Doh on behalf of Sandoz Inc.Attorney Tyler Doh added to party Sandoz Inc.(pty:dft) (Doh, Tyler) (Entered: 03/01/2023) (2)
Mar 1, 2023	261	TRANSCRIPT of Trial Preparation Conference held on February 24, 2023 before Judge Moore. Pages: 1-72. NOTICE - REDACTION OF TRANSCRIPTS: Within seven calendar days of this filing, each party shall inform the Court, by filing a Notice of Intent to Redact, of the party's intent to redact personal identifiers from the electronic transcript of the court proceeding. If a Notice of Intent to Redact is not filed within the allotted time, this transcript will be made electronically available after 90 days. Please see the Notice of Electronic Availability of Transcripts document at www.cod.uscourts.gov. Transcript may only be viewed at the court public terminal or purchased through the Court Reporter/Transcriber prior to the 90 day deadline for electronic posting on PACER. (smitc, ) (Entered: 03/01/2023) (73)
Mar 1, 2023	262	RESTRICTED TRANSCRIPT of proceedings held on February 24, 2023 before Judge Moore. Pages: 1-3. (smitc, ) (Entered: 03/01/2023) (0)
Mar 1, 2023	263	BRIEF in Support of 224 MOTION in Limine # 5 to Preclude Sandoz from Offering Evidence or Argument Regarding Non-Asserted Patents and Patent Claims (Plaintiffs' Supplemental Brief in Support of Their Motion in Limine #5 Regarding Certain Unasserted Patents) filed by Plaintiffs Allergan Sales, LLC, Duke University. (Attachments: # 1 Exhibit A - Hearing Transcript Excerpt)(Reilly, Kathryn) (Entered: 03/01/2023) (0)
Mar 1, 2023	264	RESTRICTED DOCUMENT - Level 1: Supplemental Brief in Opposition to 224 MOTION in Limine # 5 by Defendant Sandoz Inc... (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Kornfeld, Richard) Modified on 3/6/2023 to add document title and linkage. (sphil, ). (Entered: 03/01/2023) (0)
Feb 28, 2023	259	NOTICE of Entry of Appearance by Lillian Anne Wallace on behalf of Sandoz Inc.Attorney Lillian Anne Wallace added to party Sandoz Inc.(pty:dft) (Wallace, Lillian) (Entered: 02/28/2023) (2)
Feb 27, 2023	258	RESTRICTED DOCUMENT - Level 1: Reply in Support of its 221 Motion in Limine No. 4 by Defendant Sandoz Inc. (Kornfeld, Richard) Modified on 2/28/2023 to add title (sdunb, ). (Entered: 02/27/2023) (0)
Feb 24, 2023	257	COURTROOM MINUTES for proceedings held before Judge Raymond P. Moore: Trial Preparation Conference held on 2/24/2023. The following motions are denied: 219 and 222 Motions in Limine. The following motions are granted in part and denied in part: 220 and 223 Motions in Limine. The following motions were deferred: 221 and 224 Motions in Limine. Court Reporter: Sarah Mitchell. (cpear) (Entered: 02/24/2023) (3)
Feb 23, 2023	254	REPLY to Response to 228 MOTION in Limine #3 Regarding the Alleged Effect of Damages on the Price of Generic Products and Consumer Costs and the Alleged Benefits of Generic Drugs filed by Plaintiffs Allergan Sales, LLC, Duke University. (Reilly, Kathryn) (Entered: 02/23/2023) (9)
Feb 23, 2023	255	REPLY to Response to 223 MOTION in Limine # 4 to Exclude Sandoz's Undisclosed "Statements" (Reply in Support of Motion in Limine #4 to Exclude Sandoz's 2015 Notice Letter) filed by Plaintiffs Allergan Sales, LLC, Duke University. (Reilly, Kathryn) (Entered: 02/23/2023) (10)
Feb 23, 2023	256	REPLY to Response to 224 MOTION in Limine # 5 to Preclude Sandoz from Offering Evidence or Argument Regarding Non-Asserted Patents and Patent Claims Plaintiffs Reply In Support Of Its Motion In Limine #5 Regarding Certain Unasserted Patents (D.I. 224) filed by Plaintiffs Allergan Sales, LLC, Duke University. (Rey, Jacob) (Entered: 02/23/2023) (9)
Feb 22, 2023	252	STIPULATION and [Proposed] Order No. 1 by Defendant Sandoz Inc.. (Kornfeld, Richard) (Entered: 02/22/2023) (3)
Feb 22, 2023	253	STIPULATION and [Proposed] Order No. 2 by Defendant Sandoz Inc.. (Kornfeld, Richard) (Entered: 02/22/2023) (3)
Feb 17, 2023	237	Proposed Voir Dire by Plaintiffs Allergan Sales, LLC, Duke University. (Rey, Jacob) (Entered: 02/17/2023) (8)
Feb 17, 2023	238	Proposed Voir Dire by Defendant Sandoz Inc.. (Kornfeld, Richard) (Entered: 02/17/2023) (5)
Feb 17, 2023	239	RESTRICTED DOCUMENT - Level 1: Response to Plaintiffs' 220 Motion in Limine No. 3 by Defendant Sandoz Inc. (Attachments: # 1 Exhibit A)(Kornfeld, Richard) Modified on 2/21/2023 to add title (sdunb, ). (Entered: 02/17/2023) (0)
Feb 17, 2023	240	Witness List by Defendant Sandoz Inc.. (Kornfeld, Richard) (Entered: 02/17/2023) (5)
Feb 17, 2023	241	ORDER: This Matter is before the Court on Plaintiff's Unopposed Motion to Restrict Exhibits B and C to Defendant's Motion in Limine #4 (ECF Nos. 221-3, 221-4) 236 . Plaintiffs request that those unredacted exhibits be maintained at Level 1. Being fully advised, the Motion is GRANTED. The Clerk of the Court is directed to maintain Exhibits B and C to Defendant's Motion in Limine #4 [221-3] and [221-4] UNDER RESTRICTION AT LEVEL 1. The Clerk of the Court is directed to docket [236-1], Exhibit B to Defendant's Motion in Limine #4, and [236-2], Exhibit C to Defendant's Motion in Limine #4 as separate entries. SO ORDERED by Judge Raymond P. Moore on 2/17/2023. (Text Only Entry)(rmsec) (Entered: 02/17/2023) (0)
Feb 17, 2023	242	RESPONSE to 226 MOTION in Limine #3 Relating to Sandoz's Burden of Proof on Invalidity filed by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E)(Rey, Jacob) (Entered: 02/17/2023) (0)
Feb 17, 2023	243	Opposition to Sandoz's 221 Motion in Limine # 4 by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # 1 Restricted - Exhibit A)(Rey, Jacob) Modified on 2/21/2023 to add title (sdunb, ). Modified on 3/2/2023 to remove restriction on main document.(sphil, ). (Entered: 02/17/2023) (0)
Feb 17, 2023	244	RESTRICTED DOCUMENT - Level 1: Opposition to Sandoz's 219 Motion in Limine #2 by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E)(Rey, Jacob) Modified on 2/21/2023 to add title (sdunb, ). (Entered: 02/17/2023) (0)
Feb 17, 2023	245	RESTRICTED DOCUMENT - Level 1: Response to Plaintiffs' 221 Motion in Limine No. 4 by Defendant Sandoz Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C)(Kornfeld, Richard) Modified on 2/21/2023 to add title (sdunb, ). (Entered: 02/17/2023) (0)
Feb 17, 2023	246	Exhibit List by Defendant Sandoz Inc.. (Kornfeld, Richard) (Entered: 02/17/2023) (30)
Feb 17, 2023	247	Witness List by Plaintiffs Allergan Sales, LLC, Duke University. (Rey, Jacob) (Entered: 02/17/2023) (5)
Feb 17, 2023	248	Exhibit List by Plaintiffs Allergan Sales, LLC, Duke University. (Rey, Jacob) (Entered: 02/17/2023) (30)
Feb 17, 2023	249	RESTRICTED DOCUMENT - Level 1: Response to Plaintiffs' 224 Motion in Limine No. 5 by Defendant Sandoz Inc. (Attachments: # 1 Exhibit A, # 2 Exhibit B, # 3 Exhibit C, # 4 Exhibit D, # 5 Exhibit E, # 6 Exhibit F, # 7 Exhibit G, # 8 Exhibit H, # 9 Exhibit I)(Kornfeld, Richard) Modified on 2/21/2023 to add title (sdunb, ). (Entered: 02/17/2023) (0)
Feb 17, 2023	250	Exhibit B to Defendant's 221 Motion in Limine #4 by Plaintiffs Allergan Sales, LLC, Duke University. [Docketed pursuant to 241 Order] (sdunb, ) (Entered: 02/21/2023) (27)
Feb 17, 2023	251	Exhibit C to Defendant's 221 Motion in Limine #4 by Plaintiffs Allergan Sales, LLC, Duke University. [Docketed pursuant to 241 Order] (sdunb, ) (Entered: 02/21/2023) (5)
Feb 16, 2023	235	ORDER: This matter is before the Court on Defendant's Motion for Reconsideration of the Court's Order (Dkt. 204) Excluding Sandoz from Introducing Evidence of its Belief of Invalidity in Defense of Willful Infringement 205 . Having reviewed the Motion, Plaintiffs' Response, and Defendant's Reply, and the pertinent case law, the Motion is GRANTED IN PART. The Court Amends its prior Order as set forth in 234 . In all other respects the Motion is DENIED. SO ORDERED by Judge Raymond P. Moore on 2/16/2023. (Text Only Entry)(rmsec) (Entered: 02/16/2023) (0)
Feb 16, 2023	236	Unopposed MOTION for Leave to Restrict by Plaintiffs Allergan Sales, LLC, Duke University. (Attachments: # 1 Exhibit 1, # 2 Exhibit 2)(Rey, Jacob) (Entered: 02/16/2023) (0)
Feb 15, 2023	234	AMENDED ORDER. The Court ORDERS: That Sandoz's 173 Motion in Limine is GRANTED with respect to Finding 1, GRANTED IN PART with respect to Finding 2, and DENIED with respect to Findings 3 and 4; That Allergan's 174 Motion in Limine to Exclude Evidence of Prior Litigations is GRANTED; and That Allergan's 175 Motion in Limine to Exclude Sandozs Evidence of Intent is GRANTED IN PART. By Judge Raymond P. Moore on 2/15/2023. (sdunb, ) (Entered: 02/15/2023) (22)
Feb 14, 2023	232	Proposed Jury Instructions Jointly Proposed Jury Instructions by Plaintiffs Allergan Sales, LLC, Duke University. (Rey, Jacob) (Entered: 02/14/2023) (30)
Feb 14, 2023	233	Proposed Verdict Form Joint Submission Of Proposed Verdict Forms by Plaintiffs Allergan Sales, LLC, Duke University. (Rey, Jacob) (Entered: 02/14/2023) (12)
Feb 8, 2023	230	Joint MOTION for Extension of Time to Submit Proposed Jury Instructions and Verdict Forms by Plaintiffs Allergan Sales, LLC, Duke University. (Attachments: # 1 Proposed Order (PDF Only))(Rey, Jacob) (Entered: 02/08/2023) (0)
Feb 8, 2023	231	ORDER: This matter is before the Court on the Parties' Joint Motion for Extension of Time to Submit Proposed Jury Instructions and Verdict Forms 230 . Having considered the Motion and finding good cause, the Motion is GRANTED. The Parties shall have until February 14, 2023, in which to submit their proposed jury instructions and verdict forms. SO ORDERED by Judge Raymond P. Moore on 2/8/2023. (Text Only Entry)(rmsec) (Entered: 02/08/2023) (0)
Feb 7, 2023	229	NOTICE of Entry of Appearance by Katherine H. Tellez on behalf of Sandoz Inc.Attorney Katherine H. Tellez added to party Sandoz Inc.(pty:dft) (Tellez, Katherine) (Entered: 02/07/2023) (2)
Feb 3, 2023	219	RESTRICTED DOCUMENT - Level 1: by Defendant Sandoz Inc... (Attachments: # 1 Appendix Declaration of Candice J. Kwark, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D)(Kornfeld, Richard) (Entered: 02/03/2023) (0)
Feb 3, 2023	220	RESTRICTED DOCUMENT - Level 1: by Defendant Sandoz Inc... (Attachments: # 1 Appendix Declaration of Candice J. Kwark, # 2 Exhibit A, # 3 Exhibit B)(Kornfeld, Richard) (Entered: 02/03/2023) (0)
Feb 3, 2023	221	RESTRICTED DOCUMENT - Level 1: by Defendant Sandoz Inc... (Attachments: # 1 Appendix Declaration of Candice J. Kwark, # 2 Exhibit A, # 3 Exhibit B, # 4 Exhibit C, # 5 Exhibit D)(Kornfeld, Richard) (Entered: 02/03/2023) (0)
Feb 3, 2023	222	RESTRICTED DOCUMENT - Level 1: by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc... (Attachments: # 1 Exhibit 1 - Jorge Depo, # 2 Exhibit 2 - Miller Depo)(Rey, Jacob) (Entered: 02/03/2023) (0)
Feb 3, 2023	223	MOTION in Limine # 4 to Exclude Sandoz's Undisclosed "Statements" by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Attachments: # 1 Exhibit 1 - January 31, 2023 Email, # 2 Exhibit 2 - Rule 26(a)(1) Disclosures)(Rey, Jacob) (Entered: 02/03/2023) (0)
Feb 3, 2023	224	MOTION in Limine # 5 to Preclude Sandoz from Offering Evidence or Argument Regarding Non-Asserted Patents and Patent Claims by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Attachments: # 1 Exhibit 1 - Heathcock Deposition)(Rey, Jacob) (Entered: 02/03/2023) (0)
Feb 3, 2023	225	MOTION in Limine No. 2 Regarding Evidence and Argument that Sandoz "Copied" Latisse by Defendant Sandoz Inc. (Public entry for Restricted Document 219 filed 02/03/2023) Text only entry.(sdunb, ) (Entered: 02/06/2023) (0)
Feb 3, 2023	226	MOTION in Limine No. 3 Relating to Sandoz's Burden of Proof on Invalidity by Defendant Sandoz Inc. (Public entry for Restricted Document 220 filed 2/03/2023) Text only entry. (sdunb, ) (Entered: 02/06/2023) (0)
Feb 3, 2023	227	MOTION in Limine No. 4 to Limit the Damages Period as a Matter of Law by Defendant Sandoz Inc. (Public entry for Restricted Document 221 filed 2/03/2023) Text only entry. (sdunb, ) (Entered: 02/06/2023) (0)
Feb 3, 2023	228	MOTION in Limine #3 to Exclude Argument Regarding the Alleged Effect of Damages on the Price of Generic Products and Consumer Costs and the Alleged Benefits of Generic Drugs by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Public entry for Restricted Document 222 filed 2/03/2023) Text only entry. (sdunb, ) (Entered: 02/06/2023) (0)
Jan 12, 2023	218	NOTICE of Entry of Appearance by Timothy S. Durst on behalf of Allergan Sales, LLC, Allergan, Inc., Duke University Attorney Timothy S. Durst added to party Allergan Sales, LLC(pty:pla), Attorney Timothy S. Durst added to party Allergan, Inc.(pty:cd), Attorney Timothy S. Durst added to party Duke University (pty:pla) (Durst, Timothy) (Entered: 01/12/2023) (2)
Jan 10, 2023	217	MINUTE ORDER by Magistrate Judge Kristen L. Mix on 01/10/2023. IT IS HEREBY ORDERED that the Motion to Withdraw Appearances 215 is GRANTED. Attorneys Young and Bohmann are relieved of any further representation of Sandoz Inc. The Clerk of Court is instructed to terminate Attorneys Young and Bohmann as counsel of record, and the Clerk of Court shall remove their name from the electronic certificate of mailing. Sandoz Inc. continues to be represented by the other counsel noted on the record.(alave, ) (Entered: 01/11/2023) (1)
Jan 9, 2023	214	NOTICE of Entry of Appearance of Co-Counsel by Richard Kent Kornfeld on behalf of Sandoz Inc.Attorney Richard Kent Kornfeld added to party Sandoz Inc.(pty:dft) (Kornfeld, Richard) (Entered: 01/09/2023) (2)
Jan 9, 2023	215	MOTION to Withdraw as Attorney Adsero IP Attorneys Daniel S. Young and Kathryn L. Bohmann by Defendant Sandoz Inc.. (Young, Daniel) (Entered: 01/09/2023) (4)
Jan 9, 2023	216	MEMORANDUM regarding 215 MOTION to Withdraw as Attorney Adsero IP Attorneys Daniel S. Young and Kathryn L. Bohmann filed by Sandoz Inc. Motion referred to Magistrate Judge Kristen L. Mix. By Judge Raymond P. Moore on 1/9/2023. (Text Only Entry) (rmsec) (Entered: 01/09/2023) (0)
Dec 27, 2022	213	BRIEF in Support of 205 MOTION for Reconsideration of the Court's Order (Dkt. 204) Excluding Sandoz from Introducing Evidence of Its Belief of Invalidity in Defense of Willful Infringement filed by Defendant Sandoz Inc.. (Kappers, Robert) (Entered: 12/27/2022) (4)
Dec 14, 2022	212	RESPONSE to 205 MOTION for Reconsideration of the Court's Order (Dkt. 204) Excluding Sandoz from Introducing Evidence of Its Belief of Invalidity in Defense of Willful Infringement filed by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Reilly, Kathryn) (Entered: 12/14/2022) (6)
Dec 13, 2022	211	MINUTE ORDER by Magistrate Judge Kristen L. Mix on 12/13/2022. IT IS HEREBY ORDERED that the Motion 206 is GRANTED. Attorney Dulin is relieved of any further representation of Plaintiffs in this case. The Clerk of Court is instructed to terminate Attorney Dulin as counsel of record, and the Clerk of Court shall remove his name from the electronic certificate of mailing. Plaintiffs continue to be represented by the counsel noted on the record.(alave, ) (Entered: 12/13/2022) (1)
Dec 12, 2022	208	NOTICE of Entry of Appearance by Kathryn A. Reilly on behalf of Allergan Sales, LLC, Allergan, Inc., Duke University Attorney Kathryn A. Reilly added to party Allergan Sales, LLC(pty:pla), Attorney Kathryn A. Reilly added to party Allergan, Inc.(pty:cd), Attorney Kathryn A. Reilly added to party Duke University (pty:pla) (Reilly, Kathryn) (Entered: 12/12/2022) (2)
Dec 12, 2022	209	NOTICE of Entry of Appearance by Jacob A. Rey on behalf of Allergan Sales, LLC, Allergan, Inc., Duke University Attorney Jacob A. Rey added to party Allergan Sales, LLC(pty:pla), Attorney Jacob A. Rey added to party Allergan, Inc.(pty:cd), Attorney Jacob A. Rey added to party Duke University (pty:pla) (Rey, Jacob) (Entered: 12/12/2022) (2)
Dec 12, 2022	210	NOTICE of Entry of Appearance by Chuan Cheng on behalf of Allergan Sales, LLC, Allergan, Inc., Duke University Attorney Chuan Cheng added to party Allergan Sales, LLC(pty:pla), Attorney Chuan Cheng added to party Allergan, Inc.(pty:cd), Attorney Chuan Cheng added to party Duke University (pty:pla) (Cheng, Chuan) (Entered: 12/12/2022) (2)
Dec 9, 2022	206	MOTION to Withdraw as Attorney by Plaintiffs Allergan Sales, LLC, Duke University. (Dulin, Michael) (Entered: 12/09/2022) (3)
Dec 9, 2022	207	MEMORANDUM regarding 206 MOTION to Withdraw as Attorney filed by Allergan Sales, LLC, Duke University. Motion referred to Magistrate Judge Kristen L. Mix. By Judge Raymond P. Moore on 12/9/2022. (Text Only Entry) (rmsec) (Entered: 12/09/2022) (0)
Dec 7, 2022	205	MOTION for Reconsideration of the Court's Order (Dkt. 204) Excluding Sandoz from Introducing Evidence of Its Belief of Invalidity in Defense of Willful Infringement by Defendant Sandoz Inc.. (Filarski, Thomas) (Entered: 12/07/2022) (10)
Nov 3, 2022	204	Order on Motion in Limine (22) Docket Text: ORDER. That Sandoz's [173] Motion in Limine is GRANTED with respect to Finding 1, GRANTED IN PART with respect to Finding 2, and DENIED with respect to Findings 3 and 4. That Allergan's [174] Motion in Limine to Exclude Evidence of Prior Litigations is GRANTED. That Allergan's [175] Motion in Limine to Exclude Sandoz's Evidence of Intent is GRANTED IN PART. By Judge Raymond P. Moore on 11/03/2022.(sdunb, )
Oct 17, 2022	N/A	Letter (0) Docket Text: ADVISORY NOTICE OF NONCOMPLIANCE WITH COURT RULES/PROCEDURES: Attorneys Thomas J. Filarski, John Lloyd Abramic, Robert F. Kappers, Vishal Gupta, and Candice Jaesun Kwark: your 2022 Biennial / Renewal Fee payments were ENTERED IN ERROR in this civil case. The Instructions for Payment of the Attorney 2022 Biennial Renewal Fee available on the U.S. District Court website (http://www.cod.uscourts.gov/AttorneyInformation/BiennialRenewalFeeInformation.aspx) and the bullet point guidance on the Biennial Fee page itself indicate that the fee must be paid in the specially-designated miscellaneous case, 22-mc-6000. DO NOT TAKE ANY FURTHER ACTION. Instead, in order to maintain a correct public record of payments of the biennial fee by counsel, court staff must now manually transfer the payment record from this case to 22-mc-6000. IN THE FUTURE, counsel SHALL fully review instruction documents, and if unsure how to proceed, contact the Attorney Services Division of the court at: cod_attorneyservices@cod.uscourts.gov. Signed on this date, Edward Butler, Legal Officer, U.S. District Court. (Text Only Entry) (ebutl)
Oct 5, 2022	N/A	2022 Colorado Biennial Fee (0) Docket Text: 2022 Biennial fee payment for Vishal Gupta $60, receipt number ACODC-8697679.. (Gupta, Vishal)
Oct 5, 2022	200	Notice of Entry of Appearance (2) Docket Text: NOTICE of Entry of Appearance by Candice Jaesun Kwark on behalf of Sandoz Inc.Attorney Candice Jaesun Kwark added to party Sandoz Inc.(pty:dft) (Kwark, Candice)
Oct 5, 2022	N/A	2022 Colorado Biennial Fee (0) Docket Text: 2022 Biennial fee payment for Candice Jaesun Kwark $60, receipt number ACODC-8697736.. (Kwark, Candice)
Oct 4, 2022	N/A	2022 Colorado Biennial Fee (0) Docket Text: 2022 Biennial fee payment for Thomas J. Filarski $60, receipt number ACODC-8694882.. (Filarski, Thomas)
Oct 4, 2022	N/A	2022 Colorado Biennial Fee (0) Docket Text: 2022 Biennial fee payment for John Lloyd Abramic $60, receipt number ACODC-8695073.. (Abramic, John)
Oct 4, 2022	N/A	2022 Colorado Biennial Fee (0) Docket Text: 2022 Biennial fee payment for Robert F. Kappers $60, receipt number ACODC-8695142.. (Kappers, Robert)
Oct 4, 2022	198	Order on Motion in Limine (1) Docket Text: COURTROOM MINUTES for proceedings held before Judge Raymond P. Moore: Oral Argument Hearing held on 10/4/2022. [174], [176], and [177] Motions in Limine are taken under advisement. Court Reporter: Tammy Hoffschildt. (cpear)
Sep 29, 2022	194	Exhibit List (4) Docket Text: Exhibit List Joint List of all Parties - Plaintiffs and Defendants - Hearing Exhibit List re Motions in Limine by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Dulin, Michael)
Sep 27, 2022	N/A	Order on Motion for Hearing/Conference (0) Docket Text: ORDER: This matter is before the Court on Defendant's Unopposed Motion for Telephonic Connection and Attendance for Sandoz In-House Counsel for the Hearing Scheduled for October 4, 2022 [192]. Being fully advised, the Motion is GRANTED. The Court will permit Defendant's In-House Counsel to appear either by video or telephone via VTC. Defense Counsel is directed to contact the Court's Courtroom Deputy via email (Cathy_Pearson@cod.uscourts.gov) on or before 3:30 p.m. on September 30, 2022 to obtain VTC instructions. SO ORDERED by Judge Raymond P. Moore on 9/27/2022. (Text Only Entry)(rmsec )
Sep 26, 2022	192	Motion for Hearing/Conference (Main Document) (4) Docket Text: Unopposed MOTION for Hearing/Conference re [191] Order on Motion for Leave,, Sandoz's Unopposed Motion for Telephonic Connection and Attendance for Sandoz In-House Counsel for the Hearing Scheduled October 4, 2022 by Defendant Sandoz Inc.. (Attachments: # (1) Proposed Order (PDF Only))(Filarski, Thomas)
Sep 26, 2022	192	Motion for Hearing/Conference (Proposed Order (PDF Only)) (1) Docket Text: Unopposed MOTION for Hearing/Conference re [191] Order on Motion for Leave,, Sandoz's Unopposed Motion for Telephonic Connection and Attendance for Sandoz In-House Counsel for the Hearing Scheduled October 4, 2022 by Defendant Sandoz Inc.. (Attachments: # (1) Proposed Order (PDF Only))(Filarski, Thomas)
Aug 29, 2022	N/A	Order on Motion for Leave (0) Docket Text: ORDER: This matter is before the Court on Plaintiffs' Unopposed Request for Oral Argument Regarding the Parties' Motions In Limine [189]. Being fully advised, the Motion is GRANTED. The Matter is set for a half-day hearing before Judge Moore beginning at 9:00 on Tuesday, October 4, 2022 in Courtroom A601 on the Sixth Floor of the Alfred A. Arraj United States Courthouse located at 901 19th Street, Denver, Colorado. SO ORDERED by Judge Raymond P. Moore on 8/29/2022. (Text Only Entry)(rmsec )
Aug 24, 2022	190	Order on Motion to Withdraw (1) Docket Text: MINUTE ORDER by Magistrate Judge Kristen L. Mix on 08/24/2022. IT IS HEREBY ORDERED that the Discovery Master Whitehair's Motion to Withdraw from Master Appointment [187] is GRANTED. James Gregory Whitehair is hereby withdrawn as the Special Master in this case, and shall be removed from the electronic certificate of mailing.(alave, )
Aug 22, 2022	189	Motion for Leave (3) Docket Text: Unopposed MOTION for Leave to Request for Oral Argument Regarding the Parties' Motions in Limine by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Dulin, Michael)
Aug 17, 2022	N/A	Memorandum (0) Docket Text: MEMORANDUM regarding [187] MOTION to Withdraw [102] Order Referring Case to Special Master, filed by James Gregory Whitehair. Motion referred to Magistrate Judge Kristen L. Mix. By Judge Raymond P. Moore on 8/17/2022. (Text Only Entry) (rmsec )
Aug 16, 2022	187	Motion to Withdraw (2) Docket Text: MOTION to Withdraw [102] Order Referring Case to Special Master, by Special Master James Gregory Whitehair. (Whitehair, James)
Aug 15, 2022	184	Reply to Response to Motion (Main Document) (18) Docket Text: REPLY to Response to [176] MOTION in Limine No. 1 Issue Preclusion Binds Plaintiffs to a Subset of Findings About the Prior Art and Limits the Scope of Trial filed by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit 6, # (2) Exhibit 7, # (3) Exhibit 8, # (4) Exhibit 9, # (5) Exhibit 10, # (6) Exhibit 11, # (7) Exhibit 12, # (8) Exhibit 13, # (9) Exhibit 14)(Filarski, Thomas)
Aug 15, 2022	184	Reply to Response to Motion (Exhibit 6) (12) Docket Text: REPLY to Response to [176] MOTION in Limine No. 1 Issue Preclusion Binds Plaintiffs to a Subset of Findings About the Prior Art and Limits the Scope of Trial filed by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit 6, # (2) Exhibit 7, # (3) Exhibit 8, # (4) Exhibit 9, # (5) Exhibit 10, # (6) Exhibit 11, # (7) Exhibit 12, # (8) Exhibit 13, # (9) Exhibit 14)(Filarski, Thomas)
Aug 15, 2022	184	Reply to Response to Motion (Exhibit 7) (12) Docket Text: REPLY to Response to [176] MOTION in Limine No. 1 Issue Preclusion Binds Plaintiffs to a Subset of Findings About the Prior Art and Limits the Scope of Trial filed by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit 6, # (2) Exhibit 7, # (3) Exhibit 8, # (4) Exhibit 9, # (5) Exhibit 10, # (6) Exhibit 11, # (7) Exhibit 12, # (8) Exhibit 13, # (9) Exhibit 14)(Filarski, Thomas)
Aug 15, 2022	184	Reply to Response to Motion (Exhibit 8) (15) Docket Text: REPLY to Response to [176] MOTION in Limine No. 1 Issue Preclusion Binds Plaintiffs to a Subset of Findings About the Prior Art and Limits the Scope of Trial filed by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit 6, # (2) Exhibit 7, # (3) Exhibit 8, # (4) Exhibit 9, # (5) Exhibit 10, # (6) Exhibit 11, # (7) Exhibit 12, # (8) Exhibit 13, # (9) Exhibit 14)(Filarski, Thomas)
Aug 15, 2022	184	Reply to Response to Motion (Exhibit 9) (14) Docket Text: REPLY to Response to [176] MOTION in Limine No. 1 Issue Preclusion Binds Plaintiffs to a Subset of Findings About the Prior Art and Limits the Scope of Trial filed by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit 6, # (2) Exhibit 7, # (3) Exhibit 8, # (4) Exhibit 9, # (5) Exhibit 10, # (6) Exhibit 11, # (7) Exhibit 12, # (8) Exhibit 13, # (9) Exhibit 14)(Filarski, Thomas)
Aug 15, 2022	184	Reply to Response to Motion (Exhibit 10) (15) Docket Text: REPLY to Response to [176] MOTION in Limine No. 1 Issue Preclusion Binds Plaintiffs to a Subset of Findings About the Prior Art and Limits the Scope of Trial filed by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit 6, # (2) Exhibit 7, # (3) Exhibit 8, # (4) Exhibit 9, # (5) Exhibit 10, # (6) Exhibit 11, # (7) Exhibit 12, # (8) Exhibit 13, # (9) Exhibit 14)(Filarski, Thomas)
Aug 15, 2022	184	Reply to Response to Motion (Exhibit 11) (9) Docket Text: REPLY to Response to [176] MOTION in Limine No. 1 Issue Preclusion Binds Plaintiffs to a Subset of Findings About the Prior Art and Limits the Scope of Trial filed by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit 6, # (2) Exhibit 7, # (3) Exhibit 8, # (4) Exhibit 9, # (5) Exhibit 10, # (6) Exhibit 11, # (7) Exhibit 12, # (8) Exhibit 13, # (9) Exhibit 14)(Filarski, Thomas)
Aug 15, 2022	184	Reply to Response to Motion (Exhibit 12) (13) Docket Text: REPLY to Response to [176] MOTION in Limine No. 1 Issue Preclusion Binds Plaintiffs to a Subset of Findings About the Prior Art and Limits the Scope of Trial filed by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit 6, # (2) Exhibit 7, # (3) Exhibit 8, # (4) Exhibit 9, # (5) Exhibit 10, # (6) Exhibit 11, # (7) Exhibit 12, # (8) Exhibit 13, # (9) Exhibit 14)(Filarski, Thomas)
Aug 15, 2022	184	Reply to Response to Motion (Exhibit 13) (4) Docket Text: REPLY to Response to [176] MOTION in Limine No. 1 Issue Preclusion Binds Plaintiffs to a Subset of Findings About the Prior Art and Limits the Scope of Trial filed by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit 6, # (2) Exhibit 7, # (3) Exhibit 8, # (4) Exhibit 9, # (5) Exhibit 10, # (6) Exhibit 11, # (7) Exhibit 12, # (8) Exhibit 13, # (9) Exhibit 14)(Filarski, Thomas)
Aug 15, 2022	184	Reply to Response to Motion (Exhibit 14) (3) Docket Text: REPLY to Response to [176] MOTION in Limine No. 1 Issue Preclusion Binds Plaintiffs to a Subset of Findings About the Prior Art and Limits the Scope of Trial filed by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit 6, # (2) Exhibit 7, # (3) Exhibit 8, # (4) Exhibit 9, # (5) Exhibit 10, # (6) Exhibit 11, # (7) Exhibit 12, # (8) Exhibit 13, # (9) Exhibit 14)(Filarski, Thomas)
Aug 8, 2022	N/A	Minute Order (0) Docket Text: MINUTE ORDER: This matter is before the Court on Defendant's Opposition to Plaintiff's Motion in Limine Concerning Prior Litigations [179]. Attorneys for Defendant informed the Court that the Opposition was inadvertently filed without a level 1 restriction. The Court has directed the Clerk of Court to mark the Opposition as restricted-level 1. It shall retain that restriction for only 14 days unless this Court receives a Motion to Restrict pursuant to D.C.Colo.LCivR 7.2(c). SO ORDERED by Judge Raymond P. Moore on 8/8/2022. (Text Only Entry) (rmsec )
Aug 5, 2022	N/A	Conventionally Submitted Material (0) Docket Text: Conventionally Submitted Material : Flash drive of exhibits in support of the forthcoming Opposition to Allergan's Motion in Limine by Defendant Sandoz Inc. Located in Clerk's Office A-1-6. Text Only Entry (sdunb, )
Aug 5, 2022	180	Brief in Opposition to Motion (25) Docket Text: BRIEF in Opposition to [176] MOTION in Limine No. 1 filed by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Dulin, Michael)
Aug 5, 2022	182	Notice (Other) (3) Docket Text: NOTICE re [181] Restricted Document - Level 1, Notice of Conventionally Filed Exhibits I-K by Defendant Sandoz Inc. (Filarski, Thomas)
Jul 22, 2022	174	Motion in Limine (21) Docket Text: MOTION in Limine Plaintiffs' Motion in Limine to Exclude Sandoz's Evidence Concerning Prior Litigation by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Dulin, Michael)
Jul 22, 2022	N/A	Motion in Limine (0) Docket Text: MOTION in Limine No. 1 Issue Preclusion Binds Plaintiffs to a Subset of Findings About Prior Art and Limits the Scope of Trial by Defendant Sandoz Inc. (Public Entry for Level 1 Restricted Document [173] ). Text Only Entry (athom, )
Jul 22, 2022	N/A	Motion in Limine (0) Docket Text: MOTION in Limine to Exclude Sandoz's Evidence of Intent at Trial by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Public Entry for Level 1 Restricted Document [175] ). Text Only Entry (athom, )
Jun 15, 2022	N/A	Order on Motion to Clarify (0) Docket Text: ORDER: This matter is before the Court on Defendant's Unopposed Motion for Clarification of the Court's Order [171]. The Court, having reviewed the Motion and being fully advised in the matter, GRANTS the Motion. It is hereby ORDERED that the Parties shall file motions by July 22, 2022, on the three special issues identified in the Parties' Joint Motion [169], and the Parties may bring other Motions in Limine up until seven days before the Trial Preparation Conference pursuant to this Court's Civil Practice Standards. SO ORDERED by Judge Raymond P. Moore on 6/15/2022. (Text Only Entry)(rmsec )
Jun 14, 2022	171	Motion to Clarify (Main Document) (5) Docket Text: Unopposed MOTION to Clarify re [170] Order on Motion for Leave, the Parties' Joint Motion to Request Deadlines Associated with Filing Certain Motions in Limine (DKT. 170) by Defendant Sandoz Inc.. (Attachments: # (1) Proposed Order (PDF Only))(Filarski, Thomas)
Jun 14, 2022	171	Motion to Clarify (Proposed Order (PDF Only)) (2) Docket Text: Unopposed MOTION to Clarify re [170] Order on Motion for Leave, the Parties' Joint Motion to Request Deadlines Associated with Filing Certain Motions in Limine (DKT. 170) by Defendant Sandoz Inc.. (Attachments: # (1) Proposed Order (PDF Only))(Filarski, Thomas)
May 31, 2022	169	Motion for Leave (5) Docket Text: Joint MOTION for Leave to to Request Deadlines Associated with Filing Certain Motions in Limine [166] Order by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Dulin, Michael)
May 31, 2022	N/A	Order on Motion for Leave (0) Docket Text: ORDER: This matter is before the Court on the Parties' Joint Motion to Request Deadlines Associated with Filing Certain Motions in Limine [169]. Being fully advised, the Motion is GRANTED. The Parties shall file all Motions in Limine by July 22, 2022. Responses to those Motions shall be due on August 5, 2022. Any Replies shall be filed by August 15, 2022. SO ORDERED by Judge Raymond P. Moore on 5/31/2022. (Text Only Entry)(rmsec )
May 3, 2022	168	Order (3) Docket Text: ORDER SETTING CASE FOR TRIAL. This matter has been scheduled for a five-day jury trial on the docket of Judge Raymond P. Moore in the U.S. District Court, Courtroom A601, 6th Floor, 901 19th Street, Denver, Colorado to commence on March 27, 2023 at 9:00 a.m. On the first day of trial to a jury, counsel are expected to be present at 8:30 a.m. to go over any final matters before the commencement of trial. A Trial Preparation Conference is set for February 24, 2023 at 10:00 a.m. By Judge Raymond P. Moore on 05/03/2022. (sdunb, )
Apr 27, 2022	166	Order (Main Document) (30) Docket Text: REVISED FINAL PRETRIAL ORDER by Magistrate Judge Kristen L. Mix on April 27, 2022. (Attachments: # (1) Exhibit, # (2) Exhibit) (csarr, )
Apr 27, 2022	166	Order (Exhibit) (30) Docket Text: REVISED FINAL PRETRIAL ORDER by Magistrate Judge Kristen L. Mix on April 27, 2022. (Attachments: # (1) Exhibit, # (2) Exhibit) (csarr, )
Apr 27, 2022	166	Order (Exhibit) (30) Docket Text: REVISED FINAL PRETRIAL ORDER by Magistrate Judge Kristen L. Mix on April 27, 2022. (Attachments: # (1) Exhibit, # (2) Exhibit) (csarr, )
Apr 27, 2022	N/A	Minute Order (0) Docket Text: MINUTE ORDER: In light of the Revised Final Pretrial Order entered by Magistrate Judge Kristen L. Mix [166], it is ORDERED that counsel shall jointly contact the Court's Judicial Assistant via email (Deanne_bader@cod.uscourts.gov) on or before 5:00 pm on Thursday, April 28, 2022 to obtain trial dates. SO ORDERED by Judge Raymond P. Moore on 4/27/2022. (Text Only Entry) (rmsec )
Apr 26, 2022	165	Proposed Pretrial Order (Main Document) (30) Docket Text: Proposed Pretrial Order by Plaintiffs Allergan Sales, LLC, Duke University. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2)(Dulin, Michael)
Apr 26, 2022	165	Proposed Pretrial Order (Exhibit 1) (30) Docket Text: Proposed Pretrial Order by Plaintiffs Allergan Sales, LLC, Duke University. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2)(Dulin, Michael)
Apr 26, 2022	165	Proposed Pretrial Order (Exhibit 2) (30) Docket Text: Proposed Pretrial Order by Plaintiffs Allergan Sales, LLC, Duke University. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2)(Dulin, Michael)
Apr 18, 2022	164	Order (2) Docket Text: MINUTE ORDER by Magistrate Judge Kristen L. Mix on April 18, 2022. IT IS HEREBY ORDERED that the Final Pretrial Order [163] is REJECTED. IT IS FURTHER ORDERED that a Revised Proposed Final Pretrial Order shall be filed by April 27, 2022 that conforms with D.C.COLO.LCivR 16.3 and the attached form. The Claims and Defenses shall contain only a summary of the claims, facts, and legal theories, and eliminate any legal argument and eliminate stipulations that impact how the trial will be conducted. The Revised Proposed Pretrial Order to be submitted under the ECF Procedures may be submitted in WordPerfect or pdf format and shall be emailed to Mix_Chambers@cod.uscourts.gov. IT IS FURTHER ORDERED that the Final Pretrial Conference set for April 21, 2022, at 1:30 p.m. is VACATED, to be reset if necessary after the Revised Proposed Final Pretrial Order is submitted by the parties. (csarr, )
Apr 14, 2022	163	Proposed Pretrial Order (Main Document) (30) Docket Text: Proposed Pretrial Order by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3)(Dulin, Michael)
Apr 14, 2022	163	Proposed Pretrial Order (Exhibit 1) (8) Docket Text: Proposed Pretrial Order by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3)(Dulin, Michael)
Apr 14, 2022	163	Proposed Pretrial Order (Exhibit 2) (30) Docket Text: Proposed Pretrial Order by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3)(Dulin, Michael)
Apr 14, 2022	163	Proposed Pretrial Order (Exhibit 3) (30) Docket Text: Proposed Pretrial Order by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3)(Dulin, Michael)
Dec 15, 2021	162	Minute Order (1) Docket Text: MINUTE ORDER by Magistrate Judge Kristen L. Mix on 12/15/2021. Proposed Pretrial Order due by 4/14/2022. Pretrial Conference set for 4/21/2022 01:30 PM in Courtroom A 401 before Magistrate Judge Kristen L. Mix. (alave, )
Dec 9, 2021	N/A	Case Reassigned (0) Docket Text: CASE REASSIGNED pursuant to [157] ORDER DIRECTING REASSIGNMENT. This case is randomly reassigned to Judge Raymond P. Moore. All future pleadings should be designated as 18-cv-00997-RM-KLM. (Text Only Entry) (sdunb, )
Dec 9, 2021	N/A	Order Referring Case to Magistrate Judge (0) Docket Text: ORDER REFERRING CASE to Magistrate Judge Kristen L. Mix. Pursuant to 28 U.S.C. � 636(b)(1)(A) and (B) and Fed. R. Civ. P. 72(a) and (b), this case is referred to the assigned United States Magistrate Judge to (1) convene a scheduling conference under Fed. R. Civ. P. 16(b) and enter a scheduling order meeting the requirements of D.C.COLO.LCivR 16.2, (2) conduct such status conferences and issue such orders necessary for compliance with the scheduling order, including amendments or modifications of the scheduling order upon a showing of good cause, (3) hear and determine pretrial matters, including discovery and other non-dispositive motions, (4) conduct a pretrial conference and enter a pretrial order, and (5) conduct hearings, including evidentiary hearings, and submit proposed findings of fact and recommendations for rulings on dispositive motions. Court sponsored alternative dispute resolution is governed by D.C.COLO.LCivR 16.6. On the recommendation or informal request of the magistrate judge or on the request of the parties by motion, this court may direct the parties to engage in an early neutral evaluation, a settlement conference, or another alternative dispute resolution proceeding. By Judge Raymond P. Moore on 12/9/2021. (Text Only Entry) (rmsec )
Dec 9, 2021	N/A	Minute Order (0) Docket Text: MINUTE ORDER: With the assignment of this matter, the parties are advised that throughout this case they are expected to be familiar and comply with not only the Local Rules of this District, but also Judge Raymond P. Moore's Civil Practice Standards, which may be found at: http://www.cod.uscourts.gov/JudicialOfficers/ActiveArticleIIIJudges/HonRaymondPMoore.aspx. SO ORDERED by Judge Raymond P. Moore on 12/9/2021. (Text Only Entry) (rmsec )
Dec 9, 2021	N/A	Minute Order (0) Docket Text: MINUTE ORDER: The parties are instructed to contact Magistrate Judge Kristen L. Mix's Chambers at 303.335.2770 on or before the close of business on Tuesday, December 14, 2021, to schedule a Pretrial Conference. SO ORDERED by Judge Raymond P. Moore on 12/9/2021. (Text Only Entry) (rmsec )
Dec 8, 2021	N/A	Order (0) Docket Text: ORDER DIRECTING REASSIGNMENT: Due to the undersigned's unavailability to preside over a trial in this case and with the prior permission of the Chief Judge pursuant to D.C. Colo. L. Civ. R. 40.1(a), the Clerk of the Court is directed to reassign this case to another Article III judge for purposes of trial. By Judge Marcia S. Krieger on 12/8/21. Text Only Entry (msklc2, )
Nov 1, 2021	N/A	Order (0) Docket Text: ORDER: It appearing that all deadlines in the Scheduling Order have passed and there are no remaining pretrial proceedings that are required before the patent claims and defenses in this case proceed to trial, the parties shall begin preparation of a Proposed Pretrial Order and shall jointly contact chambers to schedule a Pretrial Conference. By Judge Marcia S. Krieger on 11/1/21. Text Only Entry (msklc2, )
Sep 14, 2021	154	Response (Main Document) (3) Docket Text: RESPONSE to [152] Minute Order,,, Terminate Motions,, by Defendant Sandoz Inc.. (Attachments: # (1) Redacted Docket #135)(Young, Daniel)
Sep 14, 2021	154	Response (Redacted Docket #135) (14) Docket Text: RESPONSE to [152] Minute Order,,, Terminate Motions,, by Defendant Sandoz Inc.. (Attachments: # (1) Redacted Docket #135)(Young, Daniel)
Sep 14, 2021	155	Brief in Opposition to Motion (15) Docket Text: BRIEF in Opposition to [137] MOTION for Order to Plaintiff's Opposition to Sandoz's Amended Motion Under Fed. R. Evid. 702 filed by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Dulin, Michael)
Sep 9, 2021	N/A	Order on Motion to Withdraw as Attorney (0) Docket Text: ORDER granting [147] Motion to Withdraw as Attorney. Attorney Gretchen Porter Miller terminated. By Judge Marcia S. Krieger on 9/9/21. Text Only Entry(msklc2, )
Sep 7, 2021	152	Minute Order (12) Docket Text: MINUTE ORDER by Judge Marcia S. Krieger on 9/7/2021, re: [135, 137] Sandoz's Motion to Exclude Dr. Maness' Testimony (# 135, 137) is DENIED. The parties Motions to Restrict Access (# 138, 143, 148) are GRANTED IN PART AND DENIED IN PART. Within 7 days of this Order, the parties shall publicly-file versions of Sandoz' motion and the Plaintiffs' response that redact only the units of the Y axis on Figure 5. The Clerk of the Court shall lift the provisional restriction placed on Docket # 144. The remaining provisional restrictions shall remain in place. (sphil, )
May 15, 2021	N/A	ADVISORY Notice to Attorney(s) (0) Docket Text: ADVISORY NOTICE TO ATTORNEY AND COURT: Under D.C.COLO.LAttyR 3(a), Eric Shaun Hochstadt was administratively removed from the court's attorney roll and barred from filing electronically under CM/ECF for failing to pay the 2020 Biennial Fee. Counsel must complete a Bar/ECF application through counsel's existing Attorney Services Portal account and pay the full application fee to be restored to the attorney roll and CM/ECF. Counsel, however, need not pay any delinquent biennial fees. Upon reinstatement, counsel must file a Notice of Entry of Appearance in this case. (Text Only Entry) (mfred)
Jan 26, 2021	148	Motion for Leave to Restrict (7) Docket Text: Unopposed MOTION for Leave to Restrict by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Dulin, Michael)
Jan 26, 2021	149	Notice of Entry of Appearance (2) Docket Text: NOTICE of Entry of Appearance by Caitlin Patricia Hogan on behalf of Allergan Sales, LLC, Allergan, Inc., Duke University Attorney Caitlin Patricia Hogan added to party Allergan Sales, LLC(pty:pla), Attorney Caitlin Patricia Hogan added to party Allergan, Inc.(pty:cd), Attorney Caitlin Patricia Hogan added to party Duke University (pty:pla) (Hogan, Caitlin)
Jan 26, 2021	150	Exhibits (Main Document) (1) Docket Text: Exhibits in Support of [148] Unopposed MOTION for Leave to Restrict by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Attachments: # (1) Exhibit Redacted Motion)(Hogan, Caitlin)
Jan 26, 2021	150	Exhibits (Exhibit Redacted Motion) (9) Docket Text: Exhibits in Support of [148] Unopposed MOTION for Leave to Restrict by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Attachments: # (1) Exhibit Redacted Motion)(Hogan, Caitlin)
Jan 15, 2021	146	Notice of Entry of Appearance (2) Docket Text: NOTICE of Entry of Appearance by John Lloyd Abramic on behalf of Sandoz Inc.Attorney John Lloyd Abramic added to party Sandoz Inc.(pty:dft) (Abramic, John)
Jan 15, 2021	147	Motion to Withdraw as Attorney (Main Document) (4) Docket Text: Unopposed MOTION to Withdraw as Attorney Gretchen P. Miller by Defendant Sandoz Inc.. (Attachments: # (1) Proposed Order (PDF Only))(Abramic, John)
Jan 15, 2021	147	Motion to Withdraw as Attorney (Proposed Order (PDF Only)) (1) Docket Text: Unopposed MOTION to Withdraw as Attorney Gretchen P. Miller by Defendant Sandoz Inc.. (Attachments: # (1) Proposed Order (PDF Only))(Abramic, John)
Jan 12, 2021	144	Restricted Document - Level 1 (9) Docket Text: Sandoz Inc.s Reply to [139,141] Plaintiffs Opposition To Sandozs Amended Motion Under Fed. R. Evid. 702 by Defendant Sandoz Inc... (Filarski, Thomas) Modified on 9/7/2021 to remove restriction level 1 pursuant to [152] Order. (sphil, ).
Jan 12, 2021	N/A	Reply to Response to Motion (0) Docket Text: REPLY to Response to [137] MOTION for Order filed by Defendant Sandoz Inc.. (Public Entry for Restricted Document [144] filed on 1/12/2021). Text Only Entry. (sphil, )
Jan 5, 2021	143	Motion for Leave to Restrict (Main Document) (9) Docket Text: Joint MOTION for Leave to Restrict by Plaintiffs Allergan Sales, LLC, Duke University. (Attachments: # (1) Exhibit to Joint Motion to Restrict Access)(Dulin, Michael)
Jan 5, 2021	143	Motion for Leave to Restrict (Exhibit to Joint Motion to Restrict Access) (30) Docket Text: Joint MOTION for Leave to Restrict by Plaintiffs Allergan Sales, LLC, Duke University. (Attachments: # (1) Exhibit to Joint Motion to Restrict Access)(Dulin, Michael)
Dec 24, 2020	N/A	Order on Motion for Extension of Time to File Response/Reply (0) Docket Text: ORDER granting [140] Motion for Extension of Time to File Response/Reply: Reply due Jan. 12, 2021. By Judge Marcia S. Krieger on 12/24/20.(msklc2, )
Dec 23, 2020	140	Motion for Extension of Time to File Response/Reply (Main Document) (4) Docket Text: Unopposed MOTION for Extension of Time to File Response/Reply as to [137] MOTION for Order to Sandoz Inc.s Amended Motion Under Fed. R. Evid. 702 [135] by Defendant Sandoz Inc.. (Attachments: # (1) Proposed Order (PDF Only))(Filarski, Thomas)
Dec 23, 2020	140	Motion for Extension of Time to File Response/Reply (Proposed Order (PDF Only)) (1) Docket Text: Unopposed MOTION for Extension of Time to File Response/Reply as to [137] MOTION for Order to Sandoz Inc.s Amended Motion Under Fed. R. Evid. 702 [135] by Defendant Sandoz Inc.. (Attachments: # (1) Proposed Order (PDF Only))(Filarski, Thomas)
Dec 22, 2020	N/A	Response to Motion (0) Docket Text: Plaintiffs' Opposition to [137] Sandoz Inc.'s Amended MOTION Under Fed. R. Evid. 702 filed by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Public Entry for Restricted Document [139] filed on 12/22/2020). Text Only Entry. (sphil, )
Dec 15, 2020	138	Motion for Leave (Main Document) (9) Docket Text: Joint MOTION for Leave to Restrict Access to [135] Restricted Document - Level 1 by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit Redacted Public Version of ECF No. 135)(Filarski, Thomas)
Dec 15, 2020	138	Motion for Leave (Exhibit Redacted Public Version of ECF No. 135) (30) Docket Text: Joint MOTION for Leave to Restrict Access to [135] Restricted Document - Level 1 by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit Redacted Public Version of ECF No. 135)(Filarski, Thomas)
Dec 1, 2020	136	Declaration (2) Docket Text: DECLARATION of Thomas J. Filarski regarding Restricted Document - Level 1[135] by Defendant Sandoz Inc.. (Filarski, Thomas)
Dec 1, 2020	N/A	Motion for Order (0) Docket Text: Sandoz Inc.'s Amended MOTION Under Fed. R. Evid. 702 by Defendant Sandoz Inc.. (Public Entry for Restricted Document [135] filed on 12/1/2020). Text Only Entry. (sphil, )
Nov 23, 2020	133	Motion for Extension of Time (Main Document) (4) Docket Text: Joint MOTION for Extension of Time to Refile Fed. R. Evid. 702 Motion by Defendant Sandoz Inc.. (Attachments: # (1) Proposed Order (PDF Only))(Filarski, Thomas)
Nov 23, 2020	133	Motion for Extension of Time (Proposed Order (PDF Only)) (1) Docket Text: Joint MOTION for Extension of Time to Refile Fed. R. Evid. 702 Motion by Defendant Sandoz Inc.. (Attachments: # (1) Proposed Order (PDF Only))(Filarski, Thomas)
Nov 23, 2020	N/A	Order on Motion for Extension of Time to File (0) Docket Text: ORDER granting [133] Motion for Extension of Time to File: Rule 702 motions due Dec. 1, 2020. By Judge Marcia S. Krieger on 11/23/20.(msklc2, )
Nov 13, 2020	131	Motion for Extension of Time (Main Document) (4) Docket Text: Unopposed MOTION for Extension of Time to Refile Fed. R. Evid. 702 Motion by Defendant Sandoz Inc.. (Attachments: # (1) Proposed Order (PDF Only))(Filarski, Thomas)
Nov 13, 2020	131	Motion for Extension of Time (Proposed Order (PDF Only)) (1) Docket Text: Unopposed MOTION for Extension of Time to Refile Fed. R. Evid. 702 Motion by Defendant Sandoz Inc.. (Attachments: # (1) Proposed Order (PDF Only))(Filarski, Thomas)
Nov 13, 2020	N/A	Order on Motion for Extension of Time to File (0) Docket Text: ORDER granting [131] Motion for Extension of Time to File :Rule 702 motions due Nov. 24, 2020. By Judge Marcia S. Krieger on 11/13/20. Text Only Entry(msklc2, )
Nov 6, 2020	N/A	Order on Motion to Withdraw as Attorney (0) Docket Text: ORDER granting [129] Motion to Withdraw as Attorney. Attorney Ryann Morgan Muir terminated. By Judge Marcia S. Krieger on 11/6/20. Text Only Entry(msklc2, )
Nov 5, 2020	129	Motion to Withdraw as Attorney (Main Document) (4) Docket Text: Unopposed MOTION to Withdraw as Attorney Ryann M. Muir by Defendant Sandoz Inc.. (Attachments: # (1) Proposed Order (PDF Only))(Filarski, Thomas)
Nov 5, 2020	129	Motion to Withdraw as Attorney (Proposed Order (PDF Only)) (1) Docket Text: Unopposed MOTION to Withdraw as Attorney Ryann M. Muir by Defendant Sandoz Inc.. (Attachments: # (1) Proposed Order (PDF Only))(Filarski, Thomas)
Oct 27, 2020	N/A	Order on Motion to Exclude (0) Docket Text: ORDER: The Defendant's Motion to Exclude Under Rule 702 [110] was admittedly filed in conformance with the Rule 702 procedure that the Court employed at the time the motion was filed. However, as of January 2020, the Court has modified its Rule 702 procedure to diminish the need for evidentiary hearings and favor the resolution of motions on paper. Accordingly, the Court denies the Defendant's motion without prejudice. Within 21 days of this Order, the Defendant may re-file a Rule 702 motion that complies with the current Rule 702 procedure, found at http://www.cod.uscourts.gov/Portals/0/Documents/Judges/MSK/Rule_702_Procedure.pdf. Given the age of this matter, the Court will attempt to give any re-filed Rule 702 motion prioritized consideration.As to the Plaintiffs' Motion to Restrict [112] public access to certain filings prior to the transfer of this case to this District, the sole grounds stated are that the materials in question implicate a previously-issued Protective Order. Pursuant to D.C. Colo. L. Civ. R. 7.2(c)(2), the mere fact that a document is covered by a protective order is not sufficient to warrant a restriction on public access. Accordingly, the motion is denied without prejudice. Within 14 days, any party may file a renewed motion that specifically identifies the particular portions of the documents in question and makes a sufficient showing as required by Local Rule 7.2(c). By Judge Marcia S. Krieger on 10/27/20. Text Only Entry(msklc2, )
Sep 11, 2020	N/A	Order on Motion to Withdraw as Attorney (0) Docket Text: ORDER granting [125] Motion to Withdraw as Attorney. Attorney Elizabeth Marjorie Flanagan; Phillip Wagner Goter; Susan E. Morrison; Deanna Jean Reichel; Jonathan E. Singer; Kelly A. Del Dotto and John M. Farrell terminated. By Judge Marcia S. Krieger on 9/11/20. Text Only Entry(msklc2, )
Aug 14, 2020	126	Notice (Other) (2) Docket Text: Proposed Order re [125] Unopposed MOTION to Withdraw as Attorney Proposed Order Granting Unopposed Motion to Withdraw Appearance by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Dulin, Michael) Modified on 8/19/2020 to edit document title. (sphil, ).
Aug 6, 2020	125	Motion to Withdraw as Attorney (5) Docket Text: Unopposed MOTION to Withdraw as Attorney by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Flanagan, Elizabeth)
Aug 3, 2020	123	Notice of Entry of Appearance (2) Docket Text: NOTICE of Entry of Appearance by Lisa B. Pensabene on behalf of Allergan Sales, LLC, Allergan, Inc., Duke University Attorney Lisa B. Pensabene added to party Allergan Sales, LLC(pty:pla), Attorney Lisa B. Pensabene added to party Allergan, Inc.(pty:cd), Attorney Lisa B. Pensabene added to party Duke University (pty:pla) (Pensabene, Lisa)
Aug 3, 2020	124	Notice of Entry of Appearance (2) Docket Text: NOTICE of Entry of Appearance by Hassen Amir Sayeed on behalf of Allergan Sales, LLC, Allergan, Inc., Duke University Attorney Hassen Amir Sayeed added to party Allergan Sales, LLC(pty:pla), Attorney Hassen Amir Sayeed added to party Allergan, Inc.(pty:cd), Attorney Hassen Amir Sayeed added to party Duke University (pty:pla) (Sayeed, Hassen)
May 13, 2020	121	Corporate Disclosure Statement (4) Docket Text: CORPORATE DISCLOSURE STATEMENT identifying Other Affiliate AbbVie Inc. for Allergan, Inc.. (Morrison, Susan)
May 13, 2020	122	Corporate Disclosure Statement (4) Docket Text: CORPORATE DISCLOSURE STATEMENT identifying Other Affiliate AbbVie Inc. for Allergan Sales, LLC. (Morrison, Susan)
Oct 23, 2019	120	Notice (Other) (4) Docket Text: NOTICE of Related Cases (Supplemental) by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Morrison, Susan)
Oct 10, 2019	119	Notice of Entry of Appearance (2) Docket Text: NOTICE of Entry of Appearance by Eric Shaun Hochstadt on behalf of Allergan Sales, LLC, Allergan, Inc., Duke University (Hochstadt, Eric)
Oct 9, 2019	117	Notice of Entry of Appearance (2) Docket Text: NOTICE of Entry of Appearance by Jonathan E. Singer on behalf of Allergan Sales, LLC, Allergan, Inc., Duke University Attorney Jonathan E. Singer added to party Allergan, Inc.(pty:cd) (Singer, Jonathan)
Oct 9, 2019	118	Notice of Entry of Appearance (2) Docket Text: NOTICE of Entry of Appearance by John M. Farrell on behalf of Allergan Sales, LLC, Allergan, Inc., Duke University Attorney John M. Farrell added to party Allergan, Inc.(pty:cd) (Farrell, John)
Oct 8, 2019	N/A	ADVISORY Notice to Attorney(s) (0) Docket Text: ADVISORY NOTICE TO ATTORNEY AND COURT: Under D.C.COLO.LAttyR 3(a)attorneys JOHN MICHAEL FARRELL, ERIC SHAUN HOCHSTADT, JONATHAN ELLIOT SINGER were administratively removed from the court's attorney roll and barred from filing electronically under CM/ECF for failing to pay the 2018 Biennial Fee. Each attorney must complete a Bar/ECF application through that attorney's Attorney Services Portal account and pay the full application fee to be restored to the attorney roll and CM/ECF. Upon reinstatement, counsel must file a Notice of Entry of Appearance in this case. (Text Only Entry) (mfred)
Sep 30, 2019	115	Notice (Other) (Main Document) (6) Docket Text: NOTICE of Related Cases by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) Exhibit A)(Flanagan, Elizabeth)
Sep 30, 2019	115	Notice (Other) (Exhibit A) (28) Docket Text: NOTICE of Related Cases by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) Exhibit A)(Flanagan, Elizabeth)
Sep 25, 2019	112	Motion for Leave to Restrict (4) Docket Text: MOTION for Leave to Restrict by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (Main Document) (12) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX C.A. No. 17-528 Docket Sheet) (10) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 2) (1) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 3) (3) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 4) (3) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 5) (3) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 8) (4) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 13) (2) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 17) (2) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 27) (30) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 28 Ex 1-3) (30) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 28 Ex 4) (29) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 29) (24) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 30) (30) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 31) (3) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 32) (3) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 33) (3) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 34) (3) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 39) (5) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 44) (21) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 45) (18) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 48) (8) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 49) (5) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 50) (5) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 54) (30) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 58) (2) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 59) (30) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 60) (3) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 61) (3) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 62) (23) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 63) (4) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 64) (3) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 65) (17) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 73) (30) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 76) (30) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 77) (18) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 78) (9) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 79) (10) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 80) (18) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 81) (8) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 84) (3) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 85) (9) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 86) (9) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 87) (16) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 88) (11) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 89) (9) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 90) (12) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 91) (2) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 92) (30) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 93) (30) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 94) (10) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 95) (7) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 98) (3) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 99) (3) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 100) (1) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 102) (4) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 103) (1) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 104) (7) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 105) (6) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 106) (5) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 25, 2019	113	Notice (Other) (EDTX Dkt. No. 107) (6) Docket Text: NOTICE re [111] Order,, Terminate Motions, of Compliance regarding the public documents filed in the Eastern District of Texas by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Attachments: # (1) EDTX C.A. No. 17-528 Docket Sheet, # (2) EDTX Dkt. No. 2, # (3) EDTX Dkt. No. 3, # (4) EDTX Dkt. No. 4, # (5) EDTX Dkt. No. 5, # (6) EDTX Dkt. No. 8, # (7) EDTX Dkt. No. 13, # (8) EDTX Dkt. No. 17, # (9) EDTX Dkt. No. 27, # (10) EDTX Dkt. No. 28 Ex 1-3, # (11) EDTX Dkt. No. 28 Ex 4, # (12) EDTX Dkt. No. 29, # (13) EDTX Dkt. No. 30, # (14) EDTX Dkt. No. 31, # (15) EDTX Dkt. No. 32, # (16) EDTX Dkt. No. 33, # (17) EDTX Dkt. No. 34, # (18) EDTX Dkt. No. 39, # (19) EDTX Dkt. No. 44, # (20) EDTX Dkt. No. 45, # (21) EDTX Dkt. No. 48, # (22) EDTX Dkt. No. 49, # (23) EDTX Dkt. No. 50, # (24) EDTX Dkt. No. 54, # (25) EDTX Dkt. No. 58, # (26) EDTX Dkt. No. 59, # (27) EDTX Dkt. No. 60, # (28) EDTX Dkt. No. 61, # (29) EDTX Dkt. No. 62, # (30) EDTX Dkt. No. 63, # (31) EDTX Dkt. No. 64, # (32) EDTX Dkt. No. 65, # (33) EDTX Dkt. No. 73, # (34) EDTX Dkt. No. 76, # (35) EDTX Dkt. No. 77, # (36) EDTX Dkt. No. 78, # (37) EDTX Dkt. No. 79, # (38) EDTX Dkt. No. 80, # (39) EDTX Dkt. No. 81, # (40) EDTX Dkt. No. 84, # (41) EDTX Dkt. No. 85, # (42) EDTX Dkt. No. 86, # (43) EDTX Dkt. No. 87, # (44) EDTX Dkt. No. 88, # (45) EDTX Dkt. No. 89, # (46) EDTX Dkt. No. 90, # (47) EDTX Dkt. No. 91, # (48) EDTX Dkt. No. 92, # (49) EDTX Dkt. No. 93, # (50) EDTX Dkt. No. 94, # (51) EDTX Dkt. No. 95, # (52) EDTX Dkt. No. 98, # (53) EDTX Dkt. No. 99, # (54) EDTX Dkt. No. 100, # (55) EDTX Dkt. No. 102, # (56) EDTX Dkt. No. 103, # (57) EDTX Dkt. No. 104, # (58) EDTX Dkt. No. 105, # (59) EDTX Dkt. No. 106, # (60) EDTX Dkt. No. 107)(Flanagan, Elizabeth)
Sep 18, 2019	111	Order (11) Docket Text: OPINION and ORDER by Judge Marcia S. Krieger on 9/18/2019. ORDERED the Plaintiffs' Motion to Bifurcate (#42) and Plaintiffs' Motion to Expedite (#43) consideration of the Motion to Bifurcate are DENIED AS MOOT. Sandoz's Motion for Summary Judgment (#47) is DENIED. (sphil, )
Sep 4, 2019	110	Motion to Exclude (13) Docket Text: MOTION to Exclude Sandoz Inc.'s Motion under Fed. R. Evid. 702 by Defendant Sandoz Inc.. (Filarski, Thomas)
Jul 22, 2019	109	Order on Motion to Amend/Correct/Modify (1) Docket Text: MINUTE ORDER by Magistrate Judge Kristen L. Mix on 7/22/19. Joint Motion to Amend Scheduling Order [ECF No. 36] and Minute Order [ECF Nos. 80, 92, and 105] [107] is GRANTED. Dispositive Motions due by 9/4/2019. Expert Discovery due 7/24/2019(lgale, )
Jul 19, 2019	107	Motion to Amend/Correct/Modify (Main Document) (4) Docket Text: Joint MOTION to Amend/Correct/Modify [92] Order on Motion to Amend/Correct/Modify,,,, [80] Order on Motion to Amend/Correct/Modify, [105] Order on Motion to Amend/Correct/Modify, [36] Scheduling Order by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Attachments: # (1) Proposed Order (PDF Only))(Flanagan, Elizabeth)
Jul 19, 2019	107	Motion to Amend/Correct/Modify (Proposed Order (PDF Only)) (2) Docket Text: Joint MOTION to Amend/Correct/Modify [92] Order on Motion to Amend/Correct/Modify,,,, [80] Order on Motion to Amend/Correct/Modify, [105] Order on Motion to Amend/Correct/Modify, [36] Scheduling Order by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Attachments: # (1) Proposed Order (PDF Only))(Flanagan, Elizabeth)
Jul 19, 2019	N/A	Memorandum (0) Docket Text: MEMORANDUM regarding [107] Joint Motion to Amend Scheduling Order and Minute Orders filed by Allergan Sales, LLC, Allergan, Inc., Duke University. Motion referred to Magistrate Judge Kristen L. Mix by Judge Marcia S. Krieger on 7/19/2019. Text Only Entry (msklc4)
Jul 17, 2019	106	Notice of Entry of Appearance (2) Docket Text: NOTICE of Entry of Appearance by Gretchen Porter Miller on behalf of Sandoz Inc.Attorney Gretchen Porter Miller added to party Sandoz Inc.(pty:dft) (Miller, Gretchen)
Jun 17, 2019	105	Order on Motion to Amend/Correct/Modify (1) Docket Text: MINUTE ORDER by Magistrate Judge Kristen L. Mix on 6/17/19. Joint Motion to Amend Scheduling Order [ECF No. 36] and Minute Order [ECF Nos. 80 and 92] [103] is GRANTED. Discovery due by 7/19/2019. Dispositive Motions due by 8/9/2019. (lgale, )
Jun 14, 2019	103	Motion to Amend/Correct/Modify (Main Document) (4) Docket Text: Joint MOTION to Amend/Correct/Modify [92] Order on Motion to Amend/Correct/Modify,,,, [80] Order on Motion to Amend/Correct/Modify, [36] Scheduling Order Scheduling Order and Minute Orders by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Attachments: # (1) Proposed Order (PDF Only))(Flanagan, Elizabeth)
Jun 14, 2019	103	Motion to Amend/Correct/Modify (Proposed Order (PDF Only)) (2) Docket Text: Joint MOTION to Amend/Correct/Modify [92] Order on Motion to Amend/Correct/Modify,,,, [80] Order on Motion to Amend/Correct/Modify, [36] Scheduling Order Scheduling Order and Minute Orders by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Attachments: # (1) Proposed Order (PDF Only))(Flanagan, Elizabeth)
Jun 14, 2019	N/A	Memorandum (0) Docket Text: MEMORANDUM regarding [103] Joint MOTION to Amend/Correct/Modify [92] Order on Motion to Amend/Correct/Modify,,,, [80] Order on Motion to Amend/Correct/Modify, [36] Scheduling Order Scheduling Order and Minute Orders filed by Allergan Sales, LLC, Allergan, Inc., Duke University. Motions referred to Magistrate Judge Kristen L. Mix by Judge Marcia S. Krieger on 6/14/19. Text Only Entry (msklc2, )
May 3, 2019	102	Order Referring Case to Special Master (3) Docket Text: ORDER Appointing Master for Discovery. Pursuant to Fed. R. Civ. P. 53, J. Gregory Whitehair, Esq. is APPOINTED MASTER for the purpose of managing and supervising discovery and resolving discovery disputes until further order of this Court, by Magistrate Judge Kristen L. Mix on 5/3/2019. (agarc, )
Apr 25, 2019	101	Order (Main Document) (2) Docket Text: NOTICE AND ORDER REGARDING APPOINTMENT OF SPECIAL MASTER by Magistrate Judge Kristen L. Mix on 4/25/19. (lgale, ) (Additional attachment(s) added on 4/25/2019: # (1) Special Master Affidavit) (jgonz, ).
Apr 25, 2019	101	Order (Special Master Affidavit) (6) Docket Text: NOTICE AND ORDER REGARDING APPOINTMENT OF SPECIAL MASTER by Magistrate Judge Kristen L. Mix on 4/25/19. (lgale, ) (Additional attachment(s) added on 4/25/2019: # (1) Special Master Affidavit) (jgonz, ).
Apr 23, 2019	N/A	Order (0) Docket Text: ORDER vacating Discovery Hearing set for April 24, 2019 at 1:00 p.m. On review of the parties' submissions, the court finds that this matter is suitable for appointment of a discovery Master pursuant to Fed. R. Civ. P. 53(a)(1)(C). Accordingly, the discovery hearing set for April 24, 2019 at 1:00 p.m. is VACATED. Further orders regarding appointment of a discovery Master will be entered in due course. By Magistrate Judge Kristen L. Mix on April 23, 2019. Text Only Entry (klm)
Apr 23, 2019	100	Transcript (35) Docket Text: TRANSCRIPT of TRANSCRIPT OF PROCEEDINGS held on 04/12/2019 before Magistrate Judge Mix. Pages: 1-35. Prepared by: AB Court Reporting & Video, Inc.. NOTICE - REDACTION OF TRANSCRIPTS: Within seven calendar days of this filing, each party shall inform the Court, by filing a Notice of Intent to Redact, of the party's intent to redact personal identifiers from the electronic transcript of the court proceeding. If a Notice of Intent to Redact is not filed within the allotted time, this transcript will be made electronically available after 90 days. Please see the Notice of Electronic Availability of Transcripts document at www.cod.uscourts.gov. Transcript may only be viewed at the court public terminal or purchased through the Court Reporter/Transcriber prior to the 90 day deadline for electronic posting on PACER. (AB Court Reporting & Video, Inc., )
Apr 18, 2019	98	Status Report (3) Docket Text: Joint STATUS REPORT by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Flanagan, Elizabeth)
Apr 16, 2019	97	Minute Order (1) Docket Text: MINUTE ORDER by Magistrate Judge Kristen L. Mix on 4/16/19. Discovery Hearing set for 4/24/2019 1:00 PM in Courtroom A401 before Magistrate Judge Kristen L. Mix. (lgale, )
Apr 15, 2019	95	Motion to Withdraw Document (Main Document) (4) Docket Text: Unopposed MOTION to Withdraw Document re [41] MOTION to Dismiss Sandoz's Counterclaims by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Attachments: # (1) Proposed Order (PDF Only))(Flanagan, Elizabeth)
Apr 15, 2019	95	Motion to Withdraw Document (Proposed Order (PDF Only)) (1) Docket Text: Unopposed MOTION to Withdraw Document re [41] MOTION to Dismiss Sandoz's Counterclaims by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Attachments: # (1) Proposed Order (PDF Only))(Flanagan, Elizabeth)
Apr 15, 2019	N/A	Order on Motion to Dismiss (0) Docket Text: ORDER withdrawing [41] Motion to Dismiss; granting [95] Motion to Withdraw Document: The motion to dismiss is deemed withdrawn. By Judge Marcia S. Krieger on 4/15/19. Text Only Entry (msklc2, )
Apr 12, 2019	94	Discovery Hearing (2) Docket Text: MINUTE ENTRY for Discovery Hearing held before Magistrate Judge Kristen L. Mix on 4/12/2019. FTR: KLM Courtroom A401. (lgale, )
Apr 4, 2019	93	Minute Order (1) Docket Text: MINUTE ORDER by Magistrate Judge Kristen L. Mix on 4/4/19. This matter is before the Court on a disputed discovery issue. Discovery Hearing set for 4/12/2019 09:00 AM in Courtroom A 401 before Magistrate Judge Kristen L. Mix. Attorneys who will be representing a party and who reside in Colorado shall appear in person in Courtroom A-401 of the Alfred A. Arraj United StatesCourthouse, 901 19th Street, Denver, Colorado. Any attorneys who do not reside in Colorado and who plan to attend the hearing shall appear by telephone by first conferencing together and then calling Chambers at (303) 335-2770 via a land line at the designated time. (nmarb, )
Apr 2, 2019	N/A	Set/Reset Deadlines (0) Docket Text: ***Set/Reset Deadlines: Status Report due by 4/18/2019 pursuant to [92] Order. (nmarb, )
Apr 2, 2019	N/A	Order on Motion to Bifurcate (0) Docket Text: ORDER granting [76] Joint Motion to Stay Discovery on Counterclaims and Bifurcate Trial on Counterclaims. For the reasons set forth in the Motion, discovery on Defendant's Counterclaims is STAYED and trial on the Counterclaims is BIFURCATED. Counterclaim Defendants shall file a motion to withdraw their pending Motion to Dismiss Counterclaims [41] no later than April 15, 2019. B Magistrate Judge Kristen L. Mix on April 2, 2019. Text Only Entry (klm)
Apr 2, 2019	N/A	Order on Motion for Hearing/Conference (0) Docket Text: ORDER denying as moot [85] Motion for Hearing/Conference. In light of the Order on the parties' Joint Motion to Bifurcate and Stay Discovery and Trial on Counterclaims [76], no hearing is necessary. By Magistrate Judge Kristen L. Mix on April 2, 2019. Text Only Entry (klm)
Apr 2, 2019	N/A	Order on Motion to Amend/Correct/Modify (0) Docket Text: ORDER granting in part and denying in part [88] Motion to Amend/Correct/ModifyScheduling Order. In light of the previous Order staying discovery as to antitrust issues and for good cause shown, the Scheduling Order is amended as follows: The deadline to complete fact discovery relating to patent issues is extended to April 12, 2019 except for completion of the deposition of Christine Miller. The deadline to complete Ms. Miller's deposition is April 30, 2019. The deadline to file a Joint Status Report is extended to April 18, 2019. The deadline for final infringement contentions is extended to April 19, 2019. The deadline for final invalidity contentions is extended to May 3, 2019. The deadline for opening expert reports is extended to May 17, 2019. The deadline for rebuttal expert reports is extended to June 14, 2019. The expert discovery deadline is extended to June 28, 2019. All other deadlines are unchanged. The parties shall jointly propose a Scheduling Order regarding adjudication of Defendant's Counterclaims within 30 days of final adjudication of the patent claims in this Court. By Magistrate Judge Kristen L. Mix on April 2, 2019. Text Only Entry (klm)
Mar 29, 2019	N/A	Memorandum (0) Docket Text: MEMORANDUM regarding [88] Joint MOTION to Amend/Correct/Modify [80] Order on Motion to Amend/Correct/Modify, [36] Scheduling Order filed by Sandoz Inc.. Motions referred to Magistrate Judge Kristen L. Mix by Judge Marcia S. Krieger on 3/29/19. Text Only Entry (msklc2, )
Mar 28, 2019	88	Motion to Amend/Correct/Modify (Main Document) (11) Docket Text: Joint MOTION to Amend/Correct/Modify [80] Order on Motion to Amend/Correct/Modify, [36] Scheduling Order by Defendant Sandoz Inc.. (Attachments: # (1) Proposed Order (PDF Only))(Filarski, Thomas)
Mar 28, 2019	88	Motion to Amend/Correct/Modify (Proposed Order (PDF Only)) (4) Docket Text: Joint MOTION to Amend/Correct/Modify [80] Order on Motion to Amend/Correct/Modify, [36] Scheduling Order by Defendant Sandoz Inc.. (Attachments: # (1) Proposed Order (PDF Only))(Filarski, Thomas)
Mar 14, 2019	87	Notice of Entry of Appearance (2) Docket Text: NOTICE of Entry of Appearance of Counsel by Kelly Nicole Williams on behalf of Allergan Sales, LLC, Allergan, Inc., Duke University (Williams, Kelly)
Mar 13, 2019	85	Motion for Hearing/Conference (Main Document) (4) Docket Text: Joint MOTION for Hearing/Conference re [76] Joint MOTION to Bifurcate and Stay Discovery and Trial Regarding Sandoz Inc.'s Counterclaims by Defendant Sandoz Inc.. (Attachments: # (1) Proposed Order (PDF Only))(Young, Daniel)
Mar 13, 2019	85	Motion for Hearing/Conference (Proposed Order (PDF Only)) (2) Docket Text: Joint MOTION for Hearing/Conference re [76] Joint MOTION to Bifurcate and Stay Discovery and Trial Regarding Sandoz Inc.'s Counterclaims by Defendant Sandoz Inc.. (Attachments: # (1) Proposed Order (PDF Only))(Young, Daniel)
Mar 13, 2019	N/A	Memorandum (0) Docket Text: MEMORANDUM regarding [76] Joint MOTION to Bifurcate and Stay Discovery and Trial Regarding Sandoz Inc.'s Counterclaims filed by Sandoz Inc., [85] Joint MOTION for Hearing/Conference re [76] Joint MOTION to Bifurcate and Stay Discovery and Trial Regarding Sandoz Inc.'s Counterclaims filed by Sandoz Inc.. Motions referred to Magistrate Judge Kristen L. Mix by Judge Marcia S. Krieger on 3/12/19. Text Only Entry (msklc2, )
Mar 5, 2019	N/A	Order on Motion to Withdraw as Attorney (0) Docket Text: ORDER granting [83] Motion to Withdraw as Attorney. Attorney Matthew Michael Zuziak terminated. By Judge Marcia S. Krieger on 3/5/19. Text Only Entry (msklc2, )
Feb 27, 2019	83	Motion to Withdraw as Attorney (Main Document) (4) Docket Text: Unopposed MOTION to Withdraw as Attorney Matthew M. Zuziak by Defendant Sandoz Inc.. (Attachments: # (1) Proposed Order (PDF Only))(Kappers, Robert)
Feb 27, 2019	83	Motion to Withdraw as Attorney (Proposed Order (PDF Only)) (1) Docket Text: Unopposed MOTION to Withdraw as Attorney Matthew M. Zuziak by Defendant Sandoz Inc.. (Attachments: # (1) Proposed Order (PDF Only))(Kappers, Robert)
Feb 20, 2019	82	Stipulation for Extension of Time (4) Docket Text: STIPULATION for Extension of Time various discovery deadlines by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Flanagan, Elizabeth)
Feb 1, 2019	81	Stipulation for Extension of Time (2) Docket Text: STIPULATION for Extension of Time to Respond to Sandoz, Inc.s Subpoena to Gregory J. Hartwig by Defendant Sandoz Inc.. (Filarski, Thomas)
Jan 31, 2019	80	Order on Motion to Amend/Correct/Modify (1) Docket Text: MINUTE ORDER by Magistrate Judge Kristen L. Mix on 1/31/19. Stipulated Motion to Amend Scheduling Order [78] is GRANTED. Fact Discovery due 4/1/2019. Final Infringement Contentions due 4/15/2019. Final Invalidity Contentions due 4/29/2019. Opinion of Counsel due 2/11/2019. Status Report due by 4/8/2019. (lgale, )
Jan 30, 2019	78	Motion to Amend/Correct/Modify (Main Document) (4) Docket Text: Stipulated MOTION to Amend/Correct/Modify [36] Scheduling Order by Defendant Sandoz Inc.. (Attachments: # (1) Proposed Order (PDF Only))(Filarski, Thomas)
Jan 30, 2019	78	Motion to Amend/Correct/Modify (Proposed Order (PDF Only)) (2) Docket Text: Stipulated MOTION to Amend/Correct/Modify [36] Scheduling Order by Defendant Sandoz Inc.. (Attachments: # (1) Proposed Order (PDF Only))(Filarski, Thomas)
Jan 30, 2019	N/A	Memorandum (0) Docket Text: MEMORANDUM regarding [78] Stipulated MOTION to Amend/Correct/Modify [36] Scheduling Order filed by Sandoz Inc.. Motions referred to Magistrate Judge Kristen L. Mix by Chief Judge Marcia S. Krieger on 1/30/19. Text Only Entry (msklc2, )
Jan 28, 2019	77	Notice (Other) (5) Docket Text: NOTICE Plaintiffs' Request for Oral Argument on Defendant's Motion for Summary Judgment Based on Collateral Estoppel by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc. (Flanagan, Elizabeth)
Jan 22, 2019	76	Motion to Bifurcate (Main Document) (4) Docket Text: Joint MOTION to Bifurcate and Stay Discovery and Trial Regarding Sandoz Inc.'s Counterclaims by Defendant Sandoz Inc.. (Attachments: # (1) Proposed Order (PDF Only))(Filarski, Thomas)
Jan 22, 2019	76	Motion to Bifurcate (Proposed Order (PDF Only)) (2) Docket Text: Joint MOTION to Bifurcate and Stay Discovery and Trial Regarding Sandoz Inc.'s Counterclaims by Defendant Sandoz Inc.. (Attachments: # (1) Proposed Order (PDF Only))(Filarski, Thomas)
Jan 18, 2019	75	Stipulation for Extension of Time (3) Docket Text: STIPULATION for Extension of Time to respond to Sandoz Subpoena to Dr. Mitchel deLong by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Flanagan, Elizabeth)
Jan 17, 2019	74	Reply to Response to Motion (24) Docket Text: REPLY to Response to [47] MOTION for Summary Judgment based on Collateral Estoppel filed by Defendant Sandoz Inc.. (Filarski, Thomas)
Jan 11, 2019	70	Notice of Entry of Appearance (2) Docket Text: NOTICE of Entry of Appearance by Deanna Jean Reichel on behalf of Allergan Sales, LLC, Allergan, Inc., Duke University Attorney Deanna Jean Reichel added to party Allergan Sales, LLC(pty:pla), Attorney Deanna Jean Reichel added to party Allergan, Inc.(pty:cd), Attorney Deanna Jean Reichel added to party Duke University (pty:pla) (Reichel, Deanna)
Jan 11, 2019	71	Notice of Entry of Appearance (2) Docket Text: NOTICE of Entry of Appearance by Phillip Wagner Goter on behalf of Allergan Sales, LLC, Allergan, Inc., Duke University Attorney Phillip Wagner Goter added to party Allergan Sales, LLC(pty:pla), Attorney Phillip Wagner Goter added to party Allergan, Inc.(pty:cd), Attorney Phillip Wagner Goter added to party Duke University (pty:pla) (Goter, Phillip)
Jan 11, 2019	72	Notice of Entry of Appearance (2) Docket Text: NOTICE of Entry of Appearance by Kelly A. Del Dotto on behalf of Allergan Sales, LLC, Allergan, Inc., Duke University Attorney Kelly A. Del Dotto added to party Allergan Sales, LLC(pty:pla), Attorney Kelly A. Del Dotto added to party Allergan, Inc.(pty:cd), Attorney Kelly A. Del Dotto added to party Duke University (pty:pla) (Del Dotto, Kelly)
Jan 11, 2019	73	Notice of Entry of Appearance (2) Docket Text: NOTICE of Entry of Appearance by Susan E. Morrison on behalf of Allergan Sales, LLC, Allergan, Inc., Duke University Attorney Susan E. Morrison added to party Allergan Sales, LLC(pty:pla), Attorney Susan E. Morrison added to party Allergan, Inc.(pty:cd), Attorney Susan E. Morrison added to party Duke University (pty:pla) (Morrison, Susan)
Dec 31, 2018	69	Stipulation for Extension of Time (3) Docket Text: STIPULATION for Extension of Time to Respond to Discovery Requests by Defendant Sandoz Inc.. (Filarski, Thomas)
Dec 20, 2018	68	Brief in Opposition to Motion (Main Document) (30) Docket Text: BRIEF in Opposition to [47] MOTION for Summary Judgment based on Collateral Estoppel filed by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Attachments: # (1) Exhibit 10, # (2) Exhibit 11, # (3) Exhibit 12, # (4) Exhibit 13, # (5) Exhibit 14, # (6) Exhibit 15, # (7) Exhibit 16, # (8) Exhibit 17, # (9) Exhibit 18, # (10) Exhibit 19, # (11) Exhibit 20, # (12) Exhibit 21, # (13) Exhibit 22, # (14) Exhibit 23, # (15) Exhibit 24, # (16) Exhibit 25, # (17) Exhibit 26, # (18) Exhibit 27, # (19) Exhibit 28, # (20) Exhibit 29, # (21) Exhibit 30, # (22) Exhibit 31, # (23) Exhibit 32, # (24) Exhibit 33, # (25) Exhibit 34, # (26) Exhibit 35, # (27) Exhibit 36, # (28) Exhibit 37)(Flanagan, Elizabeth)
Dec 20, 2018	68	Brief in Opposition to Motion (Exhibit 10) (30) Docket Text: BRIEF in Opposition to [47] MOTION for Summary Judgment based on Collateral Estoppel filed by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Attachments: # (1) Exhibit 10, # (2) Exhibit 11, # (3) Exhibit 12, # (4) Exhibit 13, # (5) Exhibit 14, # (6) Exhibit 15, # (7) Exhibit 16, # (8) Exhibit 17, # (9) Exhibit 18, # (10) Exhibit 19, # (11) Exhibit 20, # (12) Exhibit 21, # (13) Exhibit 22, # (14) Exhibit 23, # (15) Exhibit 24, # (16) Exhibit 25, # (17) Exhibit 26, # (18) Exhibit 27, # (19) Exhibit 28, # (20) Exhibit 29, # (21) Exhibit 30, # (22) Exhibit 31, # (23) Exhibit 32, # (24) Exhibit 33, # (25) Exhibit 34, # (26) Exhibit 35, # (27) Exhibit 36, # (28) Exhibit 37)(Flanagan, Elizabeth)
Dec 20, 2018	68	Brief in Opposition to Motion (Exhibit 11) (30) Docket Text: BRIEF in Opposition to [47] MOTION for Summary Judgment based on Collateral Estoppel filed by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Attachments: # (1) Exhibit 10, # (2) Exhibit 11, # (3) Exhibit 12, # (4) Exhibit 13, # (5) Exhibit 14, # (6) Exhibit 15, # (7) Exhibit 16, # (8) Exhibit 17, # (9) Exhibit 18, # (10) Exhibit 19, # (11) Exhibit 20, # (12) Exhibit 21, # (13) Exhibit 22, # (14) Exhibit 23, # (15) Exhibit 24, # (16) Exhibit 25, # (17) Exhibit 26, # (18) Exhibit 27, # (19) Exhibit 28, # (20) Exhibit 29, # (21) Exhibit 30, # (22) Exhibit 31, # (23) Exhibit 32, # (24) Exhibit 33, # (25) Exhibit 34, # (26) Exhibit 35, # (27) Exhibit 36, # (28) Exhibit 37)(Flanagan, Elizabeth)
Dec 20, 2018	68	Brief in Opposition to Motion (Exhibit 12) (15) Docket Text: BRIEF in Opposition to [47] MOTION for Summary Judgment based on Collateral Estoppel filed by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Attachments: # (1) Exhibit 10, # (2) Exhibit 11, # (3) Exhibit 12, # (4) Exhibit 13, # (5) Exhibit 14, # (6) Exhibit 15, # (7) Exhibit 16, # (8) Exhibit 17, # (9) Exhibit 18, # (10) Exhibit 19, # (11) Exhibit 20, # (12) Exhibit 21, # (13) Exhibit 22, # (14) Exhibit 23, # (15) Exhibit 24, # (16) Exhibit 25, # (17) Exhibit 26, # (18) Exhibit 27, # (19) Exhibit 28, # (20) Exhibit 29, # (21) Exhibit 30, # (22) Exhibit 31, # (23) Exhibit 32, # (24) Exhibit 33, # (25) Exhibit 34, # (26) Exhibit 35, # (27) Exhibit 36, # (28) Exhibit 37)(Flanagan, Elizabeth)
Dec 20, 2018	68	Brief in Opposition to Motion (Exhibit 13) (18) Docket Text: BRIEF in Opposition to [47] MOTION for Summary Judgment based on Collateral Estoppel filed by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Attachments: # (1) Exhibit 10, # (2) Exhibit 11, # (3) Exhibit 12, # (4) Exhibit 13, # (5) Exhibit 14, # (6) Exhibit 15, # (7) Exhibit 16, # (8) Exhibit 17, # (9) Exhibit 18, # (10) Exhibit 19, # (11) Exhibit 20, # (12) Exhibit 21, # (13) Exhibit 22, # (14) Exhibit 23, # (15) Exhibit 24, # (16) Exhibit 25, # (17) Exhibit 26, # (18) Exhibit 27, # (19) Exhibit 28, # (20) Exhibit 29, # (21) Exhibit 30, # (22) Exhibit 31, # (23) Exhibit 32, # (24) Exhibit 33, # (25) Exhibit 34, # (26) Exhibit 35, # (27) Exhibit 36, # (28) Exhibit 37)(Flanagan, Elizabeth)
Dec 20, 2018	68	Brief in Opposition to Motion (Exhibit 14) (7) Docket Text: BRIEF in Opposition to [47] MOTION for Summary Judgment based on Collateral Estoppel filed by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Attachments: # (1) Exhibit 10, # (2) Exhibit 11, # (3) Exhibit 12, # (4) Exhibit 13, # (5) Exhibit 14, # (6) Exhibit 15, # (7) Exhibit 16, # (8) Exhibit 17, # (9) Exhibit 18, # (10) Exhibit 19, # (11) Exhibit 20, # (12) Exhibit 21, # (13) Exhibit 22, # (14) Exhibit 23, # (15) Exhibit 24, # (16) Exhibit 25, # (17) Exhibit 26, # (18) Exhibit 27, # (19) Exhibit 28, # (20) Exhibit 29, # (21) Exhibit 30, # (22) Exhibit 31, # (23) Exhibit 32, # (24) Exhibit 33, # (25) Exhibit 34, # (26) Exhibit 35, # (27) Exhibit 36, # (28) Exhibit 37)(Flanagan, Elizabeth)
Dec 20, 2018	68	Brief in Opposition to Motion (Exhibit 15) (3) Docket Text: BRIEF in Opposition to [47] MOTION for Summary Judgment based on Collateral Estoppel filed by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Attachments: # (1) Exhibit 10, # (2) Exhibit 11, # (3) Exhibit 12, # (4) Exhibit 13, # (5) Exhibit 14, # (6) Exhibit 15, # (7) Exhibit 16, # (8) Exhibit 17, # (9) Exhibit 18, # (10) Exhibit 19, # (11) Exhibit 20, # (12) Exhibit 21, # (13) Exhibit 22, # (14) Exhibit 23, # (15) Exhibit 24, # (16) Exhibit 25, # (17) Exhibit 26, # (18) Exhibit 27, # (19) Exhibit 28, # (20) Exhibit 29, # (21) Exhibit 30, # (22) Exhibit 31, # (23) Exhibit 32, # (24) Exhibit 33, # (25) Exhibit 34, # (26) Exhibit 35, # (27) Exhibit 36, # (28) Exhibit 37)(Flanagan, Elizabeth)
Dec 20, 2018	68	Brief in Opposition to Motion (Exhibit 16) (4) Docket Text: BRIEF in Opposition to [47] MOTION for Summary Judgment based on Collateral Estoppel filed by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Attachments: # (1) Exhibit 10, # (2) Exhibit 11, # (3) Exhibit 12, # (4) Exhibit 13, # (5) Exhibit 14, # (6) Exhibit 15, # (7) Exhibit 16, # (8) Exhibit 17, # (9) Exhibit 18, # (10) Exhibit 19, # (11) Exhibit 20, # (12) Exhibit 21, # (13) Exhibit 22, # (14) Exhibit 23, # (15) Exhibit 24, # (16) Exhibit 25, # (17) Exhibit 26, # (18) Exhibit 27, # (19) Exhibit 28, # (20) Exhibit 29, # (21) Exhibit 30, # (22) Exhibit 31, # (23) Exhibit 32, # (24) Exhibit 33, # (25) Exhibit 34, # (26) Exhibit 35, # (27) Exhibit 36, # (28) Exhibit 37)(Flanagan, Elizabeth)
Dec 20, 2018	68	Brief in Opposition to Motion (Exhibit 17) (5) Docket Text: BRIEF in Opposition to [47] MOTION for Summary Judgment based on Collateral Estoppel filed by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Attachments: # (1) Exhibit 10, # (2) Exhibit 11, # (3) Exhibit 12, # (4) Exhibit 13, # (5) Exhibit 14, # (6) Exhibit 15, # (7) Exhibit 16, # (8) Exhibit 17, # (9) Exhibit 18, # (10) Exhibit 19, # (11) Exhibit 20, # (12) Exhibit 21, # (13) Exhibit 22, # (14) Exhibit 23, # (15) Exhibit 24, # (16) Exhibit 25, # (17) Exhibit 26, # (18) Exhibit 27, # (19) Exhibit 28, # (20) Exhibit 29, # (21) Exhibit 30, # (22) Exhibit 31, # (23) Exhibit 32, # (24) Exhibit 33, # (25) Exhibit 34, # (26) Exhibit 35, # (27) Exhibit 36, # (28) Exhibit 37)(Flanagan, Elizabeth)
Dec 20, 2018	68	Brief in Opposition to Motion (Exhibit 18) (16) Docket Text: BRIEF in Opposition to [47] MOTION for Summary Judgment based on Collateral Estoppel filed by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Attachments: # (1) Exhibit 10, # (2) Exhibit 11, # (3) Exhibit 12, # (4) Exhibit 13, # (5) Exhibit 14, # (6) Exhibit 15, # (7) Exhibit 16, # (8) Exhibit 17, # (9) Exhibit 18, # (10) Exhibit 19, # (11) Exhibit 20, # (12) Exhibit 21, # (13) Exhibit 22, # (14) Exhibit 23, # (15) Exhibit 24, # (16) Exhibit 25, # (17) Exhibit 26, # (18) Exhibit 27, # (19) Exhibit 28, # (20) Exhibit 29, # (21) Exhibit 30, # (22) Exhibit 31, # (23) Exhibit 32, # (24) Exhibit 33, # (25) Exhibit 34, # (26) Exhibit 35, # (27) Exhibit 36, # (28) Exhibit 37)(Flanagan, Elizabeth)
Dec 20, 2018	68	Brief in Opposition to Motion (Exhibit 19) (6) Docket Text: BRIEF in Opposition to [47] MOTION for Summary Judgment based on Collateral Estoppel filed by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Attachments: # (1) Exhibit 10, # (2) Exhibit 11, # (3) Exhibit 12, # (4) Exhibit 13, # (5) Exhibit 14, # (6) Exhibit 15, # (7) Exhibit 16, # (8) Exhibit 17, # (9) Exhibit 18, # (10) Exhibit 19, # (11) Exhibit 20, # (12) Exhibit 21, # (13) Exhibit 22, # (14) Exhibit 23, # (15) Exhibit 24, # (16) Exhibit 25, # (17) Exhibit 26, # (18) Exhibit 27, # (19) Exhibit 28, # (20) Exhibit 29, # (21) Exhibit 30, # (22) Exhibit 31, # (23) Exhibit 32, # (24) Exhibit 33, # (25) Exhibit 34, # (26) Exhibit 35, # (27) Exhibit 36, # (28) Exhibit 37)(Flanagan, Elizabeth)
Dec 20, 2018	68	Brief in Opposition to Motion (Exhibit 20) (3) Docket Text: BRIEF in Opposition to [47] MOTION for Summary Judgment based on Collateral Estoppel filed by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Attachments: # (1) Exhibit 10, # (2) Exhibit 11, # (3) Exhibit 12, # (4) Exhibit 13, # (5) Exhibit 14, # (6) Exhibit 15, # (7) Exhibit 16, # (8) Exhibit 17, # (9) Exhibit 18, # (10) Exhibit 19, # (11) Exhibit 20, # (12) Exhibit 21, # (13) Exhibit 22, # (14) Exhibit 23, # (15) Exhibit 24, # (16) Exhibit 25, # (17) Exhibit 26, # (18) Exhibit 27, # (19) Exhibit 28, # (20) Exhibit 29, # (21) Exhibit 30, # (22) Exhibit 31, # (23) Exhibit 32, # (24) Exhibit 33, # (25) Exhibit 34, # (26) Exhibit 35, # (27) Exhibit 36, # (28) Exhibit 37)(Flanagan, Elizabeth)
Dec 20, 2018	68	Brief in Opposition to Motion (Exhibit 21) (10) Docket Text: BRIEF in Opposition to [47] MOTION for Summary Judgment based on Collateral Estoppel filed by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Attachments: # (1) Exhibit 10, # (2) Exhibit 11, # (3) Exhibit 12, # (4) Exhibit 13, # (5) Exhibit 14, # (6) Exhibit 15, # (7) Exhibit 16, # (8) Exhibit 17, # (9) Exhibit 18, # (10) Exhibit 19, # (11) Exhibit 20, # (12) Exhibit 21, # (13) Exhibit 22, # (14) Exhibit 23, # (15) Exhibit 24, # (16) Exhibit 25, # (17) Exhibit 26, # (18) Exhibit 27, # (19) Exhibit 28, # (20) Exhibit 29, # (21) Exhibit 30, # (22) Exhibit 31, # (23) Exhibit 32, # (24) Exhibit 33, # (25) Exhibit 34, # (26) Exhibit 35, # (27) Exhibit 36, # (28) Exhibit 37)(Flanagan, Elizabeth)
Dec 20, 2018	68	Brief in Opposition to Motion (Exhibit 22) (9) Docket Text: BRIEF in Opposition to [47] MOTION for Summary Judgment based on Collateral Estoppel filed by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Attachments: # (1) Exhibit 10, # (2) Exhibit 11, # (3) Exhibit 12, # (4) Exhibit 13, # (5) Exhibit 14, # (6) Exhibit 15, # (7) Exhibit 16, # (8) Exhibit 17, # (9) Exhibit 18, # (10) Exhibit 19, # (11) Exhibit 20, # (12) Exhibit 21, # (13) Exhibit 22, # (14) Exhibit 23, # (15) Exhibit 24, # (16) Exhibit 25, # (17) Exhibit 26, # (18) Exhibit 27, # (19) Exhibit 28, # (20) Exhibit 29, # (21) Exhibit 30, # (22) Exhibit 31, # (23) Exhibit 32, # (24) Exhibit 33, # (25) Exhibit 34, # (26) Exhibit 35, # (27) Exhibit 36, # (28) Exhibit 37)(Flanagan, Elizabeth)
Dec 20, 2018	68	Brief in Opposition to Motion (Exhibit 23) (3) Docket Text: BRIEF in Opposition to [47] MOTION for Summary Judgment based on Collateral Estoppel filed by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Attachments: # (1) Exhibit 10, # (2) Exhibit 11, # (3) Exhibit 12, # (4) Exhibit 13, # (5) Exhibit 14, # (6) Exhibit 15, # (7) Exhibit 16, # (8) Exhibit 17, # (9) Exhibit 18, # (10) Exhibit 19, # (11) Exhibit 20, # (12) Exhibit 21, # (13) Exhibit 22, # (14) Exhibit 23, # (15) Exhibit 24, # (16) Exhibit 25, # (17) Exhibit 26, # (18) Exhibit 27, # (19) Exhibit 28, # (20) Exhibit 29, # (21) Exhibit 30, # (22) Exhibit 31, # (23) Exhibit 32, # (24) Exhibit 33, # (25) Exhibit 34, # (26) Exhibit 35, # (27) Exhibit 36, # (28) Exhibit 37)(Flanagan, Elizabeth)
Dec 20, 2018	68	Brief in Opposition to Motion (Exhibit 24) (4) Docket Text: BRIEF in Opposition to [47] MOTION for Summary Judgment based on Collateral Estoppel filed by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Attachments: # (1) Exhibit 10, # (2) Exhibit 11, # (3) Exhibit 12, # (4) Exhibit 13, # (5) Exhibit 14, # (6) Exhibit 15, # (7) Exhibit 16, # (8) Exhibit 17, # (9) Exhibit 18, # (10) Exhibit 19, # (11) Exhibit 20, # (12) Exhibit 21, # (13) Exhibit 22, # (14) Exhibit 23, # (15) Exhibit 24, # (16) Exhibit 25, # (17) Exhibit 26, # (18) Exhibit 27, # (19) Exhibit 28, # (20) Exhibit 29, # (21) Exhibit 30, # (22) Exhibit 31, # (23) Exhibit 32, # (24) Exhibit 33, # (25) Exhibit 34, # (26) Exhibit 35, # (27) Exhibit 36, # (28) Exhibit 37)(Flanagan, Elizabeth)
Dec 20, 2018	68	Brief in Opposition to Motion (Exhibit 25) (10) Docket Text: BRIEF in Opposition to [47] MOTION for Summary Judgment based on Collateral Estoppel filed by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Attachments: # (1) Exhibit 10, # (2) Exhibit 11, # (3) Exhibit 12, # (4) Exhibit 13, # (5) Exhibit 14, # (6) Exhibit 15, # (7) Exhibit 16, # (8) Exhibit 17, # (9) Exhibit 18, # (10) Exhibit 19, # (11) Exhibit 20, # (12) Exhibit 21, # (13) Exhibit 22, # (14) Exhibit 23, # (15) Exhibit 24, # (16) Exhibit 25, # (17) Exhibit 26, # (18) Exhibit 27, # (19) Exhibit 28, # (20) Exhibit 29, # (21) Exhibit 30, # (22) Exhibit 31, # (23) Exhibit 32, # (24) Exhibit 33, # (25) Exhibit 34, # (26) Exhibit 35, # (27) Exhibit 36, # (28) Exhibit 37)(Flanagan, Elizabeth)
Dec 20, 2018	68	Brief in Opposition to Motion (Exhibit 26) (22) Docket Text: BRIEF in Opposition to [47] MOTION for Summary Judgment based on Collateral Estoppel filed by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Attachments: # (1) Exhibit 10, # (2) Exhibit 11, # (3) Exhibit 12, # (4) Exhibit 13, # (5) Exhibit 14, # (6) Exhibit 15, # (7) Exhibit 16, # (8) Exhibit 17, # (9) Exhibit 18, # (10) Exhibit 19, # (11) Exhibit 20, # (12) Exhibit 21, # (13) Exhibit 22, # (14) Exhibit 23, # (15) Exhibit 24, # (16) Exhibit 25, # (17) Exhibit 26, # (18) Exhibit 27, # (19) Exhibit 28, # (20) Exhibit 29, # (21) Exhibit 30, # (22) Exhibit 31, # (23) Exhibit 32, # (24) Exhibit 33, # (25) Exhibit 34, # (26) Exhibit 35, # (27) Exhibit 36, # (28) Exhibit 37)(Flanagan, Elizabeth)
Dec 20, 2018	68	Brief in Opposition to Motion (Exhibit 27) (12) Docket Text: BRIEF in Opposition to [47] MOTION for Summary Judgment based on Collateral Estoppel filed by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Attachments: # (1) Exhibit 10, # (2) Exhibit 11, # (3) Exhibit 12, # (4) Exhibit 13, # (5) Exhibit 14, # (6) Exhibit 15, # (7) Exhibit 16, # (8) Exhibit 17, # (9) Exhibit 18, # (10) Exhibit 19, # (11) Exhibit 20, # (12) Exhibit 21, # (13) Exhibit 22, # (14) Exhibit 23, # (15) Exhibit 24, # (16) Exhibit 25, # (17) Exhibit 26, # (18) Exhibit 27, # (19) Exhibit 28, # (20) Exhibit 29, # (21) Exhibit 30, # (22) Exhibit 31, # (23) Exhibit 32, # (24) Exhibit 33, # (25) Exhibit 34, # (26) Exhibit 35, # (27) Exhibit 36, # (28) Exhibit 37)(Flanagan, Elizabeth)
Dec 20, 2018	68	Brief in Opposition to Motion (Exhibit 28) (11) Docket Text: BRIEF in Opposition to [47] MOTION for Summary Judgment based on Collateral Estoppel filed by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Attachments: # (1) Exhibit 10, # (2) Exhibit 11, # (3) Exhibit 12, # (4) Exhibit 13, # (5) Exhibit 14, # (6) Exhibit 15, # (7) Exhibit 16, # (8) Exhibit 17, # (9) Exhibit 18, # (10) Exhibit 19, # (11) Exhibit 20, # (12) Exhibit 21, # (13) Exhibit 22, # (14) Exhibit 23, # (15) Exhibit 24, # (16) Exhibit 25, # (17) Exhibit 26, # (18) Exhibit 27, # (19) Exhibit 28, # (20) Exhibit 29, # (21) Exhibit 30, # (22) Exhibit 31, # (23) Exhibit 32, # (24) Exhibit 33, # (25) Exhibit 34, # (26) Exhibit 35, # (27) Exhibit 36, # (28) Exhibit 37)(Flanagan, Elizabeth)
Dec 20, 2018	68	Brief in Opposition to Motion (Exhibit 29) (8) Docket Text: BRIEF in Opposition to [47] MOTION for Summary Judgment based on Collateral Estoppel filed by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Attachments: # (1) Exhibit 10, # (2) Exhibit 11, # (3) Exhibit 12, # (4) Exhibit 13, # (5) Exhibit 14, # (6) Exhibit 15, # (7) Exhibit 16, # (8) Exhibit 17, # (9) Exhibit 18, # (10) Exhibit 19, # (11) Exhibit 20, # (12) Exhibit 21, # (13) Exhibit 22, # (14) Exhibit 23, # (15) Exhibit 24, # (16) Exhibit 25, # (17) Exhibit 26, # (18) Exhibit 27, # (19) Exhibit 28, # (20) Exhibit 29, # (21) Exhibit 30, # (22) Exhibit 31, # (23) Exhibit 32, # (24) Exhibit 33, # (25) Exhibit 34, # (26) Exhibit 35, # (27) Exhibit 36, # (28) Exhibit 37)(Flanagan, Elizabeth)
Dec 20, 2018	68	Brief in Opposition to Motion (Exhibit 30) (5) Docket Text: BRIEF in Opposition to [47] MOTION for Summary Judgment based on Collateral Estoppel filed by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Attachments: # (1) Exhibit 10, # (2) Exhibit 11, # (3) Exhibit 12, # (4) Exhibit 13, # (5) Exhibit 14, # (6) Exhibit 15, # (7) Exhibit 16, # (8) Exhibit 17, # (9) Exhibit 18, # (10) Exhibit 19, # (11) Exhibit 20, # (12) Exhibit 21, # (13) Exhibit 22, # (14) Exhibit 23, # (15) Exhibit 24, # (16) Exhibit 25, # (17) Exhibit 26, # (18) Exhibit 27, # (19) Exhibit 28, # (20) Exhibit 29, # (21) Exhibit 30, # (22) Exhibit 31, # (23) Exhibit 32, # (24) Exhibit 33, # (25) Exhibit 34, # (26) Exhibit 35, # (27) Exhibit 36, # (28) Exhibit 37)(Flanagan, Elizabeth)
Dec 20, 2018	68	Brief in Opposition to Motion (Exhibit 31) (3) Docket Text: BRIEF in Opposition to [47] MOTION for Summary Judgment based on Collateral Estoppel filed by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Attachments: # (1) Exhibit 10, # (2) Exhibit 11, # (3) Exhibit 12, # (4) Exhibit 13, # (5) Exhibit 14, # (6) Exhibit 15, # (7) Exhibit 16, # (8) Exhibit 17, # (9) Exhibit 18, # (10) Exhibit 19, # (11) Exhibit 20, # (12) Exhibit 21, # (13) Exhibit 22, # (14) Exhibit 23, # (15) Exhibit 24, # (16) Exhibit 25, # (17) Exhibit 26, # (18) Exhibit 27, # (19) Exhibit 28, # (20) Exhibit 29, # (21) Exhibit 30, # (22) Exhibit 31, # (23) Exhibit 32, # (24) Exhibit 33, # (25) Exhibit 34, # (26) Exhibit 35, # (27) Exhibit 36, # (28) Exhibit 37)(Flanagan, Elizabeth)
Dec 20, 2018	68	Brief in Opposition to Motion (Exhibit 32) (3) Docket Text: BRIEF in Opposition to [47] MOTION for Summary Judgment based on Collateral Estoppel filed by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Attachments: # (1) Exhibit 10, # (2) Exhibit 11, # (3) Exhibit 12, # (4) Exhibit 13, # (5) Exhibit 14, # (6) Exhibit 15, # (7) Exhibit 16, # (8) Exhibit 17, # (9) Exhibit 18, # (10) Exhibit 19, # (11) Exhibit 20, # (12) Exhibit 21, # (13) Exhibit 22, # (14) Exhibit 23, # (15) Exhibit 24, # (16) Exhibit 25, # (17) Exhibit 26, # (18) Exhibit 27, # (19) Exhibit 28, # (20) Exhibit 29, # (21) Exhibit 30, # (22) Exhibit 31, # (23) Exhibit 32, # (24) Exhibit 33, # (25) Exhibit 34, # (26) Exhibit 35, # (27) Exhibit 36, # (28) Exhibit 37)(Flanagan, Elizabeth)
Dec 20, 2018	68	Brief in Opposition to Motion (Exhibit 33) (3) Docket Text: BRIEF in Opposition to [47] MOTION for Summary Judgment based on Collateral Estoppel filed by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Attachments: # (1) Exhibit 10, # (2) Exhibit 11, # (3) Exhibit 12, # (4) Exhibit 13, # (5) Exhibit 14, # (6) Exhibit 15, # (7) Exhibit 16, # (8) Exhibit 17, # (9) Exhibit 18, # (10) Exhibit 19, # (11) Exhibit 20, # (12) Exhibit 21, # (13) Exhibit 22, # (14) Exhibit 23, # (15) Exhibit 24, # (16) Exhibit 25, # (17) Exhibit 26, # (18) Exhibit 27, # (19) Exhibit 28, # (20) Exhibit 29, # (21) Exhibit 30, # (22) Exhibit 31, # (23) Exhibit 32, # (24) Exhibit 33, # (25) Exhibit 34, # (26) Exhibit 35, # (27) Exhibit 36, # (28) Exhibit 37)(Flanagan, Elizabeth)
Dec 20, 2018	68	Brief in Opposition to Motion (Exhibit 34) (30) Docket Text: BRIEF in Opposition to [47] MOTION for Summary Judgment based on Collateral Estoppel filed by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Attachments: # (1) Exhibit 10, # (2) Exhibit 11, # (3) Exhibit 12, # (4) Exhibit 13, # (5) Exhibit 14, # (6) Exhibit 15, # (7) Exhibit 16, # (8) Exhibit 17, # (9) Exhibit 18, # (10) Exhibit 19, # (11) Exhibit 20, # (12) Exhibit 21, # (13) Exhibit 22, # (14) Exhibit 23, # (15) Exhibit 24, # (16) Exhibit 25, # (17) Exhibit 26, # (18) Exhibit 27, # (19) Exhibit 28, # (20) Exhibit 29, # (21) Exhibit 30, # (22) Exhibit 31, # (23) Exhibit 32, # (24) Exhibit 33, # (25) Exhibit 34, # (26) Exhibit 35, # (27) Exhibit 36, # (28) Exhibit 37)(Flanagan, Elizabeth)
Dec 20, 2018	68	Brief in Opposition to Motion (Exhibit 35) (30) Docket Text: BRIEF in Opposition to [47] MOTION for Summary Judgment based on Collateral Estoppel filed by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Attachments: # (1) Exhibit 10, # (2) Exhibit 11, # (3) Exhibit 12, # (4) Exhibit 13, # (5) Exhibit 14, # (6) Exhibit 15, # (7) Exhibit 16, # (8) Exhibit 17, # (9) Exhibit 18, # (10) Exhibit 19, # (11) Exhibit 20, # (12) Exhibit 21, # (13) Exhibit 22, # (14) Exhibit 23, # (15) Exhibit 24, # (16) Exhibit 25, # (17) Exhibit 26, # (18) Exhibit 27, # (19) Exhibit 28, # (20) Exhibit 29, # (21) Exhibit 30, # (22) Exhibit 31, # (23) Exhibit 32, # (24) Exhibit 33, # (25) Exhibit 34, # (26) Exhibit 35, # (27) Exhibit 36, # (28) Exhibit 37)(Flanagan, Elizabeth)
Dec 20, 2018	68	Brief in Opposition to Motion (Exhibit 36) (5) Docket Text: BRIEF in Opposition to [47] MOTION for Summary Judgment based on Collateral Estoppel filed by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Attachments: # (1) Exhibit 10, # (2) Exhibit 11, # (3) Exhibit 12, # (4) Exhibit 13, # (5) Exhibit 14, # (6) Exhibit 15, # (7) Exhibit 16, # (8) Exhibit 17, # (9) Exhibit 18, # (10) Exhibit 19, # (11) Exhibit 20, # (12) Exhibit 21, # (13) Exhibit 22, # (14) Exhibit 23, # (15) Exhibit 24, # (16) Exhibit 25, # (17) Exhibit 26, # (18) Exhibit 27, # (19) Exhibit 28, # (20) Exhibit 29, # (21) Exhibit 30, # (22) Exhibit 31, # (23) Exhibit 32, # (24) Exhibit 33, # (25) Exhibit 34, # (26) Exhibit 35, # (27) Exhibit 36, # (28) Exhibit 37)(Flanagan, Elizabeth)
Dec 20, 2018	68	Brief in Opposition to Motion (Exhibit 37) (30) Docket Text: BRIEF in Opposition to [47] MOTION for Summary Judgment based on Collateral Estoppel filed by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Attachments: # (1) Exhibit 10, # (2) Exhibit 11, # (3) Exhibit 12, # (4) Exhibit 13, # (5) Exhibit 14, # (6) Exhibit 15, # (7) Exhibit 16, # (8) Exhibit 17, # (9) Exhibit 18, # (10) Exhibit 19, # (11) Exhibit 20, # (12) Exhibit 21, # (13) Exhibit 22, # (14) Exhibit 23, # (15) Exhibit 24, # (16) Exhibit 25, # (17) Exhibit 26, # (18) Exhibit 27, # (19) Exhibit 28, # (20) Exhibit 29, # (21) Exhibit 30, # (22) Exhibit 31, # (23) Exhibit 32, # (24) Exhibit 33, # (25) Exhibit 34, # (26) Exhibit 35, # (27) Exhibit 36, # (28) Exhibit 37)(Flanagan, Elizabeth)
Dec 13, 2018	N/A	Order on Motion for Extension of Time to File Response/Reply (0) Docket Text: ORDER granting [66] Motion for Extension of Time to File Response/Reply: Reply due Jan. 17, 2019. By Chief Judge Marcia S. Krieger on 12/13/18. Text Only Entry (msklc2, )
Dec 12, 2018	66	Motion for Extension of Time to File Response/Reply (Main Document) (4) Docket Text: Unopposed MOTION for Extension of Time to File Response/Reply as to [47] MOTION for Summary Judgment based on Collateral Estoppel by Defendant Sandoz Inc.. (Attachments: # (1) Proposed Order (PDF Only) Proposed Order)(Filarski, Thomas)
Dec 12, 2018	66	Motion for Extension of Time to File Response/Reply (Proposed Order (PDF Only) Proposed Order) (1) Docket Text: Unopposed MOTION for Extension of Time to File Response/Reply as to [47] MOTION for Summary Judgment based on Collateral Estoppel by Defendant Sandoz Inc.. (Attachments: # (1) Proposed Order (PDF Only) Proposed Order)(Filarski, Thomas)
Nov 20, 2018	N/A	Order on Motion for Extension of Time to File Response/Reply (0) Docket Text: ORDER granting [59] Motion for Extension of Time to File Response/Reply: Plaintiffs shall respond to Defendant's [47] Motion for Summary Judgment by not later than 12/20/2018. by Chief Judge Marcia S. Krieger on 11/20/2018. Text Only Entry (msklc1, )
Nov 20, 2018	63	Reply to Response to Motion (23) Docket Text: REPLY to Response to [41] MOTION to Dismiss Sandoz's Counterclaims filed by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Hochstadt, Eric)
Nov 20, 2018	64	Reply to Response to Motion (12) Docket Text: REPLY to Response to [42] MOTION to Stay MOTION to Bifurcate Antitrust and Patent Misuse Counterclaims filed by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Hochstadt, Eric)
Nov 20, 2018	65	Reply to Response to Motion (5) Docket Text: REPLY to Response to [43] MOTION for Order to Requesting Prioritized Consideration of Plaintiffs' Motions, ECF Nos. 41 and 42 filed by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Hochstadt, Eric)
Nov 19, 2018	61	Response to Motion (5) Docket Text: RESPONSE to [59] MOTION for Extension of Time to File Response/Reply as to [47] MOTION for Summary Judgment based on Collateral Estoppel filed by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Flanagan, Elizabeth)
Nov 16, 2018	59	Motion for Extension of Time to File Response/Reply (Main Document) (8) Docket Text: MOTION for Extension of Time to File Response/Reply as to [47] MOTION for Summary Judgment based on Collateral Estoppel by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Attachments: # (1) Exhibit A)(Flanagan, Elizabeth)
Nov 16, 2018	59	Motion for Extension of Time to File Response/Reply (Exhibit A) (8) Docket Text: MOTION for Extension of Time to File Response/Reply as to [47] MOTION for Summary Judgment based on Collateral Estoppel by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Attachments: # (1) Exhibit A)(Flanagan, Elizabeth)
Nov 16, 2018	60	Response to Motion (5) Docket Text: RESPONSE to [59] MOTION for Extension of Time to File Response/Reply as to [47] MOTION for Summary Judgment based on Collateral Estoppel filed by Defendant Sandoz Inc.. (Filarski, Thomas)
Nov 13, 2018	58	Order on Motion to Transfer Case (7) Docket Text: ORDER denying [23] Motion to Transfer Venue, and [24] Motion for Stay of Proceedings pending determination of its Motion to Transfer Venue, by Chief Judge Marcia S. Krieger on 11/13/18. (dkals, )
Nov 9, 2018	N/A	Notice of Noncompliance with Court Procedures/Rules (0) Docket Text: ADVISORY NOTICE OF NONCOMPLIANCE WITH COURT RULES/PROCEDURES:re:[48] Declaration, filed by attorneyMatthew Michael Zuziak.The s/signature did not match the filers name on the account for which the login and password are registered. DO NOT REFILE THE DOCUMENT. Action to take - future documents must be filed pursuant to D.C.COLO.LCivR 5.1(a) and 4.3(c) of the Electronic Case Filing Procedures (Civil cases).(Text Only Entry) (dkals, )
Nov 9, 2018	N/A	Notice of Noncompliance with Court Procedures/Rules (0) Docket Text: ADVISORY NOTICE OF NONCOMPLIANCE WITH COURT RULES/PROCEDURES:re:[50] Declaration, filed by attorneyRobert F. Kappers.The s/signature did not match the filers name on the account for which the login and password are registered. DO NOT REFILE THE DOCUMENT. Action to take - future documents must be filed pursuant to D.C.COLO.LCivR 5.1(a) and 4.3(c) of the Electronic Case Filing Procedures (Civil cases).(Text Only Entry) (dkals, )
Nov 9, 2018	N/A	Notice of Noncompliance with Court Procedures/Rules (0) Docket Text: ADVISORY NOTICE OF NONCOMPLIANCE WITH COURT RULES/PROCEDURES:re:[53] Declaration, filed by attorneyRobert F. Kappers.Attorney or pro se has used an incorrect signature format in violation of D.C.COLO.LCivR 5.1(a) and 4.3(a) of the Electronic Case Filing Procedures (Civil cases). DO NOT REFILE THE DOCUMENT. (Text Only Entry) (dkals, )
Nov 9, 2018	57	Brief in Opposition to Motion (13) Docket Text: BRIEF in Opposition to [43] MOTION for Order to Requesting Prioritized Consideration of Plaintiffs' Motions, ECF Nos. 41 and 42 (correcting ECF 52, inadvertently linked to ECF 41, 42) filed by Defendant Sandoz Inc.. (Filarski, Thomas)
Nov 8, 2018	47	Motion for Summary Judgment (22) Docket Text: MOTION for Summary Judgment based on Collateral Estoppel by Defendant Sandoz Inc.. (Filarski, Thomas)
Nov 8, 2018	48	Declaration (Main Document) (3) Docket Text: DECLARATION of Matthew M. Zuziak regarding MOTION for Summary Judgment based on Collateral Estoppel[47] by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit 1 - 11-cv-298 (MDNC) Final Judgment, # (2) Exhibit 2 - 13-cv-16 (MDNC) Final Judgment, # (3) Exhibit 3 - 14-cv-1034 (MDNC) Order and Judgment, # (4) Exhibit 4 - 17-cv-823 (MDNC) Pltfs' Memo in Support of Mtn for Summary Judgment based on Collateral Estoppel, # (5) Exhibit 5 - 17-cv-823 (MDNC) Defs' Opposition to Plfts' Mtn for Summary Judgment based on Collateral Estoppel, # (6) Exhibit 6 - 17-cv-823 (MDNC) Pltfs' Reply in Support of Motion for Summary Judgment Based on Collateral Estoppel, # (7) Exhibit 7- International Patent Application No. PCT/US98/02289, # (8) Exhibit 8 - United States Patent No. 5,688,819, # (9) Exhibit 9 - 11-cv-298 (MDNC) Complaint for Patent Infringement, # (10) Proposed Order (PDF Only))(Filarski, Thomas)
Nov 8, 2018	48	Declaration (Exhibit 1 - 11-cv-298 (MDNC) Final Judgment) (3) Docket Text: DECLARATION of Matthew M. Zuziak regarding MOTION for Summary Judgment based on Collateral Estoppel[47] by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit 1 - 11-cv-298 (MDNC) Final Judgment, # (2) Exhibit 2 - 13-cv-16 (MDNC) Final Judgment, # (3) Exhibit 3 - 14-cv-1034 (MDNC) Order and Judgment, # (4) Exhibit 4 - 17-cv-823 (MDNC) Pltfs' Memo in Support of Mtn for Summary Judgment based on Collateral Estoppel, # (5) Exhibit 5 - 17-cv-823 (MDNC) Defs' Opposition to Plfts' Mtn for Summary Judgment based on Collateral Estoppel, # (6) Exhibit 6 - 17-cv-823 (MDNC) Pltfs' Reply in Support of Motion for Summary Judgment Based on Collateral Estoppel, # (7) Exhibit 7- International Patent Application No. PCT/US98/02289, # (8) Exhibit 8 - United States Patent No. 5,688,819, # (9) Exhibit 9 - 11-cv-298 (MDNC) Complaint for Patent Infringement, # (10) Proposed Order (PDF Only))(Filarski, Thomas)
Nov 8, 2018	48	Declaration (Exhibit 2 - 13-cv-16 (MDNC) Final Judgment) (4) Docket Text: DECLARATION of Matthew M. Zuziak regarding MOTION for Summary Judgment based on Collateral Estoppel[47] by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit 1 - 11-cv-298 (MDNC) Final Judgment, # (2) Exhibit 2 - 13-cv-16 (MDNC) Final Judgment, # (3) Exhibit 3 - 14-cv-1034 (MDNC) Order and Judgment, # (4) Exhibit 4 - 17-cv-823 (MDNC) Pltfs' Memo in Support of Mtn for Summary Judgment based on Collateral Estoppel, # (5) Exhibit 5 - 17-cv-823 (MDNC) Defs' Opposition to Plfts' Mtn for Summary Judgment based on Collateral Estoppel, # (6) Exhibit 6 - 17-cv-823 (MDNC) Pltfs' Reply in Support of Motion for Summary Judgment Based on Collateral Estoppel, # (7) Exhibit 7- International Patent Application No. PCT/US98/02289, # (8) Exhibit 8 - United States Patent No. 5,688,819, # (9) Exhibit 9 - 11-cv-298 (MDNC) Complaint for Patent Infringement, # (10) Proposed Order (PDF Only))(Filarski, Thomas)
Nov 8, 2018	48	Declaration (Exhibit 3 - 14-cv-1034 (MDNC) Order and Judgment) (3) Docket Text: DECLARATION of Matthew M. Zuziak regarding MOTION for Summary Judgment based on Collateral Estoppel[47] by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit 1 - 11-cv-298 (MDNC) Final Judgment, # (2) Exhibit 2 - 13-cv-16 (MDNC) Final Judgment, # (3) Exhibit 3 - 14-cv-1034 (MDNC) Order and Judgment, # (4) Exhibit 4 - 17-cv-823 (MDNC) Pltfs' Memo in Support of Mtn for Summary Judgment based on Collateral Estoppel, # (5) Exhibit 5 - 17-cv-823 (MDNC) Defs' Opposition to Plfts' Mtn for Summary Judgment based on Collateral Estoppel, # (6) Exhibit 6 - 17-cv-823 (MDNC) Pltfs' Reply in Support of Motion for Summary Judgment Based on Collateral Estoppel, # (7) Exhibit 7- International Patent Application No. PCT/US98/02289, # (8) Exhibit 8 - United States Patent No. 5,688,819, # (9) Exhibit 9 - 11-cv-298 (MDNC) Complaint for Patent Infringement, # (10) Proposed Order (PDF Only))(Filarski, Thomas)
Nov 8, 2018	48	Declaration (Exhibit 4 - 17-cv-823 (MDNC) Pltfs' Memo in Support of Mtn for Summary Judg) (19) Docket Text: DECLARATION of Matthew M. Zuziak regarding MOTION for Summary Judgment based on Collateral Estoppel[47] by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit 1 - 11-cv-298 (MDNC) Final Judgment, # (2) Exhibit 2 - 13-cv-16 (MDNC) Final Judgment, # (3) Exhibit 3 - 14-cv-1034 (MDNC) Order and Judgment, # (4) Exhibit 4 - 17-cv-823 (MDNC) Pltfs' Memo in Support of Mtn for Summary Judgment based on Collateral Estoppel, # (5) Exhibit 5 - 17-cv-823 (MDNC) Defs' Opposition to Plfts' Mtn for Summary Judgment based on Collateral Estoppel, # (6) Exhibit 6 - 17-cv-823 (MDNC) Pltfs' Reply in Support of Motion for Summary Judgment Based on Collateral Estoppel, # (7) Exhibit 7- International Patent Application No. PCT/US98/02289, # (8) Exhibit 8 - United States Patent No. 5,688,819, # (9) Exhibit 9 - 11-cv-298 (MDNC) Complaint for Patent Infringement, # (10) Proposed Order (PDF Only))(Filarski, Thomas)
Nov 8, 2018	48	Declaration (Exhibit 5 - 17-cv-823 (MDNC) Defs' Opposition to Plfts' Mtn for Summar) (30) Docket Text: DECLARATION of Matthew M. Zuziak regarding MOTION for Summary Judgment based on Collateral Estoppel[47] by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit 1 - 11-cv-298 (MDNC) Final Judgment, # (2) Exhibit 2 - 13-cv-16 (MDNC) Final Judgment, # (3) Exhibit 3 - 14-cv-1034 (MDNC) Order and Judgment, # (4) Exhibit 4 - 17-cv-823 (MDNC) Pltfs' Memo in Support of Mtn for Summary Judgment based on Collateral Estoppel, # (5) Exhibit 5 - 17-cv-823 (MDNC) Defs' Opposition to Plfts' Mtn for Summary Judgment based on Collateral Estoppel, # (6) Exhibit 6 - 17-cv-823 (MDNC) Pltfs' Reply in Support of Motion for Summary Judgment Based on Collateral Estoppel, # (7) Exhibit 7- International Patent Application No. PCT/US98/02289, # (8) Exhibit 8 - United States Patent No. 5,688,819, # (9) Exhibit 9 - 11-cv-298 (MDNC) Complaint for Patent Infringement, # (10) Proposed Order (PDF Only))(Filarski, Thomas)
Nov 8, 2018	48	Declaration (Exhibit 6 - 17-cv-823 (MDNC) Pltfs' Reply in Support of Motion for Summary) (17) Docket Text: DECLARATION of Matthew M. Zuziak regarding MOTION for Summary Judgment based on Collateral Estoppel[47] by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit 1 - 11-cv-298 (MDNC) Final Judgment, # (2) Exhibit 2 - 13-cv-16 (MDNC) Final Judgment, # (3) Exhibit 3 - 14-cv-1034 (MDNC) Order and Judgment, # (4) Exhibit 4 - 17-cv-823 (MDNC) Pltfs' Memo in Support of Mtn for Summary Judgment based on Collateral Estoppel, # (5) Exhibit 5 - 17-cv-823 (MDNC) Defs' Opposition to Plfts' Mtn for Summary Judgment based on Collateral Estoppel, # (6) Exhibit 6 - 17-cv-823 (MDNC) Pltfs' Reply in Support of Motion for Summary Judgment Based on Collateral Estoppel, # (7) Exhibit 7- International Patent Application No. PCT/US98/02289, # (8) Exhibit 8 - United States Patent No. 5,688,819, # (9) Exhibit 9 - 11-cv-298 (MDNC) Complaint for Patent Infringement, # (10) Proposed Order (PDF Only))(Filarski, Thomas)
Nov 8, 2018	48	Declaration (Exhibit 7- International Patent Application No. PCT/US98/02289) (30) Docket Text: DECLARATION of Matthew M. Zuziak regarding MOTION for Summary Judgment based on Collateral Estoppel[47] by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit 1 - 11-cv-298 (MDNC) Final Judgment, # (2) Exhibit 2 - 13-cv-16 (MDNC) Final Judgment, # (3) Exhibit 3 - 14-cv-1034 (MDNC) Order and Judgment, # (4) Exhibit 4 - 17-cv-823 (MDNC) Pltfs' Memo in Support of Mtn for Summary Judgment based on Collateral Estoppel, # (5) Exhibit 5 - 17-cv-823 (MDNC) Defs' Opposition to Plfts' Mtn for Summary Judgment based on Collateral Estoppel, # (6) Exhibit 6 - 17-cv-823 (MDNC) Pltfs' Reply in Support of Motion for Summary Judgment Based on Collateral Estoppel, # (7) Exhibit 7- International Patent Application No. PCT/US98/02289, # (8) Exhibit 8 - United States Patent No. 5,688,819, # (9) Exhibit 9 - 11-cv-298 (MDNC) Complaint for Patent Infringement, # (10) Proposed Order (PDF Only))(Filarski, Thomas)
Nov 8, 2018	48	Declaration (Exhibit 8 - United States Patent No. 5,688,819) (13) Docket Text: DECLARATION of Matthew M. Zuziak regarding MOTION for Summary Judgment based on Collateral Estoppel[47] by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit 1 - 11-cv-298 (MDNC) Final Judgment, # (2) Exhibit 2 - 13-cv-16 (MDNC) Final Judgment, # (3) Exhibit 3 - 14-cv-1034 (MDNC) Order and Judgment, # (4) Exhibit 4 - 17-cv-823 (MDNC) Pltfs' Memo in Support of Mtn for Summary Judgment based on Collateral Estoppel, # (5) Exhibit 5 - 17-cv-823 (MDNC) Defs' Opposition to Plfts' Mtn for Summary Judgment based on Collateral Estoppel, # (6) Exhibit 6 - 17-cv-823 (MDNC) Pltfs' Reply in Support of Motion for Summary Judgment Based on Collateral Estoppel, # (7) Exhibit 7- International Patent Application No. PCT/US98/02289, # (8) Exhibit 8 - United States Patent No. 5,688,819, # (9) Exhibit 9 - 11-cv-298 (MDNC) Complaint for Patent Infringement, # (10) Proposed Order (PDF Only))(Filarski, Thomas)
Nov 8, 2018	48	Declaration (Exhibit 9 - 11-cv-298 (MDNC) Complaint for Patent Infringement) (30) Docket Text: DECLARATION of Matthew M. Zuziak regarding MOTION for Summary Judgment based on Collateral Estoppel[47] by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit 1 - 11-cv-298 (MDNC) Final Judgment, # (2) Exhibit 2 - 13-cv-16 (MDNC) Final Judgment, # (3) Exhibit 3 - 14-cv-1034 (MDNC) Order and Judgment, # (4) Exhibit 4 - 17-cv-823 (MDNC) Pltfs' Memo in Support of Mtn for Summary Judgment based on Collateral Estoppel, # (5) Exhibit 5 - 17-cv-823 (MDNC) Defs' Opposition to Plfts' Mtn for Summary Judgment based on Collateral Estoppel, # (6) Exhibit 6 - 17-cv-823 (MDNC) Pltfs' Reply in Support of Motion for Summary Judgment Based on Collateral Estoppel, # (7) Exhibit 7- International Patent Application No. PCT/US98/02289, # (8) Exhibit 8 - United States Patent No. 5,688,819, # (9) Exhibit 9 - 11-cv-298 (MDNC) Complaint for Patent Infringement, # (10) Proposed Order (PDF Only))(Filarski, Thomas)
Nov 8, 2018	48	Declaration (Proposed Order (PDF Only)) (1) Docket Text: DECLARATION of Matthew M. Zuziak regarding MOTION for Summary Judgment based on Collateral Estoppel[47] by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit 1 - 11-cv-298 (MDNC) Final Judgment, # (2) Exhibit 2 - 13-cv-16 (MDNC) Final Judgment, # (3) Exhibit 3 - 14-cv-1034 (MDNC) Order and Judgment, # (4) Exhibit 4 - 17-cv-823 (MDNC) Pltfs' Memo in Support of Mtn for Summary Judgment based on Collateral Estoppel, # (5) Exhibit 5 - 17-cv-823 (MDNC) Defs' Opposition to Plfts' Mtn for Summary Judgment based on Collateral Estoppel, # (6) Exhibit 6 - 17-cv-823 (MDNC) Pltfs' Reply in Support of Motion for Summary Judgment Based on Collateral Estoppel, # (7) Exhibit 7- International Patent Application No. PCT/US98/02289, # (8) Exhibit 8 - United States Patent No. 5,688,819, # (9) Exhibit 9 - 11-cv-298 (MDNC) Complaint for Patent Infringement, # (10) Proposed Order (PDF Only))(Filarski, Thomas)
Nov 8, 2018	49	Brief in Opposition to Motion (30) Docket Text: BRIEF in Opposition to [41] MOTION to Dismiss Sandoz's Counterclaims filed by Defendant Sandoz Inc.. (Filarski, Thomas)
Nov 8, 2018	50	Declaration (Main Document) (2) Docket Text: DECLARATION of Robert F. Kappers regarding Brief in Opposition to Motion[49] by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6)(Filarski, Thomas)
Nov 8, 2018	50	Declaration (Exhibit 1) (30) Docket Text: DECLARATION of Robert F. Kappers regarding Brief in Opposition to Motion[49] by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6)(Filarski, Thomas)
Nov 8, 2018	50	Declaration (Exhibit 2) (13) Docket Text: DECLARATION of Robert F. Kappers regarding Brief in Opposition to Motion[49] by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6)(Filarski, Thomas)
Nov 8, 2018	50	Declaration (Exhibit 3) (30) Docket Text: DECLARATION of Robert F. Kappers regarding Brief in Opposition to Motion[49] by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6)(Filarski, Thomas)
Nov 8, 2018	50	Declaration (Exhibit 4) (30) Docket Text: DECLARATION of Robert F. Kappers regarding Brief in Opposition to Motion[49] by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6)(Filarski, Thomas)
Nov 8, 2018	50	Declaration (Exhibit 5) (2) Docket Text: DECLARATION of Robert F. Kappers regarding Brief in Opposition to Motion[49] by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6)(Filarski, Thomas)
Nov 8, 2018	50	Declaration (Exhibit 6) (2) Docket Text: DECLARATION of Robert F. Kappers regarding Brief in Opposition to Motion[49] by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6)(Filarski, Thomas)
Nov 8, 2018	51	Brief in Opposition to Motion (15) Docket Text: BRIEF in Opposition to [42] MOTION to Stay MOTION to Bifurcate Antitrust and Patent Misuse Counterclaims filed by Defendant Sandoz Inc.. (Filarski, Thomas)
Nov 8, 2018	52	Brief in Opposition to Motion (13) Docket Text: BRIEF in Opposition to [41] MOTION to Dismiss Sandoz's Counterclaims, [42] MOTION to Stay MOTION to Bifurcate Antitrust and Patent Misuse Counterclaims filed by Defendant Sandoz Inc.. (Filarski, Thomas)
Nov 8, 2018	53	Declaration (Main Document) (2) Docket Text: DECLARATION of Robert F. Kappers regarding MOTION for Order to Requesting Prioritized Consideration of Plaintiffs' Motions, ECF Nos. 41 and 42[43] by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2)(Filarski, Thomas)
Nov 8, 2018	53	Declaration (Exhibit 1) (24) Docket Text: DECLARATION of Robert F. Kappers regarding MOTION for Order to Requesting Prioritized Consideration of Plaintiffs' Motions, ECF Nos. 41 and 42[43] by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2)(Filarski, Thomas)
Nov 8, 2018	53	Declaration (Exhibit 2) (30) Docket Text: DECLARATION of Robert F. Kappers regarding MOTION for Order to Requesting Prioritized Consideration of Plaintiffs' Motions, ECF Nos. 41 and 42[43] by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2)(Filarski, Thomas)
Nov 7, 2018	46	Transcript (50) Docket Text: TRANSCRIPT of TRANSCRIPT OF PROCEEDINGS held on 09/20/2018 before Magistrate Judge Mix. Pages: 1-50. Prepared by: AB Court Reporting & Video, Inc.. NOTICE - REDACTION OF TRANSCRIPTS: Within seven calendar days of this filing, each party shall inform the Court, by filing a Notice of Intent to Redact, of the party's intent to redact personal identifiers from the electronic transcript of the court proceeding. If a Notice of Intent to Redact is not filed within the allotted time, this transcript will be made electronically available after 90 days. Please see the Notice of Electronic Availability of Transcripts document at www.cod.uscourts.gov. Transcript may only be viewed at the court public terminal or purchased through the Court Reporter/Transcriber prior to the 90 day deadline for electronic posting on PACER. (AB Court Reporting & Video, Inc., )
Oct 22, 2018	44	Motion for Leave (Main Document) (5) Docket Text: MOTION for Leave to to File Additional Summary Judgment Motion by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit A, # (2) Proposed Order (PDF Only))(Filarski, Thomas)
Oct 22, 2018	44	Motion for Leave (Exhibit A) (12) Docket Text: MOTION for Leave to to File Additional Summary Judgment Motion by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit A, # (2) Proposed Order (PDF Only))(Filarski, Thomas)
Oct 22, 2018	44	Motion for Leave (Proposed Order (PDF Only)) (1) Docket Text: MOTION for Leave to to File Additional Summary Judgment Motion by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit A, # (2) Proposed Order (PDF Only))(Filarski, Thomas)
Oct 22, 2018	N/A	Order on Motion for Leave (0) Docket Text: ORDER denying [44] Motion for Leave: The Court sees no good cause at this time to preemptively permit multiple summary judgment motions. It is not readily apparent that all issues the Defendant intends to raise on summary judgment cannot effectively be raised in a single motion. By Chief Judge Marcia S. Krieger on 10/22/18. Text Only Entry (msklc2, )
Oct 18, 2018	40	Notice of Entry of Appearance (2) Docket Text: NOTICE of Entry of Appearance by Eric Shaun Hochstadt on behalf of Allergan Sales, LLC, Duke University, Allergan, Inc.Attorney Eric Shaun Hochstadt added to party Allergan Sales, LLC(pty:pla), Attorney Eric Shaun Hochstadt added to party Duke University (pty:pla), Attorney Eric Shaun Hochstadt added to party Allergan, Inc.(pty:cd) (Hochstadt, Eric)
Oct 18, 2018	41	Motion to Dismiss (Main Document) (10) Docket Text: WITHDRAWN - MOTION to Dismiss Sandoz's Counterclaims by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Attachments: # (1) Memorandum in Support, # (2) Flanagan Declaration, # (3) Ex A to Flanagan Declaration, # (4) Ex B to Flanagan Declaration, # (5) Ex C to Flanagan Declaration, # (6) Ex D to Flanagan Declaration, # (7) Ex E to Flanagan Declaration, # (8) Ex F to Flanagan Declaration, # (9) Ex G to Flanagan Declaration, # (10) Ex H to Flanagan Declaration)(Flanagan, Elizabeth) Modified on 4/16/2019 to withdraw pursuant to [96] Order (dkals, ).
Oct 18, 2018	41	Motion to Dismiss (Memorandum in Support) (30) Docket Text: WITHDRAWN - MOTION to Dismiss Sandoz's Counterclaims by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Attachments: # (1) Memorandum in Support, # (2) Flanagan Declaration, # (3) Ex A to Flanagan Declaration, # (4) Ex B to Flanagan Declaration, # (5) Ex C to Flanagan Declaration, # (6) Ex D to Flanagan Declaration, # (7) Ex E to Flanagan Declaration, # (8) Ex F to Flanagan Declaration, # (9) Ex G to Flanagan Declaration, # (10) Ex H to Flanagan Declaration)(Flanagan, Elizabeth) Modified on 4/16/2019 to withdraw pursuant to [96] Order (dkals, ).
Oct 18, 2018	41	Motion to Dismiss (Flanagan Declaration) (3) Docket Text: WITHDRAWN - MOTION to Dismiss Sandoz's Counterclaims by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Attachments: # (1) Memorandum in Support, # (2) Flanagan Declaration, # (3) Ex A to Flanagan Declaration, # (4) Ex B to Flanagan Declaration, # (5) Ex C to Flanagan Declaration, # (6) Ex D to Flanagan Declaration, # (7) Ex E to Flanagan Declaration, # (8) Ex F to Flanagan Declaration, # (9) Ex G to Flanagan Declaration, # (10) Ex H to Flanagan Declaration)(Flanagan, Elizabeth) Modified on 4/16/2019 to withdraw pursuant to [96] Order (dkals, ).
Oct 18, 2018	41	Motion to Dismiss (Ex A to Flanagan Declaration) (28) Docket Text: WITHDRAWN - MOTION to Dismiss Sandoz's Counterclaims by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Attachments: # (1) Memorandum in Support, # (2) Flanagan Declaration, # (3) Ex A to Flanagan Declaration, # (4) Ex B to Flanagan Declaration, # (5) Ex C to Flanagan Declaration, # (6) Ex D to Flanagan Declaration, # (7) Ex E to Flanagan Declaration, # (8) Ex F to Flanagan Declaration, # (9) Ex G to Flanagan Declaration, # (10) Ex H to Flanagan Declaration)(Flanagan, Elizabeth) Modified on 4/16/2019 to withdraw pursuant to [96] Order (dkals, ).
Oct 18, 2018	41	Motion to Dismiss (Ex B to Flanagan Declaration) (7) Docket Text: WITHDRAWN - MOTION to Dismiss Sandoz's Counterclaims by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Attachments: # (1) Memorandum in Support, # (2) Flanagan Declaration, # (3) Ex A to Flanagan Declaration, # (4) Ex B to Flanagan Declaration, # (5) Ex C to Flanagan Declaration, # (6) Ex D to Flanagan Declaration, # (7) Ex E to Flanagan Declaration, # (8) Ex F to Flanagan Declaration, # (9) Ex G to Flanagan Declaration, # (10) Ex H to Flanagan Declaration)(Flanagan, Elizabeth) Modified on 4/16/2019 to withdraw pursuant to [96] Order (dkals, ).
Oct 18, 2018	41	Motion to Dismiss (Ex C to Flanagan Declaration) (4) Docket Text: WITHDRAWN - MOTION to Dismiss Sandoz's Counterclaims by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Attachments: # (1) Memorandum in Support, # (2) Flanagan Declaration, # (3) Ex A to Flanagan Declaration, # (4) Ex B to Flanagan Declaration, # (5) Ex C to Flanagan Declaration, # (6) Ex D to Flanagan Declaration, # (7) Ex E to Flanagan Declaration, # (8) Ex F to Flanagan Declaration, # (9) Ex G to Flanagan Declaration, # (10) Ex H to Flanagan Declaration)(Flanagan, Elizabeth) Modified on 4/16/2019 to withdraw pursuant to [96] Order (dkals, ).
Oct 18, 2018	41	Motion to Dismiss (Ex D to Flanagan Declaration) (14) Docket Text: WITHDRAWN - MOTION to Dismiss Sandoz's Counterclaims by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Attachments: # (1) Memorandum in Support, # (2) Flanagan Declaration, # (3) Ex A to Flanagan Declaration, # (4) Ex B to Flanagan Declaration, # (5) Ex C to Flanagan Declaration, # (6) Ex D to Flanagan Declaration, # (7) Ex E to Flanagan Declaration, # (8) Ex F to Flanagan Declaration, # (9) Ex G to Flanagan Declaration, # (10) Ex H to Flanagan Declaration)(Flanagan, Elizabeth) Modified on 4/16/2019 to withdraw pursuant to [96] Order (dkals, ).
Oct 18, 2018	41	Motion to Dismiss (Ex E to Flanagan Declaration) (3) Docket Text: WITHDRAWN - MOTION to Dismiss Sandoz's Counterclaims by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Attachments: # (1) Memorandum in Support, # (2) Flanagan Declaration, # (3) Ex A to Flanagan Declaration, # (4) Ex B to Flanagan Declaration, # (5) Ex C to Flanagan Declaration, # (6) Ex D to Flanagan Declaration, # (7) Ex E to Flanagan Declaration, # (8) Ex F to Flanagan Declaration, # (9) Ex G to Flanagan Declaration, # (10) Ex H to Flanagan Declaration)(Flanagan, Elizabeth) Modified on 4/16/2019 to withdraw pursuant to [96] Order (dkals, ).
Oct 18, 2018	41	Motion to Dismiss (Ex F to Flanagan Declaration) (4) Docket Text: WITHDRAWN - MOTION to Dismiss Sandoz's Counterclaims by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Attachments: # (1) Memorandum in Support, # (2) Flanagan Declaration, # (3) Ex A to Flanagan Declaration, # (4) Ex B to Flanagan Declaration, # (5) Ex C to Flanagan Declaration, # (6) Ex D to Flanagan Declaration, # (7) Ex E to Flanagan Declaration, # (8) Ex F to Flanagan Declaration, # (9) Ex G to Flanagan Declaration, # (10) Ex H to Flanagan Declaration)(Flanagan, Elizabeth) Modified on 4/16/2019 to withdraw pursuant to [96] Order (dkals, ).
Oct 18, 2018	41	Motion to Dismiss (Ex G to Flanagan Declaration) (2) Docket Text: WITHDRAWN - MOTION to Dismiss Sandoz's Counterclaims by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Attachments: # (1) Memorandum in Support, # (2) Flanagan Declaration, # (3) Ex A to Flanagan Declaration, # (4) Ex B to Flanagan Declaration, # (5) Ex C to Flanagan Declaration, # (6) Ex D to Flanagan Declaration, # (7) Ex E to Flanagan Declaration, # (8) Ex F to Flanagan Declaration, # (9) Ex G to Flanagan Declaration, # (10) Ex H to Flanagan Declaration)(Flanagan, Elizabeth) Modified on 4/16/2019 to withdraw pursuant to [96] Order (dkals, ).
Oct 18, 2018	41	Motion to Dismiss (Ex H to Flanagan Declaration) (25) Docket Text: WITHDRAWN - MOTION to Dismiss Sandoz's Counterclaims by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Attachments: # (1) Memorandum in Support, # (2) Flanagan Declaration, # (3) Ex A to Flanagan Declaration, # (4) Ex B to Flanagan Declaration, # (5) Ex C to Flanagan Declaration, # (6) Ex D to Flanagan Declaration, # (7) Ex E to Flanagan Declaration, # (8) Ex F to Flanagan Declaration, # (9) Ex G to Flanagan Declaration, # (10) Ex H to Flanagan Declaration)(Flanagan, Elizabeth) Modified on 4/16/2019 to withdraw pursuant to [96] Order (dkals, ).
Oct 18, 2018	42	Motion to Stay (15) Docket Text: MOTION to Stay , MOTION to Bifurcate Antitrust and Patent Misuse Counterclaims by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Flanagan, Elizabeth)
Oct 18, 2018	43	Motion for Order (7) Docket Text: MOTION for Order to Requesting Prioritized Consideration of Plaintiffs' Motions, ECF Nos. 41 and 42 by Plaintiffs Allergan Sales, LLC, Duke University, Counter Defendant Allergan, Inc.. (Flanagan, Elizabeth)
Oct 4, 2018	38	Transcript (47) Docket Text: TRANSCRIPT of Rule 16(b) Scheduling Conference held on September 20, 2018 before Magistrate Judge Mix. Pages: 1-47. NOTICE - REDACTION OF TRANSCRIPTS: Within seven calendar days of this filing, each party shall inform the Court, by filing a Notice of Intent to Redact, of the party's intent to redact personal identifiers from the electronic transcript of the court proceeding. If a Notice of Intent to Redact is not filed within the allotted time, this transcript will be made electronically available after 90 days. Please see the Notice of Electronic Availability of Transcripts document at www.cod.uscourts.gov. Transcript may only be viewed at the court public terminal or purchased through the Court Reporter/Transcriber prior to the 90 day deadline for electronic posting on PACER. (Patterson Transcription Company, )
Oct 4, 2018	39	Proposed Scheduling Order (5) Docket Text: Proposed Scheduling Order Joint Proposed Amendment to Section 9 of Scheduling Order (Dkt. No. 36) by Plaintiffs Allergan Sales, LLC, Duke University. (Flanagan, Elizabeth)
Sep 25, 2018	37	Order (9) Docket Text: TRIAL PREPARATION ORDER by Chief Judge Marcia S. Krieger on 9/25/18. (dkals, )
Sep 20, 2018	35	Scheduling Conference (Main Document) (2) Docket Text: MINUTE ENTRY for Scheduling Conference held before Magistrate Judge Kristen L. Mix on 9/20/2018. Dispositive Motions due by 7/26/2019. Expert Discovery due 6/28/2019. Final Infringement Contentions due 3/29/2019. Final Invalidity Contentions due 4/19/2019. Invalidity Contentions due 9/21/2018. Infringement Contentions due 9/21/2018. Claim Construction Brief due 5/10/2019. Opinion of Counsel due 2/8/2019. Status Report due by 3/22/2019. FTR: KLM Courtroom A401. (Attachments: # (1) Discovery Procedures and Requirements of Practice) (lgale, )
Sep 20, 2018	35	Scheduling Conference (Discovery Procedures and Requirements of Practice) (4) Docket Text: MINUTE ENTRY for Scheduling Conference held before Magistrate Judge Kristen L. Mix on 9/20/2018. Dispositive Motions due by 7/26/2019. Expert Discovery due 6/28/2019. Final Infringement Contentions due 3/29/2019. Final Invalidity Contentions due 4/19/2019. Invalidity Contentions due 9/21/2018. Infringement Contentions due 9/21/2018. Claim Construction Brief due 5/10/2019. Opinion of Counsel due 2/8/2019. Status Report due by 3/22/2019. FTR: KLM Courtroom A401. (Attachments: # (1) Discovery Procedures and Requirements of Practice) (lgale, )
Sep 20, 2018	36	Scheduling Order (28) Docket Text: SCHEDULING ORDER IN A PATENT CASE by Magistrate Judge Kristen L. Mix on 9/20/18. (lgale, )
Sep 13, 2018	34	Proposed Scheduling Order (27) Docket Text: Proposed Scheduling Order in a Patent Case by Plaintiffs Allergan Sales, LLC, Duke University. (Flanagan, Elizabeth)
Sep 11, 2018	32	Order on Motion for Protective Order (1) Docket Text: MINUTE ORDER by Magistrate Judge Kristen L. Mix on 9/11/18. Joint Motion for Entry of Stipulated Protective Order [30] is GRANTED. (lgale, )
Sep 11, 2018	33	Protective Order (20) Docket Text: STIPULATED PROTECTIVE ORDER GOVERNING CONFIDENTIALITY by Magistrate Judge Kristen L. Mix on 9/11/18. (lgale, )
Sep 10, 2018	30	Motion for Protective Order (Main Document) (4) Docket Text: Joint MOTION for Protective Order by Plaintiffs Allergan Sales, LLC, Duke University. (Attachments: # (1) Stipulated Protective Order)(Flanagan, Elizabeth)
Sep 10, 2018	30	Motion for Protective Order (Stipulated Protective Order) (20) Docket Text: Joint MOTION for Protective Order by Plaintiffs Allergan Sales, LLC, Duke University. (Attachments: # (1) Stipulated Protective Order)(Flanagan, Elizabeth)
Sep 10, 2018	N/A	Memorandum (0) Docket Text: MEMORANDUM regarding [30] Joint MOTION for Protective Order filed by Allergan Sales, LLC, Duke University. Motions referred to Magistrate Judge Kristen L. Mix by Chief Judge Marcia S. Krieger on 9/10/18. Text Only Entry (msklc2, )
Sep 6, 2018	28	Reply to Response to Motion (Main Document) (25) Docket Text: REPLY to Response to [23] MOTION to Transfer Case filed by Defendant Sandoz Inc.. (Attachments: # (1) Affidavit Declaration of Ryann M. Muir in Support of Sandoz Inc.'s Reply, # (2) Exhibit B-1, # (3) Exhibit B-2, # (4) Exhibit B-3, # (5) Exhibit B-4, # (6) Exhibit B-5, # (7) Exhibit B-6, # (8) Exhibit B-7)(Filarski, Thomas)
Sep 6, 2018	28	Reply to Response to Motion (Affidavit Declaration of Ryann M. Muir in Support of Sandoz Inc.'s Reply) (2) Docket Text: REPLY to Response to [23] MOTION to Transfer Case filed by Defendant Sandoz Inc.. (Attachments: # (1) Affidavit Declaration of Ryann M. Muir in Support of Sandoz Inc.'s Reply, # (2) Exhibit B-1, # (3) Exhibit B-2, # (4) Exhibit B-3, # (5) Exhibit B-4, # (6) Exhibit B-5, # (7) Exhibit B-6, # (8) Exhibit B-7)(Filarski, Thomas)
Sep 6, 2018	28	Reply to Response to Motion (Exhibit B-1) (6) Docket Text: REPLY to Response to [23] MOTION to Transfer Case filed by Defendant Sandoz Inc.. (Attachments: # (1) Affidavit Declaration of Ryann M. Muir in Support of Sandoz Inc.'s Reply, # (2) Exhibit B-1, # (3) Exhibit B-2, # (4) Exhibit B-3, # (5) Exhibit B-4, # (6) Exhibit B-5, # (7) Exhibit B-6, # (8) Exhibit B-7)(Filarski, Thomas)
Sep 6, 2018	28	Reply to Response to Motion (Exhibit B-2) (5) Docket Text: REPLY to Response to [23] MOTION to Transfer Case filed by Defendant Sandoz Inc.. (Attachments: # (1) Affidavit Declaration of Ryann M. Muir in Support of Sandoz Inc.'s Reply, # (2) Exhibit B-1, # (3) Exhibit B-2, # (4) Exhibit B-3, # (5) Exhibit B-4, # (6) Exhibit B-5, # (7) Exhibit B-6, # (8) Exhibit B-7)(Filarski, Thomas)
Sep 6, 2018	28	Reply to Response to Motion (Exhibit B-3) (6) Docket Text: REPLY to Response to [23] MOTION to Transfer Case filed by Defendant Sandoz Inc.. (Attachments: # (1) Affidavit Declaration of Ryann M. Muir in Support of Sandoz Inc.'s Reply, # (2) Exhibit B-1, # (3) Exhibit B-2, # (4) Exhibit B-3, # (5) Exhibit B-4, # (6) Exhibit B-5, # (7) Exhibit B-6, # (8) Exhibit B-7)(Filarski, Thomas)
Sep 6, 2018	28	Reply to Response to Motion (Exhibit B-4) (5) Docket Text: REPLY to Response to [23] MOTION to Transfer Case filed by Defendant Sandoz Inc.. (Attachments: # (1) Affidavit Declaration of Ryann M. Muir in Support of Sandoz Inc.'s Reply, # (2) Exhibit B-1, # (3) Exhibit B-2, # (4) Exhibit B-3, # (5) Exhibit B-4, # (6) Exhibit B-5, # (7) Exhibit B-6, # (8) Exhibit B-7)(Filarski, Thomas)
Sep 6, 2018	28	Reply to Response to Motion (Exhibit B-5) (5) Docket Text: REPLY to Response to [23] MOTION to Transfer Case filed by Defendant Sandoz Inc.. (Attachments: # (1) Affidavit Declaration of Ryann M. Muir in Support of Sandoz Inc.'s Reply, # (2) Exhibit B-1, # (3) Exhibit B-2, # (4) Exhibit B-3, # (5) Exhibit B-4, # (6) Exhibit B-5, # (7) Exhibit B-6, # (8) Exhibit B-7)(Filarski, Thomas)
Sep 6, 2018	28	Reply to Response to Motion (Exhibit B-6) (2) Docket Text: REPLY to Response to [23] MOTION to Transfer Case filed by Defendant Sandoz Inc.. (Attachments: # (1) Affidavit Declaration of Ryann M. Muir in Support of Sandoz Inc.'s Reply, # (2) Exhibit B-1, # (3) Exhibit B-2, # (4) Exhibit B-3, # (5) Exhibit B-4, # (6) Exhibit B-5, # (7) Exhibit B-6, # (8) Exhibit B-7)(Filarski, Thomas)
Sep 6, 2018	28	Reply to Response to Motion (Exhibit B-7) (2) Docket Text: REPLY to Response to [23] MOTION to Transfer Case filed by Defendant Sandoz Inc.. (Attachments: # (1) Affidavit Declaration of Ryann M. Muir in Support of Sandoz Inc.'s Reply, # (2) Exhibit B-1, # (3) Exhibit B-2, # (4) Exhibit B-3, # (5) Exhibit B-4, # (6) Exhibit B-5, # (7) Exhibit B-6, # (8) Exhibit B-7)(Filarski, Thomas)
Sep 6, 2018	29	Reply to Response to Motion (12) Docket Text: REPLY to Response to [24] MOTION to Stay re [23] MOTION to Transfer Case filed by Defendant Sandoz Inc.. (Filarski, Thomas)
Aug 23, 2018	25	Brief in Opposition to Motion (30) Docket Text: BRIEF in Opposition to [23] MOTION to Transfer Case filed by Plaintiffs Allergan Sales, LLC, Duke University. (Flanagan, Elizabeth)
Aug 23, 2018	26	Brief in Opposition to Motion (19) Docket Text: BRIEF in Opposition to [24] MOTION to Stay re [23] MOTION to Transfer Case filed by Plaintiffs Allergan Sales, LLC, Duke University. (Flanagan, Elizabeth)
Aug 23, 2018	27	Declaration (Main Document) (5) Docket Text: DECLARATION of Elizabeth M. Flanagan regarding Brief in Opposition to Motion[26], Brief in Opposition to Motion[25] by Plaintiffs Allergan Sales, LLC, Duke University. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10)(Flanagan, Elizabeth)
Aug 23, 2018	27	Declaration (Exhibit 1) (30) Docket Text: DECLARATION of Elizabeth M. Flanagan regarding Brief in Opposition to Motion[26], Brief in Opposition to Motion[25] by Plaintiffs Allergan Sales, LLC, Duke University. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10)(Flanagan, Elizabeth)
Aug 23, 2018	27	Declaration (Exhibit 2) (30) Docket Text: DECLARATION of Elizabeth M. Flanagan regarding Brief in Opposition to Motion[26], Brief in Opposition to Motion[25] by Plaintiffs Allergan Sales, LLC, Duke University. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10)(Flanagan, Elizabeth)
Aug 23, 2018	27	Declaration (Exhibit 3) (30) Docket Text: DECLARATION of Elizabeth M. Flanagan regarding Brief in Opposition to Motion[26], Brief in Opposition to Motion[25] by Plaintiffs Allergan Sales, LLC, Duke University. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10)(Flanagan, Elizabeth)
Aug 23, 2018	27	Declaration (Exhibit 4) (24) Docket Text: DECLARATION of Elizabeth M. Flanagan regarding Brief in Opposition to Motion[26], Brief in Opposition to Motion[25] by Plaintiffs Allergan Sales, LLC, Duke University. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10)(Flanagan, Elizabeth)
Aug 23, 2018	27	Declaration (Exhibit 5) (7) Docket Text: DECLARATION of Elizabeth M. Flanagan regarding Brief in Opposition to Motion[26], Brief in Opposition to Motion[25] by Plaintiffs Allergan Sales, LLC, Duke University. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10)(Flanagan, Elizabeth)
Aug 23, 2018	27	Declaration (Exhibit 6) (6) Docket Text: DECLARATION of Elizabeth M. Flanagan regarding Brief in Opposition to Motion[26], Brief in Opposition to Motion[25] by Plaintiffs Allergan Sales, LLC, Duke University. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10)(Flanagan, Elizabeth)
Aug 23, 2018	27	Declaration (Exhibit 7) (5) Docket Text: DECLARATION of Elizabeth M. Flanagan regarding Brief in Opposition to Motion[26], Brief in Opposition to Motion[25] by Plaintiffs Allergan Sales, LLC, Duke University. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10)(Flanagan, Elizabeth)
Aug 23, 2018	27	Declaration (Exhibit 8) (2) Docket Text: DECLARATION of Elizabeth M. Flanagan regarding Brief in Opposition to Motion[26], Brief in Opposition to Motion[25] by Plaintiffs Allergan Sales, LLC, Duke University. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10)(Flanagan, Elizabeth)
Aug 23, 2018	27	Declaration (Exhibit 9) (3) Docket Text: DECLARATION of Elizabeth M. Flanagan regarding Brief in Opposition to Motion[26], Brief in Opposition to Motion[25] by Plaintiffs Allergan Sales, LLC, Duke University. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10)(Flanagan, Elizabeth)
Aug 23, 2018	27	Declaration (Exhibit 10) (3) Docket Text: DECLARATION of Elizabeth M. Flanagan regarding Brief in Opposition to Motion[26], Brief in Opposition to Motion[25] by Plaintiffs Allergan Sales, LLC, Duke University. (Attachments: # (1) Exhibit 1, # (2) Exhibit 2, # (3) Exhibit 3, # (4) Exhibit 4, # (5) Exhibit 5, # (6) Exhibit 6, # (7) Exhibit 7, # (8) Exhibit 8, # (9) Exhibit 9, # (10) Exhibit 10)(Flanagan, Elizabeth)
Aug 2, 2018	23	Motion to Transfer Case (Main Document) (30) Docket Text: MOTION to Transfer Case by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit Declaration of R. Muir, # (2) Exhibit A-1, # (3) Exhibit A-2, # (4) Exhibit A-3, # (5) Exhibit A-4, # (6) Exhibit A-5, # (7) Exhibit A-6, # (8) Exhibit A-7, # (9) Exhibit A-8, # (10) Exhibit A-9, # (11) Exhibit A-10, # (12) Exhibit A-11, # (13) Exhibit A-12, # (14) Exhibit A-13, # (15) Exhibit A-14, # (16) Exhibit A-15, # (17) Exhibit A-16, # (18) Exhibit A-17, # (19) Exhibit A-18, # (20) Exhibit A-19, # (21) Exhibit A-20, # (22) Exhibit A-21, # (23) Exhibit A-22, # (24) Exhibit A-23, # (25) Proposed Order (PDF Only))(Filarski, Thomas)
Aug 2, 2018	23	Motion to Transfer Case (Exhibit Declaration of R. Muir) (4) Docket Text: MOTION to Transfer Case by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit Declaration of R. Muir, # (2) Exhibit A-1, # (3) Exhibit A-2, # (4) Exhibit A-3, # (5) Exhibit A-4, # (6) Exhibit A-5, # (7) Exhibit A-6, # (8) Exhibit A-7, # (9) Exhibit A-8, # (10) Exhibit A-9, # (11) Exhibit A-10, # (12) Exhibit A-11, # (13) Exhibit A-12, # (14) Exhibit A-13, # (15) Exhibit A-14, # (16) Exhibit A-15, # (17) Exhibit A-16, # (18) Exhibit A-17, # (19) Exhibit A-18, # (20) Exhibit A-19, # (21) Exhibit A-20, # (22) Exhibit A-21, # (23) Exhibit A-22, # (24) Exhibit A-23, # (25) Proposed Order (PDF Only))(Filarski, Thomas)
Aug 2, 2018	23	Motion to Transfer Case (Exhibit A-1) (13) Docket Text: MOTION to Transfer Case by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit Declaration of R. Muir, # (2) Exhibit A-1, # (3) Exhibit A-2, # (4) Exhibit A-3, # (5) Exhibit A-4, # (6) Exhibit A-5, # (7) Exhibit A-6, # (8) Exhibit A-7, # (9) Exhibit A-8, # (10) Exhibit A-9, # (11) Exhibit A-10, # (12) Exhibit A-11, # (13) Exhibit A-12, # (14) Exhibit A-13, # (15) Exhibit A-14, # (16) Exhibit A-15, # (17) Exhibit A-16, # (18) Exhibit A-17, # (19) Exhibit A-18, # (20) Exhibit A-19, # (21) Exhibit A-20, # (22) Exhibit A-21, # (23) Exhibit A-22, # (24) Exhibit A-23, # (25) Proposed Order (PDF Only))(Filarski, Thomas)
Aug 2, 2018	23	Motion to Transfer Case (Exhibit A-2) (8) Docket Text: MOTION to Transfer Case by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit Declaration of R. Muir, # (2) Exhibit A-1, # (3) Exhibit A-2, # (4) Exhibit A-3, # (5) Exhibit A-4, # (6) Exhibit A-5, # (7) Exhibit A-6, # (8) Exhibit A-7, # (9) Exhibit A-8, # (10) Exhibit A-9, # (11) Exhibit A-10, # (12) Exhibit A-11, # (13) Exhibit A-12, # (14) Exhibit A-13, # (15) Exhibit A-14, # (16) Exhibit A-15, # (17) Exhibit A-16, # (18) Exhibit A-17, # (19) Exhibit A-18, # (20) Exhibit A-19, # (21) Exhibit A-20, # (22) Exhibit A-21, # (23) Exhibit A-22, # (24) Exhibit A-23, # (25) Proposed Order (PDF Only))(Filarski, Thomas)
Aug 2, 2018	23	Motion to Transfer Case (Exhibit A-3) (3) Docket Text: MOTION to Transfer Case by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit Declaration of R. Muir, # (2) Exhibit A-1, # (3) Exhibit A-2, # (4) Exhibit A-3, # (5) Exhibit A-4, # (6) Exhibit A-5, # (7) Exhibit A-6, # (8) Exhibit A-7, # (9) Exhibit A-8, # (10) Exhibit A-9, # (11) Exhibit A-10, # (12) Exhibit A-11, # (13) Exhibit A-12, # (14) Exhibit A-13, # (15) Exhibit A-14, # (16) Exhibit A-15, # (17) Exhibit A-16, # (18) Exhibit A-17, # (19) Exhibit A-18, # (20) Exhibit A-19, # (21) Exhibit A-20, # (22) Exhibit A-21, # (23) Exhibit A-22, # (24) Exhibit A-23, # (25) Proposed Order (PDF Only))(Filarski, Thomas)
Aug 2, 2018	23	Motion to Transfer Case (Exhibit A-4) (17) Docket Text: MOTION to Transfer Case by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit Declaration of R. Muir, # (2) Exhibit A-1, # (3) Exhibit A-2, # (4) Exhibit A-3, # (5) Exhibit A-4, # (6) Exhibit A-5, # (7) Exhibit A-6, # (8) Exhibit A-7, # (9) Exhibit A-8, # (10) Exhibit A-9, # (11) Exhibit A-10, # (12) Exhibit A-11, # (13) Exhibit A-12, # (14) Exhibit A-13, # (15) Exhibit A-14, # (16) Exhibit A-15, # (17) Exhibit A-16, # (18) Exhibit A-17, # (19) Exhibit A-18, # (20) Exhibit A-19, # (21) Exhibit A-20, # (22) Exhibit A-21, # (23) Exhibit A-22, # (24) Exhibit A-23, # (25) Proposed Order (PDF Only))(Filarski, Thomas)
Aug 2, 2018	23	Motion to Transfer Case (Exhibit A-5) (16) Docket Text: MOTION to Transfer Case by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit Declaration of R. Muir, # (2) Exhibit A-1, # (3) Exhibit A-2, # (4) Exhibit A-3, # (5) Exhibit A-4, # (6) Exhibit A-5, # (7) Exhibit A-6, # (8) Exhibit A-7, # (9) Exhibit A-8, # (10) Exhibit A-9, # (11) Exhibit A-10, # (12) Exhibit A-11, # (13) Exhibit A-12, # (14) Exhibit A-13, # (15) Exhibit A-14, # (16) Exhibit A-15, # (17) Exhibit A-16, # (18) Exhibit A-17, # (19) Exhibit A-18, # (20) Exhibit A-19, # (21) Exhibit A-20, # (22) Exhibit A-21, # (23) Exhibit A-22, # (24) Exhibit A-23, # (25) Proposed Order (PDF Only))(Filarski, Thomas)
Aug 2, 2018	23	Motion to Transfer Case (Exhibit A-6) (4) Docket Text: MOTION to Transfer Case by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit Declaration of R. Muir, # (2) Exhibit A-1, # (3) Exhibit A-2, # (4) Exhibit A-3, # (5) Exhibit A-4, # (6) Exhibit A-5, # (7) Exhibit A-6, # (8) Exhibit A-7, # (9) Exhibit A-8, # (10) Exhibit A-9, # (11) Exhibit A-10, # (12) Exhibit A-11, # (13) Exhibit A-12, # (14) Exhibit A-13, # (15) Exhibit A-14, # (16) Exhibit A-15, # (17) Exhibit A-16, # (18) Exhibit A-17, # (19) Exhibit A-18, # (20) Exhibit A-19, # (21) Exhibit A-20, # (22) Exhibit A-21, # (23) Exhibit A-22, # (24) Exhibit A-23, # (25) Proposed Order (PDF Only))(Filarski, Thomas)
Aug 2, 2018	23	Motion to Transfer Case (Exhibit A-7) (26) Docket Text: MOTION to Transfer Case by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit Declaration of R. Muir, # (2) Exhibit A-1, # (3) Exhibit A-2, # (4) Exhibit A-3, # (5) Exhibit A-4, # (6) Exhibit A-5, # (7) Exhibit A-6, # (8) Exhibit A-7, # (9) Exhibit A-8, # (10) Exhibit A-9, # (11) Exhibit A-10, # (12) Exhibit A-11, # (13) Exhibit A-12, # (14) Exhibit A-13, # (15) Exhibit A-14, # (16) Exhibit A-15, # (17) Exhibit A-16, # (18) Exhibit A-17, # (19) Exhibit A-18, # (20) Exhibit A-19, # (21) Exhibit A-20, # (22) Exhibit A-21, # (23) Exhibit A-22, # (24) Exhibit A-23, # (25) Proposed Order (PDF Only))(Filarski, Thomas)
Aug 2, 2018	23	Motion to Transfer Case (Exhibit A-8) (6) Docket Text: MOTION to Transfer Case by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit Declaration of R. Muir, # (2) Exhibit A-1, # (3) Exhibit A-2, # (4) Exhibit A-3, # (5) Exhibit A-4, # (6) Exhibit A-5, # (7) Exhibit A-6, # (8) Exhibit A-7, # (9) Exhibit A-8, # (10) Exhibit A-9, # (11) Exhibit A-10, # (12) Exhibit A-11, # (13) Exhibit A-12, # (14) Exhibit A-13, # (15) Exhibit A-14, # (16) Exhibit A-15, # (17) Exhibit A-16, # (18) Exhibit A-17, # (19) Exhibit A-18, # (20) Exhibit A-19, # (21) Exhibit A-20, # (22) Exhibit A-21, # (23) Exhibit A-22, # (24) Exhibit A-23, # (25) Proposed Order (PDF Only))(Filarski, Thomas)
Aug 2, 2018	23	Motion to Transfer Case (Exhibit A-9) (3) Docket Text: MOTION to Transfer Case by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit Declaration of R. Muir, # (2) Exhibit A-1, # (3) Exhibit A-2, # (4) Exhibit A-3, # (5) Exhibit A-4, # (6) Exhibit A-5, # (7) Exhibit A-6, # (8) Exhibit A-7, # (9) Exhibit A-8, # (10) Exhibit A-9, # (11) Exhibit A-10, # (12) Exhibit A-11, # (13) Exhibit A-12, # (14) Exhibit A-13, # (15) Exhibit A-14, # (16) Exhibit A-15, # (17) Exhibit A-16, # (18) Exhibit A-17, # (19) Exhibit A-18, # (20) Exhibit A-19, # (21) Exhibit A-20, # (22) Exhibit A-21, # (23) Exhibit A-22, # (24) Exhibit A-23, # (25) Proposed Order (PDF Only))(Filarski, Thomas)
Aug 2, 2018	23	Motion to Transfer Case (Exhibit A-10) (5) Docket Text: MOTION to Transfer Case by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit Declaration of R. Muir, # (2) Exhibit A-1, # (3) Exhibit A-2, # (4) Exhibit A-3, # (5) Exhibit A-4, # (6) Exhibit A-5, # (7) Exhibit A-6, # (8) Exhibit A-7, # (9) Exhibit A-8, # (10) Exhibit A-9, # (11) Exhibit A-10, # (12) Exhibit A-11, # (13) Exhibit A-12, # (14) Exhibit A-13, # (15) Exhibit A-14, # (16) Exhibit A-15, # (17) Exhibit A-16, # (18) Exhibit A-17, # (19) Exhibit A-18, # (20) Exhibit A-19, # (21) Exhibit A-20, # (22) Exhibit A-21, # (23) Exhibit A-22, # (24) Exhibit A-23, # (25) Proposed Order (PDF Only))(Filarski, Thomas)
Aug 2, 2018	23	Motion to Transfer Case (Exhibit A-11) (24) Docket Text: MOTION to Transfer Case by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit Declaration of R. Muir, # (2) Exhibit A-1, # (3) Exhibit A-2, # (4) Exhibit A-3, # (5) Exhibit A-4, # (6) Exhibit A-5, # (7) Exhibit A-6, # (8) Exhibit A-7, # (9) Exhibit A-8, # (10) Exhibit A-9, # (11) Exhibit A-10, # (12) Exhibit A-11, # (13) Exhibit A-12, # (14) Exhibit A-13, # (15) Exhibit A-14, # (16) Exhibit A-15, # (17) Exhibit A-16, # (18) Exhibit A-17, # (19) Exhibit A-18, # (20) Exhibit A-19, # (21) Exhibit A-20, # (22) Exhibit A-21, # (23) Exhibit A-22, # (24) Exhibit A-23, # (25) Proposed Order (PDF Only))(Filarski, Thomas)
Aug 2, 2018	23	Motion to Transfer Case (Exhibit A-12) (10) Docket Text: MOTION to Transfer Case by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit Declaration of R. Muir, # (2) Exhibit A-1, # (3) Exhibit A-2, # (4) Exhibit A-3, # (5) Exhibit A-4, # (6) Exhibit A-5, # (7) Exhibit A-6, # (8) Exhibit A-7, # (9) Exhibit A-8, # (10) Exhibit A-9, # (11) Exhibit A-10, # (12) Exhibit A-11, # (13) Exhibit A-12, # (14) Exhibit A-13, # (15) Exhibit A-14, # (16) Exhibit A-15, # (17) Exhibit A-16, # (18) Exhibit A-17, # (19) Exhibit A-18, # (20) Exhibit A-19, # (21) Exhibit A-20, # (22) Exhibit A-21, # (23) Exhibit A-22, # (24) Exhibit A-23, # (25) Proposed Order (PDF Only))(Filarski, Thomas)
Aug 2, 2018	23	Motion to Transfer Case (Exhibit A-13) (7) Docket Text: MOTION to Transfer Case by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit Declaration of R. Muir, # (2) Exhibit A-1, # (3) Exhibit A-2, # (4) Exhibit A-3, # (5) Exhibit A-4, # (6) Exhibit A-5, # (7) Exhibit A-6, # (8) Exhibit A-7, # (9) Exhibit A-8, # (10) Exhibit A-9, # (11) Exhibit A-10, # (12) Exhibit A-11, # (13) Exhibit A-12, # (14) Exhibit A-13, # (15) Exhibit A-14, # (16) Exhibit A-15, # (17) Exhibit A-16, # (18) Exhibit A-17, # (19) Exhibit A-18, # (20) Exhibit A-19, # (21) Exhibit A-20, # (22) Exhibit A-21, # (23) Exhibit A-22, # (24) Exhibit A-23, # (25) Proposed Order (PDF Only))(Filarski, Thomas)
Aug 2, 2018	23	Motion to Transfer Case (Exhibit A-14) (19) Docket Text: MOTION to Transfer Case by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit Declaration of R. Muir, # (2) Exhibit A-1, # (3) Exhibit A-2, # (4) Exhibit A-3, # (5) Exhibit A-4, # (6) Exhibit A-5, # (7) Exhibit A-6, # (8) Exhibit A-7, # (9) Exhibit A-8, # (10) Exhibit A-9, # (11) Exhibit A-10, # (12) Exhibit A-11, # (13) Exhibit A-12, # (14) Exhibit A-13, # (15) Exhibit A-14, # (16) Exhibit A-15, # (17) Exhibit A-16, # (18) Exhibit A-17, # (19) Exhibit A-18, # (20) Exhibit A-19, # (21) Exhibit A-20, # (22) Exhibit A-21, # (23) Exhibit A-22, # (24) Exhibit A-23, # (25) Proposed Order (PDF Only))(Filarski, Thomas)
Aug 2, 2018	23	Motion to Transfer Case (Exhibit A-15) (5) Docket Text: MOTION to Transfer Case by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit Declaration of R. Muir, # (2) Exhibit A-1, # (3) Exhibit A-2, # (4) Exhibit A-3, # (5) Exhibit A-4, # (6) Exhibit A-5, # (7) Exhibit A-6, # (8) Exhibit A-7, # (9) Exhibit A-8, # (10) Exhibit A-9, # (11) Exhibit A-10, # (12) Exhibit A-11, # (13) Exhibit A-12, # (14) Exhibit A-13, # (15) Exhibit A-14, # (16) Exhibit A-15, # (17) Exhibit A-16, # (18) Exhibit A-17, # (19) Exhibit A-18, # (20) Exhibit A-19, # (21) Exhibit A-20, # (22) Exhibit A-21, # (23) Exhibit A-22, # (24) Exhibit A-23, # (25) Proposed Order (PDF Only))(Filarski, Thomas)
Aug 2, 2018	23	Motion to Transfer Case (Exhibit A-16) (4) Docket Text: MOTION to Transfer Case by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit Declaration of R. Muir, # (2) Exhibit A-1, # (3) Exhibit A-2, # (4) Exhibit A-3, # (5) Exhibit A-4, # (6) Exhibit A-5, # (7) Exhibit A-6, # (8) Exhibit A-7, # (9) Exhibit A-8, # (10) Exhibit A-9, # (11) Exhibit A-10, # (12) Exhibit A-11, # (13) Exhibit A-12, # (14) Exhibit A-13, # (15) Exhibit A-14, # (16) Exhibit A-15, # (17) Exhibit A-16, # (18) Exhibit A-17, # (19) Exhibit A-18, # (20) Exhibit A-19, # (21) Exhibit A-20, # (22) Exhibit A-21, # (23) Exhibit A-22, # (24) Exhibit A-23, # (25) Proposed Order (PDF Only))(Filarski, Thomas)
Aug 2, 2018	23	Motion to Transfer Case (Exhibit A-17) (3) Docket Text: MOTION to Transfer Case by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit Declaration of R. Muir, # (2) Exhibit A-1, # (3) Exhibit A-2, # (4) Exhibit A-3, # (5) Exhibit A-4, # (6) Exhibit A-5, # (7) Exhibit A-6, # (8) Exhibit A-7, # (9) Exhibit A-8, # (10) Exhibit A-9, # (11) Exhibit A-10, # (12) Exhibit A-11, # (13) Exhibit A-12, # (14) Exhibit A-13, # (15) Exhibit A-14, # (16) Exhibit A-15, # (17) Exhibit A-16, # (18) Exhibit A-17, # (19) Exhibit A-18, # (20) Exhibit A-19, # (21) Exhibit A-20, # (22) Exhibit A-21, # (23) Exhibit A-22, # (24) Exhibit A-23, # (25) Proposed Order (PDF Only))(Filarski, Thomas)
Aug 2, 2018	23	Motion to Transfer Case (Exhibit A-18) (4) Docket Text: MOTION to Transfer Case by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit Declaration of R. Muir, # (2) Exhibit A-1, # (3) Exhibit A-2, # (4) Exhibit A-3, # (5) Exhibit A-4, # (6) Exhibit A-5, # (7) Exhibit A-6, # (8) Exhibit A-7, # (9) Exhibit A-8, # (10) Exhibit A-9, # (11) Exhibit A-10, # (12) Exhibit A-11, # (13) Exhibit A-12, # (14) Exhibit A-13, # (15) Exhibit A-14, # (16) Exhibit A-15, # (17) Exhibit A-16, # (18) Exhibit A-17, # (19) Exhibit A-18, # (20) Exhibit A-19, # (21) Exhibit A-20, # (22) Exhibit A-21, # (23) Exhibit A-22, # (24) Exhibit A-23, # (25) Proposed Order (PDF Only))(Filarski, Thomas)
Aug 2, 2018	23	Motion to Transfer Case (Exhibit A-19) (9) Docket Text: MOTION to Transfer Case by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit Declaration of R. Muir, # (2) Exhibit A-1, # (3) Exhibit A-2, # (4) Exhibit A-3, # (5) Exhibit A-4, # (6) Exhibit A-5, # (7) Exhibit A-6, # (8) Exhibit A-7, # (9) Exhibit A-8, # (10) Exhibit A-9, # (11) Exhibit A-10, # (12) Exhibit A-11, # (13) Exhibit A-12, # (14) Exhibit A-13, # (15) Exhibit A-14, # (16) Exhibit A-15, # (17) Exhibit A-16, # (18) Exhibit A-17, # (19) Exhibit A-18, # (20) Exhibit A-19, # (21) Exhibit A-20, # (22) Exhibit A-21, # (23) Exhibit A-22, # (24) Exhibit A-23, # (25) Proposed Order (PDF Only))(Filarski, Thomas)
Aug 2, 2018	23	Motion to Transfer Case (Exhibit A-20) (30) Docket Text: MOTION to Transfer Case by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit Declaration of R. Muir, # (2) Exhibit A-1, # (3) Exhibit A-2, # (4) Exhibit A-3, # (5) Exhibit A-4, # (6) Exhibit A-5, # (7) Exhibit A-6, # (8) Exhibit A-7, # (9) Exhibit A-8, # (10) Exhibit A-9, # (11) Exhibit A-10, # (12) Exhibit A-11, # (13) Exhibit A-12, # (14) Exhibit A-13, # (15) Exhibit A-14, # (16) Exhibit A-15, # (17) Exhibit A-16, # (18) Exhibit A-17, # (19) Exhibit A-18, # (20) Exhibit A-19, # (21) Exhibit A-20, # (22) Exhibit A-21, # (23) Exhibit A-22, # (24) Exhibit A-23, # (25) Proposed Order (PDF Only))(Filarski, Thomas)
Aug 2, 2018	23	Motion to Transfer Case (Exhibit A-21) (3) Docket Text: MOTION to Transfer Case by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit Declaration of R. Muir, # (2) Exhibit A-1, # (3) Exhibit A-2, # (4) Exhibit A-3, # (5) Exhibit A-4, # (6) Exhibit A-5, # (7) Exhibit A-6, # (8) Exhibit A-7, # (9) Exhibit A-8, # (10) Exhibit A-9, # (11) Exhibit A-10, # (12) Exhibit A-11, # (13) Exhibit A-12, # (14) Exhibit A-13, # (15) Exhibit A-14, # (16) Exhibit A-15, # (17) Exhibit A-16, # (18) Exhibit A-17, # (19) Exhibit A-18, # (20) Exhibit A-19, # (21) Exhibit A-20, # (22) Exhibit A-21, # (23) Exhibit A-22, # (24) Exhibit A-23, # (25) Proposed Order (PDF Only))(Filarski, Thomas)
Aug 2, 2018	23	Motion to Transfer Case (Exhibit A-22) (8) Docket Text: MOTION to Transfer Case by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit Declaration of R. Muir, # (2) Exhibit A-1, # (3) Exhibit A-2, # (4) Exhibit A-3, # (5) Exhibit A-4, # (6) Exhibit A-5, # (7) Exhibit A-6, # (8) Exhibit A-7, # (9) Exhibit A-8, # (10) Exhibit A-9, # (11) Exhibit A-10, # (12) Exhibit A-11, # (13) Exhibit A-12, # (14) Exhibit A-13, # (15) Exhibit A-14, # (16) Exhibit A-15, # (17) Exhibit A-16, # (18) Exhibit A-17, # (19) Exhibit A-18, # (20) Exhibit A-19, # (21) Exhibit A-20, # (22) Exhibit A-21, # (23) Exhibit A-22, # (24) Exhibit A-23, # (25) Proposed Order (PDF Only))(Filarski, Thomas)
Aug 2, 2018	23	Motion to Transfer Case (Exhibit A-23) (3) Docket Text: MOTION to Transfer Case by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit Declaration of R. Muir, # (2) Exhibit A-1, # (3) Exhibit A-2, # (4) Exhibit A-3, # (5) Exhibit A-4, # (6) Exhibit A-5, # (7) Exhibit A-6, # (8) Exhibit A-7, # (9) Exhibit A-8, # (10) Exhibit A-9, # (11) Exhibit A-10, # (12) Exhibit A-11, # (13) Exhibit A-12, # (14) Exhibit A-13, # (15) Exhibit A-14, # (16) Exhibit A-15, # (17) Exhibit A-16, # (18) Exhibit A-17, # (19) Exhibit A-18, # (20) Exhibit A-19, # (21) Exhibit A-20, # (22) Exhibit A-21, # (23) Exhibit A-22, # (24) Exhibit A-23, # (25) Proposed Order (PDF Only))(Filarski, Thomas)
Aug 2, 2018	23	Motion to Transfer Case (Proposed Order (PDF Only)) (1) Docket Text: MOTION to Transfer Case by Defendant Sandoz Inc.. (Attachments: # (1) Exhibit Declaration of R. Muir, # (2) Exhibit A-1, # (3) Exhibit A-2, # (4) Exhibit A-3, # (5) Exhibit A-4, # (6) Exhibit A-5, # (7) Exhibit A-6, # (8) Exhibit A-7, # (9) Exhibit A-8, # (10) Exhibit A-9, # (11) Exhibit A-10, # (12) Exhibit A-11, # (13) Exhibit A-12, # (14) Exhibit A-13, # (15) Exhibit A-14, # (16) Exhibit A-15, # (17) Exhibit A-16, # (18) Exhibit A-17, # (19) Exhibit A-18, # (20) Exhibit A-19, # (21) Exhibit A-20, # (22) Exhibit A-21, # (23) Exhibit A-22, # (24) Exhibit A-23, # (25) Proposed Order (PDF Only))(Filarski, Thomas)
Aug 2, 2018	24	Motion to Stay (Main Document) (16) Docket Text: MOTION to Stay re [23] MOTION to Transfer Case by Defendant Sandoz Inc.. (Attachments: # (1) Affidavit Declaration of Ryann M. Muir in Support of Sandoz Inc.'s Motion to Stay, # (2) Exhibit A-1, # (3) Exhibit A-2, # (4) Exhibit A-3, # (5) Proposed Order (PDF Only) Proposed Order)(Filarski, Thomas)
Aug 2, 2018	24	Motion to Stay (Affidavit Declaration of Ryann M. Muir in Support of Sandoz Inc.'s Motion t) (2) Docket Text: MOTION to Stay re [23] MOTION to Transfer Case by Defendant Sandoz Inc.. (Attachments: # (1) Affidavit Declaration of Ryann M. Muir in Support of Sandoz Inc.'s Motion to Stay, # (2) Exhibit A-1, # (3) Exhibit A-2, # (4) Exhibit A-3, # (5) Proposed Order (PDF Only) Proposed Order)(Filarski, Thomas)
Aug 2, 2018	24	Motion to Stay (Exhibit A-1) (19) Docket Text: MOTION to Stay re [23] MOTION to Transfer Case by Defendant Sandoz Inc.. (Attachments: # (1) Affidavit Declaration of Ryann M. Muir in Support of Sandoz Inc.'s Motion to Stay, # (2) Exhibit A-1, # (3) Exhibit A-2, # (4) Exhibit A-3, # (5) Proposed Order (PDF Only) Proposed Order)(Filarski, Thomas)
Aug 2, 2018	24	Motion to Stay (Exhibit A-2) (17) Docket Text: MOTION to Stay re [23] MOTION to Transfer Case by Defendant Sandoz Inc.. (Attachments: # (1) Affidavit Declaration of Ryann M. Muir in Support of Sandoz Inc.'s Motion to Stay, # (2) Exhibit A-1, # (3) Exhibit A-2, # (4) Exhibit A-3, # (5) Proposed Order (PDF Only) Proposed Order)(Filarski, Thomas)
Aug 2, 2018	24	Motion to Stay (Exhibit A-3) (30) Docket Text: MOTION to Stay re [23] MOTION to Transfer Case by Defendant Sandoz Inc.. (Attachments: # (1) Affidavit Declaration of Ryann M. Muir in Support of Sandoz Inc.'s Motion to Stay, # (2) Exhibit A-1, # (3) Exhibit A-2, # (4) Exhibit A-3, # (5) Proposed Order (PDF Only) Proposed Order)(Filarski, Thomas)
Aug 2, 2018	24	Motion to Stay (Proposed Order (PDF Only) Proposed Order) (1) Docket Text: MOTION to Stay re [23] MOTION to Transfer Case by Defendant Sandoz Inc.. (Attachments: # (1) Affidavit Declaration of Ryann M. Muir in Support of Sandoz Inc.'s Motion to Stay, # (2) Exhibit A-1, # (3) Exhibit A-2, # (4) Exhibit A-3, # (5) Proposed Order (PDF Only) Proposed Order)(Filarski, Thomas)
May 31, 2018	21	Notice of Entry of Appearance (2) Docket Text: NOTICE of Entry of Appearance of Daniel S. Young by Daniel Shaw Young on behalf of Sandoz Inc.Attorney Daniel Shaw Young added to party Sandoz Inc.(pty:dft) (Young, Daniel)
May 31, 2018	22	Notice of Entry of Appearance (2) Docket Text: NOTICE of Entry of Appearance of Kathryn L. Bohmann by Kathryn Lenhart Bohmann on behalf of Sandoz Inc.Attorney Kathryn Lenhart Bohmann added to party Sandoz Inc.(pty:dft) (Bohmann, Kathryn)
May 24, 2018	16	Notice of Entry of Appearance (2) Docket Text: NOTICE of Entry of Appearance by Thomas J. Filarski on behalf of Sandoz Inc.Attorney Thomas J. Filarski added to party Sandoz Inc.(pty:dft) (Filarski, Thomas)
May 24, 2018	17	Notice of Entry of Appearance (2) Docket Text: NOTICE of Entry of Appearance by Vishal Gupta on behalf of Sandoz Inc.Attorney Vishal Gupta added to party Sandoz Inc.(pty:dft) (Gupta, Vishal)
May 24, 2018	18	Notice of Entry of Appearance (2) Docket Text: NOTICE of Entry of Appearance by Robert F. Kappers on behalf of Sandoz Inc.Attorney Robert F. Kappers added to party Sandoz Inc.(pty:dft) (Kappers, Robert)
May 24, 2018	19	Notice of Entry of Appearance (2) Docket Text: NOTICE of Entry of Appearance by Ryann Morgan Muir on behalf of Sandoz Inc.Attorney Ryann Morgan Muir added to party Sandoz Inc.(pty:dft) (Muir, Ryann)
May 24, 2018	20	Notice of Entry of Appearance (2) Docket Text: NOTICE of Entry of Appearance by Matthew Michael Zuziak on behalf of Sandoz Inc.Attorney Matthew Michael Zuziak added to party Sandoz Inc.(pty:dft) (Zuziak, Matthew)
May 21, 2018	15	Order (Main Document) (3) Docket Text: ORDER SETTING SCHEDULING/PLANNING CONFERENCE by Magistrate Judge Kristen L. Mix on 5/21/18. Scheduling Conference set for 9/20/2018 10:30 AM in Courtroom A401 before Magistrate Judge Kristen L. Mix. (Attachments: # (1) Attachment 1, # (2) Attachment 2, # (3) Attachment 3) (lgale, )
May 21, 2018	15	Order (Attachment 1) (2) Docket Text: ORDER SETTING SCHEDULING/PLANNING CONFERENCE by Magistrate Judge Kristen L. Mix on 5/21/18. Scheduling Conference set for 9/20/2018 10:30 AM in Courtroom A401 before Magistrate Judge Kristen L. Mix. (Attachments: # (1) Attachment 1, # (2) Attachment 2, # (3) Attachment 3) (lgale, )
May 21, 2018	15	Order (Attachment 2) (8) Docket Text: ORDER SETTING SCHEDULING/PLANNING CONFERENCE by Magistrate Judge Kristen L. Mix on 5/21/18. Scheduling Conference set for 9/20/2018 10:30 AM in Courtroom A401 before Magistrate Judge Kristen L. Mix. (Attachments: # (1) Attachment 1, # (2) Attachment 2, # (3) Attachment 3) (lgale, )
May 21, 2018	15	Order (Attachment 3) (1) Docket Text: ORDER SETTING SCHEDULING/PLANNING CONFERENCE by Magistrate Judge Kristen L. Mix on 5/21/18. Scheduling Conference set for 9/20/2018 10:30 AM in Courtroom A401 before Magistrate Judge Kristen L. Mix. (Attachments: # (1) Attachment 1, # (2) Attachment 2, # (3) Attachment 3) (lgale, )
May 3, 2018	14	Notice of Entry of Appearance (2) Docket Text: NOTICE of Entry of Appearance by Michael Patrick Dulin on behalf of Allergan Sales, LLC, Duke University Attorney Michael Patrick Dulin added to party Allergan Sales, LLC(pty:pla), Attorney Michael Patrick Dulin added to party Duke University (pty:pla) (Dulin, Michael)
Apr 27, 2018	11	Notice of Entry of Appearance (2) Docket Text: NOTICE of Entry of Appearance by Jonathan Elliot Singer on behalf of Allergan Sales, LLC, Duke University Attorney Jonathan Elliot Singer added to party Allergan Sales, LLC(pty:pla), Attorney Jonathan Elliot Singer added to party Duke University (pty:pla) (Singer, Jonathan)
Apr 27, 2018	12	Notice of Entry of Appearance (2) Docket Text: NOTICE of Entry of Appearance by Elizabeth Marjorie Flanagan on behalf of Allergan Sales, LLC, Duke University Attorney Elizabeth Marjorie Flanagan added to party Allergan Sales, LLC(pty:pla), Attorney Elizabeth Marjorie Flanagan added to party Duke University (pty:pla) (Flanagan, Elizabeth)
Apr 27, 2018	13	Notice of Entry of Appearance (2) Docket Text: NOTICE of Entry of Appearance by John Michael Farrell on behalf of Allergan Sales, LLC, Duke University Attorney John Michael Farrell added to party Allergan Sales, LLC(pty:pla), Attorney John Michael Farrell added to party Duke University (pty:pla) (Farrell, John)
Apr 26, 2018	5	Case Transferred In - District Transfer (Main Document Public Docket Sheet) (3) Docket Text: Case transferred in from District of Texas Eastern; Case Number 2:18-cv-00129. File, transfer order and docket sheet received
Apr 26, 2018	N/A	Notice to Attorney(s) in Removed, Transferred or Other Cases (0) Docket Text: FIRST AND FINAL NOTICE TO ALL ATTORNEY(S) AND UNREPRESENTED PARTIES IN REMOVED, TRANSFERRED, OR OTHER CASES. To receive any further notice in a case removed or transferred to this court, or special matters including discovery disputes, bankruptcy appeals, or withdrawls of reference, Multi-district litigation (MDL), etc., all attorneys and unrepresented parties must enter an appearance under D.C.COLO.LAttyR 5(a). An attorney must be an active member of this court's bar and be in good standing in accordance with D.C.COLO.LAttyR 3. A waiver of the fee for bar admission may apply in limited situations. (rvill, )
Apr 26, 2018	7	Report on the Filing or Determination of Patent or Trademark (1) Docket Text: Report re Patent/Trademark: Report on the filing of an action emailed (NEF) to the Director of the U.S. Patent and Trademark Office. (rvill, )
Apr 26, 2018	N/A	Case Assigned to Judge (0) Docket Text: Case assigned to Chief Judge Marcia S. Krieger and drawn to Magistrate Judge Kristen L. Mix. Text Only Entry. (rvill, )
Apr 26, 2018	9	Magistrate Judge (4) Docket Text: Magistrate Judge consent form issued pursuant to 28 U.S.C. 636(c). (rvill, )
Apr 26, 2018	N/A	Order Referring Case to Magistrate Judge (0) Docket Text: ORDER REFERRING CASE to Magistrate Judge Kristen L. Mix IT IS ORDERED that pursuant to 28 U.S.C. 636(b)(1)(A) and (B) and FED. R. CIV. P. 72(a) and (b), this matter is referred to the assigned United States Magistrate Judge to:(1) Convene a scheduling conference under FED. R. CIV. P. 16(b), enter a Scheduling Order meeting the requirements of D.C.COLO.LCivR 16.2, enter such orders as appropriate to enforce the Scheduling Order, and resolve discovery matters;(2) ADR: Court sponsored alternative dispute resolution is governed by D.C.COLO.LCivR 16.6. Early Neutral Evaluation is approved. On the informal request of the magistrate judge or on the request of the parties by motion, the Court may direct the parties to engage in a settlement conference conducted by the magistrate judge if the parties have engaged in an Early Neutral Evaluation and are unable to afford or otherwise attain private settlement assistance;(3) Hear and determine referred matters in accordance with 28 U.S.C. 636(b)(1)(A) and (B). by Chief Judge Marcia S. Krieger on 04/26/2018. Text Only Entry (msklc4, )
Apr 25, 2018	N/A	Case Transferred In - District Transfer (0) Docket Text: *FILED IN ERROR PER CLERK*Interdistrict transfer to the Northern District of Texas Dallas Division. (ch, ) Modified on 4/25/2018 (ch, ). [Transferred from Texas Eastern on 4/26/2018.]
Apr 25, 2018	N/A	Case Transferred In - District Transfer (0) Docket Text: Interdistrict transfer to the District of Colorado. (ch, ) [Transferred from Texas Eastern on 4/26/2018.]
Apr 12, 2018	4	Order (1) Docket Text: ORDER - Attorney Andrea Leigh Fair terminated.. Signed by District Judge Rodney Gilstrap on 4/11/2018. (nkl, ) [Transferred from Texas Eastern on 4/26/2018.]
Apr 9, 2018	3	Motion to Withdraw as Attorney (Main Document) (3) Docket Text: Unopposed MOTION to Withdraw as Attorney by Allergan Sales, LLC, Duke University. (Attachments: # (1) Text of Proposed Order)(Fair, Andrea) [Transferred from Texas Eastern on 4/26/2018.]
Apr 9, 2018	3	Motion to Withdraw as Attorney (Text of Proposed Order) (1) Docket Text: Unopposed MOTION to Withdraw as Attorney by Allergan Sales, LLC, Duke University. (Attachments: # (1) Text of Proposed Order)(Fair, Andrea) [Transferred from Texas Eastern on 4/26/2018.]
Apr 3, 2018	1	Order (6) Docket Text: ORDER - ORDERED that Plaintiffs claims against Sandoz are SEVERED and TRANSFERRED to the District of Colorado, and Plaintiffs claims against Alcon are SEVERED and TRANSFERRED to the District of Delaware. (SEVERED FROM CASE 2:17-CV-528). Signed by District Judge Rodney Gilstrap on 4/3/2018. (ch, ) [Transferred from Texas Eastern on 4/26/2018.]
Apr 3, 2018	2	Complaint (Main Document) (19) Docket Text: COMPLAINT against Sandoz Inc., filed by Duke University, Allergan Sales, LLC. (Attachments: # (1) Civil Cover Sheet, # (2) Exhibit A, # (3) Exhibit B)(ch, ) [Transferred from Texas Eastern on 4/26/2018.]
Apr 3, 2018	2	Complaint (Civil Cover Sheet) (1) Docket Text: COMPLAINT against Sandoz Inc., filed by Duke University, Allergan Sales, LLC. (Attachments: # (1) Civil Cover Sheet, # (2) Exhibit A, # (3) Exhibit B)(ch, ) [Transferred from Texas Eastern on 4/26/2018.]
Apr 3, 2018	2	Complaint (Exhibit A) (15) Docket Text: COMPLAINT against Sandoz Inc., filed by Duke University, Allergan Sales, LLC. (Attachments: # (1) Civil Cover Sheet, # (2) Exhibit A, # (3) Exhibit B)(ch, ) [Transferred from Texas Eastern on 4/26/2018.]
Apr 3, 2018	2	Complaint (Exhibit B) (30) Docket Text: COMPLAINT against Sandoz Inc., filed by Duke University, Allergan Sales, LLC. (Attachments: # (1) Civil Cover Sheet, # (2) Exhibit A, # (3) Exhibit B)(ch, ) [Transferred from Texas Eastern on 4/26/2018.]

Lawsuits

Duke University et al v. Sandoz Inc. > Documents